{
 "cells": [
  {
   "cell_type": "markdown",
   "source": [
    "# Using APIs via Python\n",
    "\n",
    "[![Open In Colab](https://colab.research.google.com/assets/colab-badge.svg)](https://colab.research.google.com/github/googlecolab/colabtools/blob/master/notebooks/colab-github-demo.ipynb) \n",
    "\n",
    "From now on, we'll use these interactive Jupyter notebooks so you can get a hands-on experience with the APIs. This Jupyter notebooks are interactive files that intermix code and content. You can click the button above to open this notebook in Google Colab, which is a free Jupyter notebook environment that runs in the cloud. You can also download these files if you have Jupyter installed in your computer and run them locally.\n",
    "\n",
    "These notebooks are the equivalent to R notebooks in the Python world. For a quick overview of Python basics, some good resources include:\n",
    "\n",
    "- [https://www.learnpython.org/](https://www.learnpython.org/)\n",
    "- [https://www.w3schools.com/python/](https://www.w3schools.com/python/)\n",
    "- [https://learnxinyminutes.com/docs/python/](https://learnxinyminutes.com/docs/python/)\n",
    "\n",
    "If you are not just viewing this notebook, e.g., if you opened it in colab using the button above, notebooks cells can be run by putting your mouse cursor inside one of the cells and pressing `Shift + Enter`. You can also run cells by clicking the `Run` button if there is a toolbar above.\n",
    "\n",
    "Start by running the cell below that sets up the environment for the rest of the notebook."
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "12d0efbb644a132b"
  },
  {
   "cell_type": "code",
   "outputs": [],
   "source": [
    "!pip install --upgrade pip -q\n",
    "!pip install requests pandas -q\n",
    "import requests\n",
    "import pandas as pd"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-05T12:15:08.998137Z",
     "start_time": "2024-04-05T12:15:06.972202Z"
    }
   },
   "id": "b30a4ef83e8630d3",
   "execution_count": 80
  },
  {
   "cell_type": "markdown",
   "source": [
    "## Initial Exploration of the PubMed API\n",
    "\n",
    "We'll now make the same request as before, but using the `requests` library with Python."
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "6316b910d043b0fa"
  },
  {
   "cell_type": "code",
   "outputs": [
    {
     "data": {
      "text/plain": "{'header': {'type': 'esearch', 'version': '0.3'},\n 'esearchresult': {'count': '11797794',\n  'retmax': '20',\n  'retstart': '0',\n  'idlist': ['38577845',\n   '38577820',\n   '38577811',\n   '38577809',\n   '38577804',\n   '38577794',\n   '38577791',\n   '38577788',\n   '38577784',\n   '38577783',\n   '38577761',\n   '38577756',\n   '38577746',\n   '38577740',\n   '38577738',\n   '38577726',\n   '38577722',\n   '38577717',\n   '38577713',\n   '38577711'],\n  'translationset': [{'from': 'diagnostic',\n    'to': '\"diagnosis\"[MeSH Terms] OR \"diagnosis\"[All Fields] OR \"diagnostic\"[All Fields] OR \"diagnostical\"[All Fields] OR \"diagnostically\"[All Fields] OR \"diagnostics\"[All Fields]'}],\n  'querytranslation': '\"diagnosis\"[MeSH Terms] OR \"diagnosis\"[All Fields] OR \"diagnostic\"[All Fields] OR \"diagnostical\"[All Fields] OR \"diagnostically\"[All Fields] OR \"diagnostics\"[All Fields]'}}"
     },
     "execution_count": 81,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response = requests.get(  # GET request\n",
    "    url=\"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi\",  # URL of the API\n",
    "    params={  # Parameters of the request\n",
    "        \"db\": \"pubmed\",\n",
    "        \"term\": \"diagnostic\",\n",
    "        \"format\": \"json\"\n",
    "    }\n",
    ").json()  # Parse the response as JSON\n",
    "response"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-05T12:15:10.023197Z",
     "start_time": "2024-04-05T12:15:08.999637Z"
    }
   },
   "id": "dd78d666da656fed",
   "execution_count": 81
  },
  {
   "cell_type": "markdown",
   "source": [
    "The only difference now is that we can directly manipulate the data that we got from the API. For example, we can extract from these results the number of articles that match our search term."
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "83493b1390ac6ce2"
  },
  {
   "cell_type": "code",
   "outputs": [
    {
     "data": {
      "text/plain": "'11797794'"
     },
     "execution_count": 82,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response[\"esearchresult\"][\"count\"]"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-05T12:15:10.030450Z",
     "start_time": "2024-04-05T12:15:10.025548Z"
    }
   },
   "id": "f01ae457b1e8d124",
   "execution_count": 82
  },
  {
   "cell_type": "markdown",
   "source": [
    "We can also extract the list of PMIDs that match our search term. "
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "634f6a49c703a922"
  },
  {
   "cell_type": "code",
   "outputs": [
    {
     "data": {
      "text/plain": "['38577845',\n '38577820',\n '38577811',\n '38577809',\n '38577804',\n '38577794',\n '38577791',\n '38577788',\n '38577784',\n '38577783',\n '38577761',\n '38577756',\n '38577746',\n '38577740',\n '38577738',\n '38577726',\n '38577722',\n '38577717',\n '38577713',\n '38577711']"
     },
     "execution_count": 83,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response[\"esearchresult\"][\"idlist\"]"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-05T12:15:10.035170Z",
     "start_time": "2024-04-05T12:15:10.032048Z"
    }
   },
   "id": "b3541fcbdbd0c8d6",
   "execution_count": 83
  },
  {
   "cell_type": "markdown",
   "source": [
    "Note that we only get the first 20 PMIDs, as this is the default behavior of the API. We can change this by adding the `retmax` parameter to the request."
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "a644abf28348bac3"
  },
  {
   "cell_type": "code",
   "outputs": [
    {
     "data": {
      "text/plain": "['38577845',\n '38577820',\n '38577811',\n '38577809',\n '38577804',\n '38577794',\n '38577791',\n '38577788',\n '38577784',\n '38577783',\n '38577761',\n '38577756',\n '38577746',\n '38577740',\n '38577738',\n '38577726',\n '38577722',\n '38577717',\n '38577713',\n '38577711',\n '38577700',\n '38577697',\n '38577695',\n '38577694',\n '38577693',\n '38577664',\n '38577653',\n '38577649',\n '38577648',\n '38577646',\n '38577645',\n '38577643',\n '38577638',\n '38577637',\n '38577636',\n '38577616',\n '38577603',\n '38577595',\n '38577594',\n '38577593',\n '38577592',\n '38577590',\n '38577588',\n '38577572',\n '38577570',\n '38577565',\n '38577559',\n '38577558',\n '38577555',\n '38577550',\n '38577549',\n '38577539',\n '38577534',\n '38577533',\n '38577530',\n '38577529',\n '38577528',\n '38577525',\n '38577522',\n '38577516',\n '38577506',\n '38577479',\n '38577475',\n '38577468',\n '38577465',\n '38577464',\n '38577463',\n '38577461',\n '38577457',\n '38577452',\n '38577451',\n '38577449',\n '38577446',\n '38577444',\n '38577440',\n '38577438',\n '38577429',\n '38577403',\n '38577402',\n '38577399',\n '38577398',\n '38577387',\n '38577384',\n '38577369',\n '38577343',\n '38577341',\n '38577339',\n '38577334',\n '38577333',\n '38577331',\n '38577329',\n '38577325',\n '38577323',\n '38577321',\n '38577320',\n '38577318',\n '38577317',\n '38577305',\n '38577280',\n '38577268']"
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response = requests.get(  # GET request\n",
    "    url=\"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi\",  # URL of the API\n",
    "    params={  # Parameters of the request\n",
    "        \"db\": \"pubmed\",\n",
    "        \"term\": \"diagnostic\",\n",
    "        \"format\": \"json\",\n",
    "        \"retmax\": 100,  # <- We've changed the default value of 20 to 100\n",
    "    }\n",
    ").json()  # Parse the response as JSON\n",
    "response[\"esearchresult\"][\"idlist\"]"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-05T12:15:11.355135Z",
     "start_time": "2024-04-05T12:15:10.036117Z"
    }
   },
   "id": "8206669369e2a3e3",
   "execution_count": 84
  },
  {
   "cell_type": "markdown",
   "source": [
    "## Initial Exploration of the ClinicalTrials.gov API\n",
    "\n",
    "We can also use the same code snippet to explore the ClinicalTrials.gov API. Let's start by searching for clinical trials that contain the term \"heart attack\"."
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "8870e81891bc94cd"
  },
  {
   "cell_type": "code",
   "outputs": [
    {
     "data": {
      "text/plain": "{'FullStudiesResponse': {'APIVrs': '1.01.05',\n  'DataVrs': '2024:04:03 23:23:31.327',\n  'Expression': 'heart+attack',\n  'NStudiesAvail': 489715,\n  'NStudiesFound': 2108,\n  'MinRank': 1,\n  'MaxRank': 20,\n  'NStudiesReturned': 20,\n  'FullStudies': [{'Rank': 1,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT00929994',\n       'OrgStudyIdInfo': {'OrgStudyId': 'Brooks - 001'},\n       'Organization': {'OrgFullName': 'Toronto Rehabilitation Institute',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'Effects of Cardiac Rehabilitation for Individuals With Transient Ischemic Attack',\n       'OfficialTitle': 'Effects of Cardiac Rehabilitation for Individuals With Transient Ischemic Attack'},\n      'StatusModule': {'StatusVerifiedDate': 'April 2019',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'March 2010'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'November 2014',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'November 2014',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'June 29, 2009',\n       'StudyFirstSubmitQCDate': 'June 29, 2009',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'June 30, 2009',\n        'StudyFirstPostDateType': 'Estimate'},\n       'ResultsFirstSubmitDate': 'April 15, 2017',\n       'ResultsFirstSubmitQCDate': 'April 20, 2019',\n       'ResultsFirstPostDateStruct': {'ResultsFirstPostDate': 'April 23, 2019',\n        'ResultsFirstPostDateType': 'Actual'},\n       'LastUpdateSubmitDate': 'April 20, 2019',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'April 23, 2019',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Principal Investigator',\n        'ResponsiblePartyInvestigatorFullName': 'Dina Brooks',\n        'ResponsiblePartyInvestigatorTitle': 'Professor',\n        'ResponsiblePartyInvestigatorAffiliation': 'Toronto Rehabilitation Institute'},\n       'LeadSponsor': {'LeadSponsorName': 'Toronto Rehabilitation Institute',\n        'LeadSponsorClass': 'OTHER'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'Heart and Stroke Foundation of Canada',\n          'CollaboratorClass': 'OTHER'}]}},\n      'OversightModule': {'OversightHasDMC': 'No'},\n      'DescriptionModule': {'BriefSummary': 'It is hypothesized that the addition of formal cardiac rehabilitation to standard care will result in long-term improvements in cardiovascular fitness and functional capacity in individuals who have suffered a transient ischemic attack (TIA) or minor stroke.\\n\\nFurthermore, it is proposed that the addition of cardiac rehabilitation will influence depressive symptoms and cognition.',\n       'DetailedDescription': 'A transient ischemic attack (TIA) is defined as an episode of neurological dysfunction caused by focal brain ischemia lasting less than 24 hours. Once an individual has suffered a TIA, preventative measures can be taken to target modifiable risk factors, one of which is physical inactivity. The current proposal focuses on the use of an established model of care (cardiac rehabilitation (CR)) and applies it to those who have suffered a TIA in order to maximize physical activity and minimize risk of future cardiovascular events. This will be a one-group pre/post design study with a 3 month non-intervention period. Participants will undergo measures at baseline and 3 months (non intervention period) then after 6 months of cardiac rehabilitation (cardiovascular fitness, 6 minute walk test, cognition, and depressive symptoms).'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Transient Ischemic Attack']},\n       'KeywordList': {'Keyword': ['cardiac rehab']}},\n      'DesignModule': {'StudyType': 'Observational',\n       'PatientRegistry': 'No',\n       'DesignInfo': {'DesignObservationalModelList': {'DesignObservationalModel': ['Cohort']},\n        'DesignTimePerspectiveList': {'DesignTimePerspective': ['Prospective']}},\n       'EnrollmentInfo': {'EnrollmentCount': '20',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'Exercise',\n          'ArmGroupDescription': 'Following a 3 month non intervention period, participants will participate in Cardiac Rehabilitation, carrying out an exercise program which will last 6 months and combine both resistance and aerobic training.',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Behavioral: Cardiac Rehabilitation']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Behavioral',\n          'InterventionName': 'Cardiac Rehabilitation',\n          'InterventionDescription': 'Individualized cardiac rehabilitation for 6 months, including health education sessions, as well as supervised exercise classes which include aerobic and resistance training.',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Exercise']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Functional Walk Test',\n          'PrimaryOutcomeDescription': '6 minute walk test: the longest distance a person can walk for a duration of 6 minutes',\n          'PrimaryOutcomeTimeFrame': 'Baseline, 3 months, 6 months (Six Minute Walk Distance)'},\n         {'PrimaryOutcomeMeasure': 'Cardiovascular Fitness (VO2peak)',\n          'PrimaryOutcomeDescription': 'To measure cardiovascular fitness, a stress test on either an upright cycle ergometer (Ergoselect 200P, Germany), or a treadmill (same modality pre- and post-training) was performed depending on patient balance and comfort.',\n          'PrimaryOutcomeTimeFrame': 'Baseline (after the 3 month non-intervention period) and after 6 months of participation.'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Center for Epidemiologic Studies Depression Scale (CES-D).',\n          'SecondaryOutcomeDescription': 'Depressive symptoms using the validated Center for Epidemiologic Studies Depression Scale (CES-D). This is a score from a 20 item questionnaire with minimum value of 0 and maximum value of 60 with higher numbers indicated greater depressive symptoms (worse).',\n          'SecondaryOutcomeTimeFrame': 'Baseline and 3 months (non-intervention period), after 6 months of cardiac rehabilitation participation'},\n         {'SecondaryOutcomeMeasure': 'Cognition',\n          'SecondaryOutcomeDescription': 'Montreal Cognitive Assessment. The MoCA score ranges from 0 to 30 points with a higher score indicating better cognitive function.',\n          'SecondaryOutcomeTimeFrame': 'Baseline and 3 months (non-intervention period), after 6 months of cardiac rehabilitation participation'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nDiagnosed with TIA\\nThree months post-TIA\\nAbility to understand the process and instructions for exercise training and provide informed consent\\n\\nExclusion Criteria:\\n\\nResting Blood Pressure greater than 160/100 despite medication\\nOther cardiovascular morbidity which would limit exercise tolerance (heart failure, abnormal BP responses or STsegment depression > 2 mm, symptomatic aortic stenosis, complex arrhythmias)\\nCurrent and extensive exercise participation\\nHypertrophic Cardiomyopathy\\nUnstable Angina\\nOrthostatic BP decrease of > 20 mm Hg with symptoms\\nOther musculoskeletal impairments which would limit the participants ability to walk sufficient durations\\nPain or other co-morbidities (e.g., unclipped aneurysms, uncontrolled seizures etc.) which would preclude participation\\nCognitive or behavioural issues that would limit participation in exercise testing and training',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'MaximumAge': '100 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']},\n       'StudyPopulation': 'TIA',\n       'SamplingMethod': 'Probability Sample'},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Dina Brooks, PhD',\n          'OverallOfficialAffiliation': 'Toronto Rehabilitation Institute',\n          'OverallOfficialRole': 'Principal Investigator'},\n         {'OverallOfficialName': 'William E McIllroy, PhD',\n          'OverallOfficialAffiliation': 'University of Waterloo',\n          'OverallOfficialRole': 'Principal Investigator'},\n         {'OverallOfficialName': 'Paul Oh, MD',\n          'OverallOfficialAffiliation': 'Toronto Rehabilitation Institute',\n          'OverallOfficialRole': 'Principal Investigator'},\n         {'OverallOfficialName': 'Sandra Black, MD',\n          'OverallOfficialAffiliation': \"Sunnybrook and Women's College Health Centre\",\n          'OverallOfficialRole': 'Principal Investigator'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'Toronto Rehabilitation Institute - Rumsey Center',\n          'LocationCity': 'Toronto',\n          'LocationState': 'Ontario',\n          'LocationZip': 'M4G 1R7',\n          'LocationCountry': 'Canada'}]}}},\n     'ResultsSection': {'ParticipantFlowModule': {'FlowGroupList': {'FlowGroup': [{'FlowGroupId': 'FG000',\n          'FlowGroupTitle': 'Exercise',\n          'FlowGroupDescription': 'Participants will participate in Cardiac Rehabilitation, carrying out an exercise program which will last 6 months and combine both resistance and aerobic training. There will be a 3 month non-intervention period preceding the exercise program.\\n\\nCardiac Rehabilitation: Individualized cardiac rehabilitation for 6 months, including health education sessions, as well as supervised exercise classes which include aerobic and resistance training.'}]},\n       'FlowPeriodList': {'FlowPeriod': [{'FlowPeriodTitle': 'Overall Study',\n          'FlowMilestoneList': {'FlowMilestone': [{'FlowMilestoneType': 'STARTED',\n             'FlowAchievementList': {'FlowAchievement': [{'FlowAchievementGroupId': 'FG000',\n                'FlowAchievementNumSubjects': '20'}]}},\n            {'FlowMilestoneType': 'COMPLETED',\n             'FlowAchievementList': {'FlowAchievement': [{'FlowAchievementGroupId': 'FG000',\n                'FlowAchievementNumSubjects': '14'}]}},\n            {'FlowMilestoneType': 'NOT COMPLETED',\n             'FlowAchievementList': {'FlowAchievement': [{'FlowAchievementGroupId': 'FG000',\n                'FlowAchievementNumSubjects': '6'}]}}]},\n          'FlowDropWithdrawList': {'FlowDropWithdraw': [{'FlowDropWithdrawType': 'Withdrawal by Subject',\n             'FlowReasonList': {'FlowReason': [{'FlowReasonGroupId': 'FG000',\n                'FlowReasonNumSubjects': '1'}]}},\n            {'FlowDropWithdrawType': 'medical issue unrelated to intervention',\n             'FlowReasonList': {'FlowReason': [{'FlowReasonGroupId': 'FG000',\n                'FlowReasonNumSubjects': '4'}]}},\n            {'FlowDropWithdrawType': 'employment',\n             'FlowReasonList': {'FlowReason': [{'FlowReasonGroupId': 'FG000',\n                'FlowReasonNumSubjects': '1'}]}}]}}]}},\n      'BaselineCharacteristicsModule': {'BaselineGroupList': {'BaselineGroup': [{'BaselineGroupId': 'BG000',\n          'BaselineGroupTitle': 'Exercise',\n          'BaselineGroupDescription': 'Participants in this group will participate in Cardiac Rehabilitation, carrying out an exercise program which will last 6 months and combine both resistance and aerobic training.\\n\\nCardiac Rehabilitation: Individualized cardiac rehabilitation for 6 months, including health education sessions, as well as supervised exercise classes which include aerobic and resistance training.'}]},\n       'BaselineDenomList': {'BaselineDenom': [{'BaselineDenomUnits': 'Participants',\n          'BaselineDenomCountList': {'BaselineDenomCount': [{'BaselineDenomCountGroupId': 'BG000',\n             'BaselineDenomCountValue': '20'}]}}]},\n       'BaselineMeasureList': {'BaselineMeasure': [{'BaselineMeasureTitle': 'Age, Continuous',\n          'BaselineMeasureParamType': 'Mean',\n          'BaselineMeasureDispersionType': 'Standard Deviation',\n          'BaselineMeasureUnitOfMeasure': 'years',\n          'BaselineClassList': {'BaselineClass': [{'BaselineCategoryList': {'BaselineCategory': [{'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '65',\n                   'BaselineMeasurementSpread': '11.2'}]}}]}}]}},\n         {'BaselineMeasureTitle': 'Sex: Female, Male',\n          'BaselineMeasureParamType': 'Count of Participants',\n          'BaselineMeasureUnitOfMeasure': 'Participants',\n          'BaselineClassList': {'BaselineClass': [{'BaselineCategoryList': {'BaselineCategory': [{'BaselineCategoryTitle': 'Female',\n                'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '13'}]}},\n               {'BaselineCategoryTitle': 'Male',\n                'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '7'}]}}]}}]}},\n         {'BaselineMeasureTitle': 'Region of Enrollment',\n          'BaselineMeasureParamType': 'Number',\n          'BaselineMeasureUnitOfMeasure': 'participants',\n          'BaselineClassList': {'BaselineClass': [{'BaselineClassTitle': 'Canada',\n             'BaselineCategoryList': {'BaselineCategory': [{'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '20'}]}}]}}]}}]}},\n      'OutcomeMeasuresModule': {'OutcomeMeasureList': {'OutcomeMeasure': [{'OutcomeMeasureType': 'Primary',\n          'OutcomeMeasureTitle': 'Functional Walk Test',\n          'OutcomeMeasureDescription': '6 minute walk test: the longest distance a person can walk for a duration of 6 minutes',\n          'OutcomeMeasurePopulationDescription': 'Transient Ischemic Attack participants who completed the 6 month intervention.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'meters',\n          'OutcomeMeasureTimeFrame': 'Baseline, 3 months, 6 months (Six Minute Walk Distance)',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Exercise',\n             'OutcomeGroupDescription': 'Participants in this group will participate in Cardiac Rehabilitation, carrying out an exercise program which will last 6 months and combine both resistance and aerobic training. A 3 month non-intervention period will precede the 6 month cardiac rehabilitation training program.\\n\\nCardiac Rehabilitation: Individualized cardiac rehabilitation for 6 months, including health education sessions, as well as supervised exercise classes which include aerobic and resistance training.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '14'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeClassTitle': 'Baseline',\n             'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '498.4',\n                   'OutcomeMeasurementSpread': '95.2'}]}}]}},\n            {'OutcomeClassTitle': '3 months',\n             'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '503.2',\n                   'OutcomeMeasurementSpread': '111.1'}]}}]}},\n            {'OutcomeClassTitle': '6 months',\n             'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '564.2',\n                   'OutcomeMeasurementSpread': '139.6'}]}}]}}]},\n          'OutcomeAnalysisList': {'OutcomeAnalysis': [{'OutcomeAnalysisGroupIdList': {'OutcomeAnalysisGroupId': ['OG000']},\n             'OutcomeAnalysisGroupDescription': 'With 1 group and 3 test times, a repeated measures analysis of variance of 6MWD, was utilized between the 3 test times 0, 3, and 6 months). A Bonferroni correction for multiple testing was used for post hoc contrasts.',\n             'OutcomeAnalysisNonInferiorityType': 'Other',\n             'OutcomeAnalysisPValue': '=0.06',\n             'OutcomeAnalysisPValueComment': 'A Bonferroni correction for multiple testing was used for post hoc contrasts. Assumption of sphericity was met for all analyses determined by the Mauchley test of sphericity (all >.05).',\n             'OutcomeAnalysisStatisticalMethod': 'ANOVA'},\n            {'OutcomeAnalysisGroupIdList': {'OutcomeAnalysisGroupId': ['OG000']},\n             'OutcomeAnalysisNonInferiorityType': 'Superiority',\n             'OutcomeAnalysisPValue': '0.06',\n             'OutcomeAnalysisStatisticalMethod': 't-test, 2 sided'}]}},\n         {'OutcomeMeasureType': 'Primary',\n          'OutcomeMeasureTitle': 'Cardiovascular Fitness (VO2peak)',\n          'OutcomeMeasureDescription': 'To measure cardiovascular fitness, a stress test on either an upright cycle ergometer (Ergoselect 200P, Germany), or a treadmill (same modality pre- and post-training) was performed depending on patient balance and comfort.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'ml/kg/min',\n          'OutcomeMeasureTimeFrame': 'Baseline (after the 3 month non-intervention period) and after 6 months of participation.',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Exercise',\n             'OutcomeGroupDescription': 'Participants in this group will participate in Cardiac Rehabilitation, carrying out an exercise program which will last 6 months and combine both resistance and aerobic training.\\n\\nCardiac Rehabilitation: Individualized cardiac rehabilitation for 6 months, including health education sessions, as well as supervised exercise classes which include aerobic and resistance training.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '14'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeClassTitle': 'Baseline',\n             'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '16.7',\n                   'OutcomeMeasurementSpread': '5'}]}}]}},\n            {'OutcomeClassTitle': '6 months',\n             'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '19.1',\n                   'OutcomeMeasurementSpread': '4.6'}]}}]}}]},\n          'OutcomeAnalysisList': {'OutcomeAnalysis': [{'OutcomeAnalysisGroupIdList': {'OutcomeAnalysisGroupId': ['OG000']},\n             'OutcomeAnalysisNonInferiorityType': 'Superiority',\n             'OutcomeAnalysisPValue': '0.01',\n             'OutcomeAnalysisStatisticalMethod': 't-test, 2 sided'}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Center for Epidemiologic Studies Depression Scale (CES-D).',\n          'OutcomeMeasureDescription': 'Depressive symptoms using the validated Center for Epidemiologic Studies Depression Scale (CES-D). This is a score from a 20 item questionnaire with minimum value of 0 and maximum value of 60 with higher numbers indicated greater depressive symptoms (worse).',\n          'OutcomeMeasurePopulationDescription': 'Transient Ischemic Attack. Two patients did not complete questionnaires.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'score on a scale',\n          'OutcomeMeasureTimeFrame': 'Baseline and 3 months (non-intervention period), after 6 months of cardiac rehabilitation participation',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Exercise',\n             'OutcomeGroupDescription': 'Participants in this group will participate in Cardiac Rehabilitation, carrying out an exercise program after a 12 week period of non intervention which will last 6 months and combine both resistance and aerobic training.\\n\\nCardiac Rehabilitation: Individualized cardiac rehabilitation for 6 months, including health education sessions, as well as supervised exercise classes which include aerobic and resistance training.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '12'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeClassTitle': 'Baseline',\n             'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '6.5',\n                   'OutcomeMeasurementSpread': '6'}]}}]}},\n            {'OutcomeClassTitle': '3 months',\n             'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '7.6',\n                   'OutcomeMeasurementSpread': '5'}]}}]}},\n            {'OutcomeClassTitle': '6 months',\n             'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '4.3',\n                   'OutcomeMeasurementSpread': '5.2'}]}}]}}]},\n          'OutcomeAnalysisList': {'OutcomeAnalysis': [{'OutcomeAnalysisGroupIdList': {'OutcomeAnalysisGroupId': ['OG000']},\n             'OutcomeAnalysisGroupDescription': 'With 1 group and 3 test times, a repeated measures analysis of variance with pairwise comparisons of CES-D was utilized between the 3 test times baseline, 3 and 6 months.',\n             'OutcomeAnalysisNonInferiorityType': 'Superiority',\n             'OutcomeAnalysisPValue': '0.04',\n             'OutcomeAnalysisPValueComment': 'A Bonferroni correction for multiple testing was used for post-hoc contrasts.',\n             'OutcomeAnalysisStatisticalMethod': 'ANOVA'}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Cognition',\n          'OutcomeMeasureDescription': 'Montreal Cognitive Assessment. The MoCA score ranges from 0 to 30 points with a higher score indicating better cognitive function.',\n          'OutcomeMeasurePopulationDescription': 'TIA. Three subjects did not complete the assessment at each time point.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'units on a scale',\n          'OutcomeMeasureTimeFrame': 'Baseline and 3 months (non-intervention period), after 6 months of cardiac rehabilitation participation',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Exercise',\n             'OutcomeGroupDescription': 'Following a 3 month non intervention period, participants in this group will participate in Cardiac Rehabilitation, carrying out an exercise program which will last 6 months and combine both resistance and aerobic training.\\n\\nCardiac Rehabilitation: Individualized cardiac rehabilitation for 6 months, including health education sessions, as well as supervised exercise classes which include aerobic and resistance training.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '11'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeClassTitle': 'Baseline',\n             'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '26.5',\n                   'OutcomeMeasurementSpread': '2.4'}]}}]}},\n            {'OutcomeClassTitle': '3 months',\n             'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '26.8',\n                   'OutcomeMeasurementSpread': '3.4'}]}}]}},\n            {'OutcomeClassTitle': '6 months',\n             'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '27.1',\n                   'OutcomeMeasurementSpread': '2'}]}}]}}]},\n          'OutcomeAnalysisList': {'OutcomeAnalysis': [{'OutcomeAnalysisGroupIdList': {'OutcomeAnalysisGroupId': ['OG000']},\n             'OutcomeAnalysisGroupDescription': 'With 1 group and 3 test times, a repeated measures analysis of variance with pairwise comparisons of MoCA was utilized between the 3 test times (-3, 0 and 6 months). A Bonferroni correction for multiple testing was used for post-hoc contrasts.',\n             'OutcomeAnalysisNonInferiorityType': 'Superiority',\n             'OutcomeAnalysisPValue': '>0.05',\n             'OutcomeAnalysisPValueComment': 'A Bonferroni correction for multiple testing was used for post-hoc contrasts',\n             'OutcomeAnalysisStatisticalMethod': 'ANOVA'}]}}]}},\n      'AdverseEventsModule': {'EventsFrequencyThreshold': '0',\n       'EventGroupList': {'EventGroup': [{'EventGroupId': 'EG000',\n          'EventGroupTitle': 'Exercise',\n          'EventGroupDescription': 'Participants will participate in Cardiac Rehabilitation, carrying out an exercise program which will last 6 months and combine both resistance and aerobic training. There will be a 3 month non-intervention period preceding cardiac rehabilitation.\\n\\nCardiac Rehabilitation: Individualized cardiac rehabilitation for 6 months, including health education sessions, as well as supervised exercise classes which include aerobic and resistance training.',\n          'EventGroupSeriousNumAffected': '0',\n          'EventGroupSeriousNumAtRisk': '20',\n          'EventGroupOtherNumAffected': '0',\n          'EventGroupOtherNumAtRisk': '20'}]}},\n      'MoreInfoModule': {'CertainAgreement': {'AgreementPISponsorEmployee': 'No',\n        'AgreementRestrictiveAgreement': 'No'},\n       'PointOfContact': {'PointOfContactTitle': 'Dr.',\n        'PointOfContactOrganization': 'Toronto Rehab',\n        'PointOfContactEMail': 'dina.brooks@utoronto.ca',\n        'PointOfContactPhone': '4169781739'}}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000002546',\n          'ConditionMeshTerm': 'Ischemic Attack, Transient'},\n         {'ConditionMeshId': 'D000007511', 'ConditionMeshTerm': 'Ischemia'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000002545',\n          'ConditionAncestorTerm': 'Brain Ischemia'},\n         {'ConditionAncestorId': 'D000002561',\n          'ConditionAncestorTerm': 'Cerebrovascular Disorders'},\n         {'ConditionAncestorId': 'D000001927',\n          'ConditionAncestorTerm': 'Brain Diseases'},\n         {'ConditionAncestorId': 'D000002493',\n          'ConditionAncestorTerm': 'Central Nervous System Diseases'},\n         {'ConditionAncestorId': 'D000009422',\n          'ConditionAncestorTerm': 'Nervous System Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafAsFound': 'Ischemic',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M5795',\n          'ConditionBrowseLeafName': 'Ischemic Attack, Transient',\n          'ConditionBrowseLeafAsFound': 'Transient Ischemic Attack',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M5794',\n          'ConditionBrowseLeafName': 'Brain Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5810',\n          'ConditionBrowseLeafName': 'Cerebrovascular Disorders',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5204',\n          'ConditionBrowseLeafName': 'Brain Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5742',\n          'ConditionBrowseLeafName': 'Central Nervous System Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC10',\n          'ConditionBrowseBranchName': 'Nervous System Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'}]}}}}},\n   {'Rank': 2,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT00536562',\n       'OrgStudyIdInfo': {'OrgStudyId': 'R-07-251'},\n       'Organization': {'OrgFullName': 'Lawson Health Research Institute',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'Cardiac Rehabilitation for TIA Patients',\n       'OfficialTitle': 'Comprehensive Cardiac Rehabilitation Programming For Patients Following Transient Ischemic Attack',\n       'Acronym': 'CR-TIA'},\n      'StatusModule': {'StatusVerifiedDate': 'August 2019',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'September 2007'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'June 15, 2014',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'June 30, 2018',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'September 27, 2007',\n       'StudyFirstSubmitQCDate': 'September 27, 2007',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'September 28, 2007',\n        'StudyFirstPostDateType': 'Estimate'},\n       'LastUpdateSubmitDate': 'August 12, 2019',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'August 13, 2019',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'Lawson Health Research Institute',\n        'LeadSponsorClass': 'OTHER'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'Heart and Stroke Foundation of Ontario',\n          'CollaboratorClass': 'OTHER'}]}},\n      'OversightModule': {'OversightHasDMC': 'Yes'},\n      'DescriptionModule': {'BriefSummary': 'The purpose of this study is to determine, in patients following a TIA, whether a 6-month case-managed exercise based multi-factorial cardiac rehabilitation program (CR), similar to those used in patients following a heart attack, can significantly improve exercise capacity, reduce cholesterol, reduce depression, and improve thinking ability.',\n       'DetailedDescription': 'Similar risk factors predispose patients to both cardiovascular and cerebrovascular events. Two hundred consecutive patients from Stroke Prevention Clinics (SPC) at London Health Sciences Centre and the Ottawa Hospital (100 patients from each site) who have sustained a Transient Ischemic Attack (TIA) or mild non-disabling stroke will participate in a randomized controlled trial in which they will either receive Usual Care (UC) as delivered by the SPC, or enter the existing multi-disciplinary 6-month comprehensive cardiac rehabilitation (CR) intervention at LHSC and Ottawa in addition to receiving UC. This study seeks to determine the benefits of providing a CR program to TIA/mild non-disabling stroke patients.'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['TIA (Transient Ischemic Attack)']},\n       'KeywordList': {'Keyword': ['Comprehensive Cardiac Rehabilitation',\n         'Randomized Controlled Trial',\n         'TIA (Transient Ischemic Attack)',\n         'Mild Non-Disabling Stroke',\n         'Vascular Protection']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Phase 3']},\n       'DesignInfo': {'DesignAllocation': 'Randomized',\n        'DesignInterventionModel': 'Parallel Assignment',\n        'DesignPrimaryPurpose': 'Treatment',\n        'DesignMaskingInfo': {'DesignMasking': 'Single',\n         'DesignWhoMaskedList': {'DesignWhoMasked': ['Outcomes Assessor']}}},\n       'EnrollmentInfo': {'EnrollmentCount': '132',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'Usual Care',\n          'ArmGroupType': 'No Intervention',\n          'ArmGroupDescription': 'Usual Care as provided through the Stroke Prevention Clinic'},\n         {'ArmGroupLabel': 'Cardiac Rehabilitation',\n          'ArmGroupType': 'Active Comparator',\n          'ArmGroupDescription': 'Usual Care plus Comprehensive Cardiac Rehabilitation Program',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Behavioral: Comprehensive Cardiac Rehabilitation (CR)']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Behavioral',\n          'InterventionName': 'Comprehensive Cardiac Rehabilitation (CR)',\n          'InterventionDescription': '6-month Comprehensive Cardiac Rehabilitation program consisting of: 1) initial medical assessment by case manager and physician to determine CR strategies; 2) entry exercise stress test; 3) multi-disciplinary assessment and intervention to achieve risk factor targets in nutrition & psychological services as needed; 4) twice per week supervised exercise training and twice per week home-based exercise following an individualized, progressive prescription; 5) Exit assessment at 6 months.',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Cardiac Rehabilitation']},\n          'InterventionOtherNameList': {'InterventionOtherName': ['Cardiac Rehabilitation']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'To determine compared to usual care, whether a 6-month CR strategy results in significant improvements of functional capacity, lipid profile, depression symptoms and cognition.',\n          'PrimaryOutcomeTimeFrame': '6 months'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Outcomes include cerebrovascular and cardiovascular events, pre-post changes in physiological, anthropometric and behavioral vascular risk factors, neurocognitive measures, and quality of life.',\n          'SecondaryOutcomeTimeFrame': '6 months'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nDocumented TIA or mild non-disabling stroke within the previous 3 months.\\nAt least one of the following vascular risk factors: hypertension, ischemic heart disease, diabetes mellitus, dyslipidemia or cigarette smoking\\n\\nExclusion Criteria:\\n\\nInability to speak or understand English or provide informed consent.\\nSevere aphasia that renders communication difficult or impossible.\\nModified Rankin Scale score of greater than or equal to 3.\\nMini-Mental Status Examination score of less than or equal to 20.\\nEvidence of intracranial hemorrhage confirmed by CT scan or MRI study.\\nAnticipated or recent (<30 days) carotid endarterectomy, angioplasty and/or stenting.\\nResides >1 hour travel time from London or Ottawa.\\nPrior participation in a CCR program.\\nInability to perform expected exercise training of CCR program.\\nEvidence of cardioembolic source for TIA/stroke such as atrial fibrillation, valvular disease, septal defect or left ventricular wall motion abnormality.\\nParticipation in another clinical trial that could interfere with the intervention or outcomes of the current study.',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '20 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Neville G. Suskin, MBChB, MSc',\n          'OverallOfficialAffiliation': 'University of Western Ontario & London Health Sciences Centre',\n          'OverallOfficialRole': 'Principal Investigator'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'London Health Sciences Centre',\n          'LocationCity': 'London',\n          'LocationState': 'Ontario',\n          'LocationZip': 'N6A 5A5',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'University of Ottawa Heart Institute',\n          'LocationCity': 'Ottawa',\n          'LocationState': 'Ontario',\n          'LocationZip': 'K1Y 4W7',\n          'LocationCountry': 'Canada'}]}}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000002546',\n          'ConditionMeshTerm': 'Ischemic Attack, Transient'},\n         {'ConditionMeshId': 'D000007511', 'ConditionMeshTerm': 'Ischemia'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000002545',\n          'ConditionAncestorTerm': 'Brain Ischemia'},\n         {'ConditionAncestorId': 'D000002561',\n          'ConditionAncestorTerm': 'Cerebrovascular Disorders'},\n         {'ConditionAncestorId': 'D000001927',\n          'ConditionAncestorTerm': 'Brain Diseases'},\n         {'ConditionAncestorId': 'D000002493',\n          'ConditionAncestorTerm': 'Central Nervous System Diseases'},\n         {'ConditionAncestorId': 'D000009422',\n          'ConditionAncestorTerm': 'Nervous System Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M22306',\n          'ConditionBrowseLeafName': 'Stroke',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafAsFound': 'Ischemic',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M5795',\n          'ConditionBrowseLeafName': 'Ischemic Attack, Transient',\n          'ConditionBrowseLeafAsFound': 'Transient Ischemic Attack',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M5794',\n          'ConditionBrowseLeafName': 'Brain Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5810',\n          'ConditionBrowseLeafName': 'Cerebrovascular Disorders',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5204',\n          'ConditionBrowseLeafName': 'Brain Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5742',\n          'ConditionBrowseLeafName': 'Central Nervous System Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC10',\n          'ConditionBrowseBranchName': 'Nervous System Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'}]}}}}},\n   {'Rank': 3,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT05230069',\n       'OrgStudyIdInfo': {'OrgStudyId': 'ECHAS One'},\n       'Organization': {'OrgFullName': 'Emergency Call for Heart Attack and Stroke (ECHAS)',\n        'OrgClass': 'INDUSTRY'},\n       'BriefTitle': 'Emergency Call for Heart Attack and Stroke (ECHAS) - ECHAS One Study',\n       'OfficialTitle': 'Assessment of a Prehospital Mobile App and Sensor Triage System to Detect Neurologic and Cardiac Emergencies: The ECHAS Assessment Study (ECHAS- One)',\n       'Acronym': 'ECHAS'},\n      'StatusModule': {'StatusVerifiedDate': 'January 2022',\n       'OverallStatus': 'Unknown status',\n       'LastKnownStatus': 'Not yet recruiting',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'April 1, 2022',\n        'StartDateType': 'Anticipated'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'October 1, 2022',\n        'PrimaryCompletionDateType': 'Anticipated'},\n       'CompletionDateStruct': {'CompletionDate': 'December 1, 2022',\n        'CompletionDateType': 'Anticipated'},\n       'StudyFirstSubmitDate': 'January 28, 2022',\n       'StudyFirstSubmitQCDate': 'January 28, 2022',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'February 8, 2022',\n        'StudyFirstPostDateType': 'Actual'},\n       'LastUpdateSubmitDate': 'January 28, 2022',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'February 8, 2022',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'Emergency Call for Heart Attack and Stroke (ECHAS)',\n        'LeadSponsorClass': 'INDUSTRY'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'University of Saskatchewan',\n          'CollaboratorClass': 'OTHER'}]}},\n      'OversightModule': {'OversightHasDMC': 'No'},\n      'DescriptionModule': {'BriefSummary': 'ECHAS One will test the use of a smartphone app to assist patients to decide if it is necessary to call for emergency care with symptoms that could represent a heart attack or stroke.',\n       'DetailedDescription': 'The ECHAS One Study will be conducted in 200 patients who have already called for emergency care for a heart or stroke, and have been evaluated. The endpoint of the study will be a decision if the initial call was an appropriate call for emergency care. The sensitivity of the app for detecting appropriate calls will be assessed.'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Heart Attack and Stroke']},\n       'KeywordList': {'Keyword': ['Triage', 'Smartphone']}},\n      'DesignModule': {'StudyType': 'Observational',\n       'PatientRegistry': 'No',\n       'DesignInfo': {'DesignObservationalModelList': {'DesignObservationalModel': ['Case-Only']},\n        'DesignTimePerspectiveList': {'DesignTimePerspective': ['Retrospective']}},\n       'EnrollmentInfo': {'EnrollmentCount': '200',\n        'EnrollmentType': 'Anticipated'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'Patients post emergency evaluation',\n          'ArmGroupDescription': 'Interview of patients post notification of emergency system',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Other: Interview']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Other',\n          'InterventionName': 'Interview',\n          'InterventionDescription': 'Patients will be interviewed post an emergency call and evaluation.',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Patients post emergency evaluation']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Appropriate Emergency Activation',\n          'PrimaryOutcomeDescription': 'Was the right call made for a possible heart attack or stroke',\n          'PrimaryOutcomeTimeFrame': '3 months'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nPresented to ED via emergency medical services (EMS) for \"Stroke alert\" symptoms, including:\\n\\nSlurred speech Asymmetric weakness or numbness Balance problems Vision changes Headache\\n\\nAnd/or \"MI alert\" symptoms including:\\n\\nChest discomfort Chest pressure or pain Palpitations Shortness of breath Lightheadedness or presyncope Syncope Age ≥ 18 years Able to provide informed consent\\n\\nExclusion Criteria:\\n\\nNon-English speaking\\nModerate or greater dementia\\nSevere visual impairment\\nInability to use smartphone (for physical, cognitive, or other reasons)\\nUnable to consent for study',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']},\n       'StudyPopulation': '200 patients who activated emergency system for symptoms of possible heart attack or stroke.',\n       'SamplingMethod': 'Non-Probability Sample'},\n      'ContactsLocationsModule': {'CentralContactList': {'CentralContact': [{'CentralContactName': 'James E Muller',\n          'CentralContactRole': 'Contact',\n          'CentralContactPhone': '6177178570',\n          'CentralContactEMail': 'james.muller19@gmail.com'}]},\n       'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'James E Muller',\n          'OverallOfficialAffiliation': 'CEO, ECHAS, LLC',\n          'OverallOfficialRole': 'Study Director'}]}},\n      'IPDSharingStatementModule': {'IPDSharing': 'No'}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000004630',\n          'ConditionMeshTerm': 'Emergencies'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000020969',\n          'ConditionAncestorTerm': 'Disease Attributes'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000007238',\n          'ConditionAncestorTerm': 'Infarction'},\n         {'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M22306',\n          'ConditionBrowseLeafName': 'Stroke',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M7796',\n          'ConditionBrowseLeafName': 'Emergencies',\n          'ConditionBrowseLeafAsFound': 'Emergency',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Heart Attack',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M22700',\n          'ConditionBrowseLeafName': 'Disease Attributes',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC10',\n          'ConditionBrowseBranchName': 'Nervous System Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'}]}}}}},\n   {'Rank': 4,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT05090618',\n       'OrgStudyIdInfo': {'OrgStudyId': '1187'},\n       'Organization': {'OrgFullName': 'Asfendiyarov Kazakh National Medical University',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'The Role of Genetic Factors in the Development of Myocardial Infarction in the Kazakh Population',\n       'OfficialTitle': 'Preventive and Personalized Medicine (2021-2023)'},\n      'StatusModule': {'StatusVerifiedDate': 'March 2023',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'October 23, 2021',\n        'StartDateType': 'Actual'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'January 20, 2023',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'January 20, 2023',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'September 25, 2021',\n       'StudyFirstSubmitQCDate': 'October 21, 2021',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'October 25, 2021',\n        'StudyFirstPostDateType': 'Actual'},\n       'LastUpdateSubmitDate': 'March 13, 2023',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'March 14, 2023',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Principal Investigator',\n        'ResponsiblePartyInvestigatorFullName': 'Ildar Fakhradiyev',\n        'ResponsiblePartyInvestigatorTitle': 'Head of the Laboratory of Experimental Medicine',\n        'ResponsiblePartyInvestigatorAffiliation': 'Asfendiyarov Kazakh National Medical University'},\n       'LeadSponsor': {'LeadSponsorName': 'Asfendiyarov Kazakh National Medical University',\n        'LeadSponsorClass': 'OTHER'}},\n      'OversightModule': {'IsFDARegulatedDrug': 'No',\n       'IsFDARegulatedDevice': 'No'},\n      'DescriptionModule': {'BriefSummary': 'This is a GWAS study that aims to identify possible candidate genes associate to heart attack by exploring single nucleotide polymorphism (SNP) in a group of heart attack, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with heart attack',\n       'DetailedDescription': 'A genome-wide association study (GWAS) is an approach used in genetics research to associate specific genetic variations with particular diseases. The method involves scanning the genomes from many different people and looking for genetic markers that can be used to predict the presence of a disease. Once such genetic markers are identified, they can be used to understand how genes contribute to the disease and develop better prevention and treatment strategies.'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Heart Attack']},\n       'KeywordList': {'Keyword': ['GWAS']}},\n      'DesignModule': {'StudyType': 'Observational',\n       'PatientRegistry': 'No',\n       'DesignInfo': {'DesignObservationalModelList': {'DesignObservationalModel': ['Other']},\n        'DesignTimePerspectiveList': {'DesignTimePerspective': ['Prospective']}},\n       'BioSpec': {'BioSpecRetention': 'Samples With DNA',\n        'BioSpecDescription': 'Blood'},\n       'EnrollmentInfo': {'EnrollmentCount': '500',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'Experimental group:',\n          'ArmGroupDescription': 'Patients with Heart Attack',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Genetic: DNA analysis']}},\n         {'ArmGroupLabel': 'Control group',\n          'ArmGroupDescription': 'Patients without Heart Attack',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Genetic: DNA analysis']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Genetic',\n          'InterventionName': 'DNA analysis',\n          'InterventionDescription': 'GWAS',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Control group',\n            'Experimental group:']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'number of SNPs associated with Heart Attack',\n          'PrimaryOutcomeDescription': 'Using GWAS to identify candidate genes associate with Heart Attack',\n          'PrimaryOutcomeTimeFrame': '1 year'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nPersons of Kazakh nationality\\nAge up to 59 years inclusive at the time of primary myocardial infarction\\nMyocardial infarction was established in accordance with the EOC criteria: An increase and / or decrease in the level of cardiac troponin must be combined with at least one of the following: • Symptoms of myocardial ischemia • Newly occurring ischemic changes on the ECG • The appearance of a pathological Q wave • Identification according to imaging data methods of new areas of non-viable myocardium, or new areas of local contractility disorders of presumably ischemic etiology • Detection of a thrombus in the coronary arteries according to coronary angiography\\nPresence of coronary angiography\\nPersons able and willing to provide written informed consent;\\n\\nExclusion Criteria:\\n\\nAge at primary myocardial infarction 60 years and older\\nHeart defects, congenital and acquired\\nNon-ischemic cardiomyopathies\\nAutoimmune diseases\\nDiabetes mellitus at the time of development of primary myocardial infarction\\nTerminal stages of renal and hepatic failure',\n       'HealthyVolunteers': 'Accepts Healthy Volunteers',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'MaximumAge': '60 Years',\n       'StdAgeList': {'StdAge': ['Adult']},\n       'StudyPopulation': 'KAZAKH POPULATION',\n       'SamplingMethod': 'Probability Sample'},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Aisulu Mussagaliyeva, PhD',\n          'OverallOfficialAffiliation': 'Research Institute of Cardiology and Internal Medicine',\n          'OverallOfficialRole': 'Study Director'},\n         {'OverallOfficialName': 'Roza Kuanyshbekova',\n          'OverallOfficialAffiliation': 'Research Institute of Cardiology and Internal Medicine',\n          'OverallOfficialRole': 'Study Director'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'Kazakhstan',\n          'LocationCity': 'Almaty',\n          'LocationZip': '050020',\n          'LocationCountry': 'Kazakhstan'}]}},\n      'IPDSharingStatementModule': {'IPDSharing': 'Undecided'}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'},\n         {'ConditionAncestorId': 'D000007238',\n          'ConditionAncestorTerm': 'Infarction'},\n         {'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Heart Attack',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'}]}}}}},\n   {'Rank': 5,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT00102128',\n       'OrgStudyIdInfo': {'OrgStudyId': 'SMC00202'},\n       'Organization': {'OrgFullName': 'Sanofi', 'OrgClass': 'INDUSTRY'},\n       'BriefTitle': 'Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.',\n       'OfficialTitle': 'Evaluation of Skeletal Myoblast Transplant for Treating Ischemic Heart Failure'},\n      'StatusModule': {'StatusVerifiedDate': 'May 2015',\n       'OverallStatus': 'Terminated',\n       'WhyStopped': 'DMC recommended stop',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'November 2002'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'April 2007',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'April 2007',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'January 21, 2005',\n       'StudyFirstSubmitQCDate': 'January 21, 2005',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'January 24, 2005',\n        'StudyFirstPostDateType': 'Estimate'},\n       'LastUpdateSubmitDate': 'May 21, 2015',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'May 22, 2015',\n        'LastUpdatePostDateType': 'Estimate'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'Genzyme, a Sanofi Company',\n        'LeadSponsorClass': 'INDUSTRY'}},\n      'OversightModule': {},\n      'DescriptionModule': {'BriefSummary': 'Study to examine the safety and effectiveness of implanted skeletal muscle cells (cells removed from the thigh muscle) into scarred areas of heart muscle after heart attack.'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Ischemic Heart Failure',\n         'Ischemic Heart Disease',\n         'Ischemic Cardiomyopathy']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Phase 2']},\n       'DesignInfo': {'DesignAllocation': 'Randomized',\n        'DesignInterventionModel': 'Parallel Assignment',\n        'DesignPrimaryPurpose': 'Treatment',\n        'DesignMaskingInfo': {'DesignMasking': 'Double'}}},\n      'ArmsInterventionsModule': {'InterventionList': {'Intervention': [{'InterventionType': 'Drug',\n          'InterventionName': 'Cellular Therapy (Cultured Autologous Skeletal Myoblast Transplantation)'}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': \"Recovery of contractility within previously akinetic areas of the heart (areas without motion/contraction) that have received treatment (cells from the patient's thigh muscle or placebo), and change in left ventricular EF as assessed by echocardiography\"}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Time-to-first major adverse cardiac event (cardiovascular related death, non-cardiovascular death, congestive heart failure, resuscitated sudden death, myocardial infarction (heart attack) and stroke.'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nPatients recommended for coronary bypass surgery (preferably with cardiopulmonary support)\\nEjection fraction ≥15% and ≤35%\\nLeft ventricular myocardial infarction (MI - heart attack) ≥4 weeks prior to screening\\n\\nExclusion Criteria:\\n\\nNeed for a rapid surgical coronary revascularization\\nNeed for any other related cardiosurgical measure during coronary surgery (e.g. mitral valve repair or valve replacement)\\nPatients with a left ventricular aneurysm who is a candidate for left ventricular aneurysmectomy or left ventricular reduction surgery; patient receiving left or biventricular (BiV) pacing therapy for heart failure (unless the patient has stabilized after 6 or more months of this therapy)\\nCardiomyopathy presumed to be of non-ischemic origin',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'MaximumAge': '80 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Medical Monitor',\n          'OverallOfficialAffiliation': 'Genzyme, a Sanofi Company',\n          'OverallOfficialRole': 'Study Director'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Aalst',\n          'LocationCountry': 'Belgium'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Brussels',\n          'LocationCountry': 'Belgium'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Gent',\n          'LocationCountry': 'Belgium'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Leuven',\n          'LocationCountry': 'Belgium'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Besancon',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Bordeaux',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Caen',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Clermont Ferrand',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Grenoble',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Lille',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Lyon',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Nantes',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Paris',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Rennes',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Rouen',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Toulouse',\n          'LocationCountry': 'France'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Bad Oeynhausen',\n          'LocationCountry': 'Germany'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Hamburg',\n          'LocationCountry': 'Germany'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Hannover',\n          'LocationCountry': 'Germany'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Bologna',\n          'LocationCountry': 'Italy'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Genova',\n          'LocationCountry': 'Italy'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Milan',\n          'LocationCountry': 'Italy'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Treviso',\n          'LocationCountry': 'Italy'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Udine',\n          'LocationCountry': 'Italy'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Lausanne',\n          'LocationCountry': 'Switzerland'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Cambridge',\n          'LocationCountry': 'United Kingdom'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'London',\n          'LocationCountry': 'United Kingdom'},\n         {'LocationFacility': 'Genzyme Corporation',\n          'LocationCity': 'Southampton',\n          'LocationCountry': 'United Kingdom'}]}}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000006333',\n          'ConditionMeshTerm': 'Heart Failure'},\n         {'ConditionMeshId': 'D000006331',\n          'ConditionMeshTerm': 'Heart Diseases'},\n         {'ConditionMeshId': 'D000009202',\n          'ConditionMeshTerm': 'Cardiomyopathies'},\n         {'ConditionMeshId': 'D000017202',\n          'ConditionMeshTerm': 'Myocardial Ischemia'},\n         {'ConditionMeshId': 'D000003324',\n          'ConditionMeshTerm': 'Coronary Artery Disease'},\n         {'ConditionMeshId': 'D000007511', 'ConditionMeshTerm': 'Ischemia'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'},\n         {'ConditionAncestorId': 'D000003327',\n          'ConditionAncestorTerm': 'Coronary Disease'},\n         {'ConditionAncestorId': 'D000001161',\n          'ConditionAncestorTerm': 'Arteriosclerosis'},\n         {'ConditionAncestorId': 'D000001157',\n          'ConditionAncestorTerm': 'Arterial Occlusive Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafAsFound': 'Ischemic Heart Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M9421',\n          'ConditionBrowseLeafName': 'Heart Failure',\n          'ConditionBrowseLeafAsFound': 'Heart Failure',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafAsFound': 'Heart Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12154',\n          'ConditionBrowseLeafName': 'Cardiomyopathies',\n          'ConditionBrowseLeafAsFound': 'Cardiomyopathy',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafAsFound': 'Ischemic Heart Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafAsFound': 'Ischemic',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6160',\n          'ConditionBrowseLeafName': 'Cicatrix',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6549',\n          'ConditionBrowseLeafName': 'Coronary Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M4469',\n          'ConditionBrowseLeafName': 'Arteriosclerosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M4465',\n          'ConditionBrowseLeafName': 'Arterial Occlusive Diseases',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'}]}}}}},\n   {'Rank': 6,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT05843006',\n       'OrgStudyIdInfo': {'OrgStudyId': '274564'},\n       'Organization': {'OrgFullName': 'Region Örebro County',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'Sweat Analysis as Prognosticator After Heart Attack',\n       'OfficialTitle': 'SWEAT Analysis for Predicting Patient Outcome After HEART Attack',\n       'Acronym': 'SWEATHEART'},\n      'StatusModule': {'StatusVerifiedDate': 'March 2022',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'March 21, 2022',\n        'StartDateType': 'Actual'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'March 31, 2023',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'March 31, 2023',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'April 24, 2023',\n       'StudyFirstSubmitQCDate': 'April 24, 2023',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'May 6, 2023',\n        'StudyFirstPostDateType': 'Actual'},\n       'LastUpdateSubmitDate': 'April 24, 2023',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'May 6, 2023',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'Region Örebro County',\n        'LeadSponsorClass': 'OTHER'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'University Hospital, Basel, Switzerland',\n          'CollaboratorClass': 'OTHER'}]}},\n      'OversightModule': {'OversightHasDMC': 'No',\n       'IsFDARegulatedDrug': 'No',\n       'IsFDARegulatedDevice': 'No'},\n      'DescriptionModule': {'BriefSummary': 'This study characterizes non-invasive body inflammation response in sweat and blood of patients suffering from acute myocardial infarction and explores the potential of non-invasive sweat analysis a an innovative approach for predicting patient outcome.',\n       'DetailedDescription': 'Background:\\n\\nDifferent risk scores exist for predicting patient outcome after acute coronary syndrome and percutaneous coronary intervention (PCI). This is of importance to optimize post interventional patient management as well as treatment and to reduce the risks of re-hospitalization and mortality. ST-elevation myocardial infarction (STEMI) has been associated with an instant upregulation of the sympathetic nervous system leading to adrenergic stimulation and immune system activation in different organs such as the heart and skin. In skin, sympathetic fibers travel together, appear as single nerve fibers in the dermis as well as in the epidermis, and activate inflammation by norepinephrine secretion. Further, STEMI has been associated with increased sweating during the acute phase. In an unpublished pilot trial, we detected a broad panel of inflammation markers in sweat (such as MCP-1, TGFβ, uPa, TRAIL) of healthy volunteers. Sweat immunologic marker analysis is an interesting and novel approach for assessment of sympathetic activation and inflammation.\\n\\nObjective and methods:\\n\\nOur primary objective is to assess a non-invasive body inflammation response in sweat and blood of patients suffering from STEMI after PCI (+4h) and at outpatient follow up (±4-6 weeks). Body inflammation marker concentrations in sweat and blood will be set into context to cardiovascular risk factors, GRACE and TIMI STEMI scores, door-to-balloon time, length of hospital stay , left ventricular ejection fraction, peak troponin-I, and NT-proBNP concentrations to investigate the STEMI/PCI - sympathetic nervous system - inflammation axis. A total of 18 subjects with STEMI and 6 patients undergoing diagnostic coronary angiography without PCI will be recruited in a clinical, single-center pilot study at Örebro University Hospital. Sweat will be collected using the CE certified Macroduct Collecting System and blood samples will be taken. Analysis will be performed with Olink proteomic analysis.\\n\\nClinical relevance:\\n\\nSTEMI and subsequent reperfusion are associated with an increase in inflammatory response. Myocardial reperfusion injury contributes significant to myocardial injury after STEMI. Adequate patient monitoring and therapy after PCI is essential to preserve cardiac function, prevent re-hospitalization, heart failure and death.\\n\\nProspects:\\n\\nBiomarkers can be collected by smart biosensors and may provide novel longitudinal insights into health and disease. On-skin sweat analysis using wearable devices are increasingly available and will allow collection of non-invasive and patient-centered molecular health information in the future. This may help to investigate a better understanding of sympathetic nervous system upregulation after STEMI/PCI.'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Acute Myocardial Infarction']},\n       'KeywordList': {'Keyword': ['Sweat analysis',\n         'Myocardial reperfusion injury',\n         'Personalized patient monitoring',\n         'Acute myocardial infarction',\n         'Upregulated sympathetic nervous system',\n         'Inflammation']}},\n      'DesignModule': {'StudyType': 'Observational',\n       'PatientRegistry': 'Yes',\n       'TargetDuration': '6 Weeks',\n       'DesignInfo': {'DesignObservationalModelList': {'DesignObservationalModel': ['Cohort']},\n        'DesignTimePerspectiveList': {'DesignTimePerspective': ['Prospective']}},\n       'BioSpec': {'BioSpecRetention': 'Samples With DNA',\n        'BioSpecDescription': 'Sweat and venous blood samples for analysis and storage in a biobank in Örebro for potential future analysis.'},\n       'EnrollmentInfo': {'EnrollmentCount': '24',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'STEMI + PCI',\n          'ArmGroupDescription': '18 subjects referred for coronary angiography/PCI due to ST-segment elevation myocardial infarction (STEMI)',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Diagnostic Test: Examination and analysis of sweat and blood samples at baseline and at follow up']}},\n         {'ArmGroupLabel': 'Diagnostic coronary angiography without a resulting intervention (PCI)',\n          'ArmGroupDescription': '6 subjects undergoing a diagnostic coronary angiography without a resulting intervention (PCI)',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Diagnostic Test: Examination and analysis of sweat and blood samples at baseline']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Diagnostic Test',\n          'InterventionName': 'Examination and analysis of sweat and blood samples at baseline and at follow up',\n          'InterventionDescription': 'Subjects will be assessed at baseline (as inpatients) and at 4-6 weeks at follow-up as outpatients according to standard operating procedures. Sweat samples will be collected using the CE certified Macroduct Sweat Collector and inflammatory parameters measured. Venous blood will be drawn and inflammatory parameters, Troponin-I and nt-proBNP measured. Further examinations include measurement of left ventricular ejection fraction by echocardiography at baseline and blood pressure, heart rate, risk scores and health information will be collected at baseline and follow up.',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['STEMI + PCI']}},\n         {'InterventionType': 'Diagnostic Test',\n          'InterventionName': 'Examination and analysis of sweat and blood samples at baseline',\n          'InterventionDescription': 'Sweat samples will be collected using the CE certified Macroduct Sweat Collector and inflammatory parameters measured. Venous blood will be drawn and inflammatory parameters, Troponin-I and nt-proBNP measured. Blood pressure, heart rate, risk scores and health information will collected.',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Diagnostic coronary angiography without a resulting intervention (PCI)']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Inflammation panels in sweat and blood correlated to clinical outcome',\n          'PrimaryOutcomeDescription': 'The primary result is detection of inflammation markers in sweat and blood samples in patients with STEMI and PCI. Inflammation markers will be correlated to clinical outcome. Clinical endpoints will be assessed in all patients included in the study using data from the Swedish Web System for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) registry - death, new AMI and new, unplanned revascularization. Assessment is exploratory only.',\n          'PrimaryOutcomeTimeFrame': '6 weeks'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Comparing inflammation panels of patients with coronary angiography without any need for an intervention',\n          'SecondaryOutcomeDescription': 'Secondary results are detection of inflammation markers in sweat and blood of patients with coronary angiography but no need for intervention and compared to patients with STEMI and PCI. Clinical endpoints will be assessed as described for the primary outcome measure.',\n          'SecondaryOutcomeTimeFrame': '6 weeks'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nStudy participants will be recruited among subjects referred to Hospital for coronary angiography/PCI due to ST-segment elevation myocardial infarction (STEMI) or diagnostic coronary angiography.\\n\\nSubjects with a diagnosis of STEMI as defined by chest pain suggestive for myocardial ischemia for at least 30 minutes before hospital admission, time from onset of symptoms of less than 24 hours, and an ECG with new ST-segment elevation in two or more contiguous leads of ≥0.2 mV in leads V2-V3 and/or ≥0.1 mV in other leads or a probable new-onset left bundle branch block\\n\\nOr:\\n\\nSubjects undergoing a diagnostic coronary angiography without a resulting intervention (PCI)\\n\\nand:\\n\\nWritten informed consent\\n\\nExclusion Criteria:\\n\\nEmergency coronary artery bypass grafting\\nOn immunosuppression pharmacotherapy\\nPacemaker patients',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '45 Years',\n       'MaximumAge': '65 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']},\n       'StudyPopulation': 'Study participants will be recruited among patients referred to Örebro University Hospital a tertiary teaching hospital and regional acute care hospital.',\n       'SamplingMethod': 'Probability Sample'},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Ole Fröbert, MD, PhD',\n          'OverallOfficialAffiliation': 'Department of Cardiology, Örebro University Hospital and Örebro University',\n          'OverallOfficialRole': 'Study Chair'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'Department of cardiology',\n          'LocationCity': 'Örebro',\n          'LocationZip': '70185',\n          'LocationCountry': 'Sweden'}]}}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000007238',\n          'ConditionMeshTerm': 'Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'},\n         {'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M10293',\n          'ConditionBrowseLeafName': 'Inflammation',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafAsFound': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M18099',\n          'ConditionBrowseLeafName': 'Reperfusion Injury',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M18100',\n          'ConditionBrowseLeafName': 'Myocardial Reperfusion Injury',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'T170',\n          'ConditionBrowseLeafName': 'Acute Graft Versus Host Disease',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'Rare',\n          'ConditionBrowseBranchName': 'Rare Diseases'}]}}}}},\n   {'Rank': 7,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT00067236',\n       'OrgStudyIdInfo': {'OrgStudyId': '2002135'},\n       'Organization': {'OrgFullName': 'Procter and Gamble',\n        'OrgClass': 'INDUSTRY'},\n       'BriefTitle': 'Study of Oral PG-116800 Following a Heart Attack',\n       'OfficialTitle': 'A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral PG-116800 Following a Heart Attack'},\n      'StatusModule': {'StatusVerifiedDate': 'September 2011',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'September 2003'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'December 2004',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'December 2004',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'August 13, 2003',\n       'StudyFirstSubmitQCDate': 'August 13, 2003',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'August 14, 2003',\n        'StudyFirstPostDateType': 'Estimate'},\n       'ResultsFirstSubmitDate': 'August 3, 2011',\n       'ResultsFirstSubmitQCDate': 'September 27, 2011',\n       'ResultsFirstPostDateStruct': {'ResultsFirstPostDate': 'November 4, 2011',\n        'ResultsFirstPostDateType': 'Estimate'},\n       'LastUpdateSubmitDate': 'September 27, 2011',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'November 4, 2011',\n        'LastUpdatePostDateType': 'Estimate'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'Procter and Gamble',\n        'LeadSponsorClass': 'INDUSTRY'}},\n      'OversightModule': {'OversightHasDMC': 'No'},\n      'DescriptionModule': {'BriefSummary': 'The main purpose of the study is to test whether a possible new drug (called PG-116800) can prevent some of the damage to heart muscle in patients who have had a heart attack. The study will also supply information regarding possible uses of this compound in cardiovascular disease.',\n       'DetailedDescription': 'Heart attacks cause damage to heart muscle that can weaken the heart and lead to changes in the shape and pumping ability of the heart. These changes can lead to heart failure. An enzyme called metalloproteinase (MMP) plays a role in this damage.\\n\\nThe main purpose of the study is to test whether a possible new drug (called PG-116800) that interferes with the MMP enzyme can prevent some of the damage to heart muscle in patients who have had a heart attack. The study will also supply information regarding possible uses of this compound in cardiovascular disease.\\n\\nThis is a Phase II \"proof-of-concept\" study; that is, it is a first attempt to treat sick people with the drug to see if it works.\\n\\nThe study is interventional since we will be using a drug to interfere with the heart tissue damage that follows a heart attack.'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Myocardial Infarction',\n         'Heart Failure',\n         'Heart Enlargement']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Phase 2']},\n       'DesignInfo': {'DesignAllocation': 'Randomized',\n        'DesignInterventionModel': 'Parallel Assignment',\n        'DesignPrimaryPurpose': 'Treatment',\n        'DesignMaskingInfo': {'DesignMasking': 'Double',\n         'DesignWhoMaskedList': {'DesignWhoMasked': ['Participant',\n           'Investigator']}}},\n       'EnrollmentInfo': {'EnrollmentCount': '253',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'PG-116800 tablet',\n          'ArmGroupType': 'Experimental',\n          'ArmGroupDescription': 'PG-116800 tablet (200 mg) taken twice daily for 90 days',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Drug: PG-116800 (given as PG-530742)']}},\n         {'ArmGroupLabel': 'Placebo tablet',\n          'ArmGroupType': 'Placebo Comparator',\n          'ArmGroupDescription': 'Placebo tablet taken twice daily for 90 days',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Drug: Placebo tablet']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Drug',\n          'InterventionName': 'PG-116800 (given as PG-530742)',\n          'InterventionDescription': '200 mg tablet of PG-116800 (given as PG-530742)twice a day for 90 days',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['PG-116800 tablet']}},\n         {'InterventionType': 'Drug',\n          'InterventionName': 'Placebo tablet',\n          'InterventionDescription': 'placebo tablet, twice a day for 90 days',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Placebo tablet']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Change From Baseline in Left Ventricular End Diastolic Volume Index (LVEDVi in mL/m2) at Day 90 Post Myocardial Infarction (MI)',\n          'PrimaryOutcomeDescription': 'Mean change of left ventricular end diastolic volume index (mL/m2) as evaluated via ventricular end-diastolic volume index augmentation 90 days post Myocardial Infarction (MI)',\n          'PrimaryOutcomeTimeFrame': '90 days'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion:\\n\\nBe at least 18 years of age but not older than 80 years of age at screening;\\nBe diagnosed with a heart attack based on electrocardiogram (ECG) and cardiac enzymes criteria;\\nThe qualifying heart attack has to be a first heart attack;\\nThe qualifying heart attack has to result in a left ventricular ejection fraction (a measure of the working efficiency of the heart) between 15% and 40%.\\n\\nExclusion:\\n\\nDocumented previous history of heart attack;\\nAny past history of heart failure;\\nHemodynamic instability (no instability of circulatory system);\\nHistory of congenital heart disease and cardiomyopathy (weakened heart muscle) associated with connective tissue disorders;\\nRecent history or current moderate-to-severe kidney or liver impairment;\\nSignificant blood dyscrasias (disorders of the blood cells);\\nFemales who are currently: pregnant; breast-feeding; or are of childbearing potential.',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'MaximumAge': '80 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Jose Brum, MD',\n          'OverallOfficialAffiliation': 'Procter and Gamble',\n          'OverallOfficialRole': 'Study Director'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'University of Arkansas for Medical Sciences and Central Arkansas Veterans Health Care System',\n          'LocationCity': 'Little Rock',\n          'LocationState': 'Arkansas',\n          'LocationZip': '72205',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Mercy Community Medical Center',\n          'LocationCity': 'Merced',\n          'LocationState': 'California',\n          'LocationZip': '95340',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Porter Adventist Hospital',\n          'LocationCity': 'Denver',\n          'LocationState': 'Colorado',\n          'LocationZip': '80210',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'University of Connecticut Health Center',\n          'LocationCity': 'Farmington',\n          'LocationState': 'Connecticut',\n          'LocationZip': '06030-2202',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'JFK Medical Center',\n          'LocationCity': 'Atlantis',\n          'LocationState': 'Florida',\n          'LocationZip': '33462',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Morton Plant Hospital',\n          'LocationCity': 'Clearwater',\n          'LocationState': 'Florida',\n          'LocationZip': '33756',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Piedmont Hospital',\n          'LocationCity': 'Atlanta',\n          'LocationState': 'Georgia',\n          'LocationZip': '30309',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Henry Ford Hospital',\n          'LocationCity': 'Detroit',\n          'LocationState': 'Michigan',\n          'LocationZip': '48202',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Abbott-Northwestern Hospital',\n          'LocationCity': 'Minneapolis',\n          'LocationState': 'Minnesota',\n          'LocationZip': '55407-1139',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Barnes Jewish Hospital',\n          'LocationCity': 'St. Louis',\n          'LocationState': 'Missouri',\n          'LocationZip': '63110',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Strong Memorial Hospital',\n          'LocationCity': 'Rochester',\n          'LocationState': 'New York',\n          'LocationZip': '14642',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Presbyterian Hospital',\n          'LocationCity': 'Charlotte',\n          'LocationState': 'North Carolina',\n          'LocationZip': '28204',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Moses Cone Hospital',\n          'LocationCity': 'Greensboro',\n          'LocationState': 'North Carolina',\n          'LocationZip': '27401',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Oklahoma Heart Hospital',\n          'LocationCity': 'Oklahoma City',\n          'LocationState': 'Oklahoma',\n          'LocationZip': '73120',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Westmoreland Regional Hospital',\n          'LocationCity': 'Greensburg',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '15601-2745',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Hershey Medical Center',\n          'LocationCity': 'Hershey',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '17033-0850',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Rhode Island Hospital',\n          'LocationCity': 'Providence',\n          'LocationState': 'Rhode Island',\n          'LocationZip': '02903',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Medical University of South Carolina',\n          'LocationCity': 'Charleston',\n          'LocationState': 'South Carolina',\n          'LocationZip': '29403',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Memorial Hospital',\n          'LocationCity': 'Chattanooga',\n          'LocationState': 'Tennessee',\n          'LocationZip': '37404-1127',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Memorial Hermann Hospital',\n          'LocationCity': 'Houston',\n          'LocationState': 'Texas',\n          'LocationZip': '77030',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'West Virginia University Hospital',\n          'LocationCity': 'Morgantown',\n          'LocationState': 'West Virginia',\n          'LocationZip': '26506-9157',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Foothills Hospital',\n          'LocationCity': 'Calgary',\n          'LocationState': 'Alberta',\n          'LocationZip': 'T2N 4N1',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Royal Alexandra Hospital',\n          'LocationCity': 'Edmonton',\n          'LocationState': 'Alberta',\n          'LocationZip': 'T5G 3C8',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'University of Alberta Hospital',\n          'LocationCity': 'Edmonton',\n          'LocationState': 'Alberta',\n          'LocationZip': 'T6G 2B7',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Grey Nuns Hospital',\n          'LocationCity': 'Edmonton',\n          'LocationState': 'Alberta',\n          'LocationZip': 'T6L 5X8',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Alder Medical Centre',\n          'LocationCity': 'Campbell River',\n          'LocationState': 'British Columbia',\n          'LocationZip': 'V9W 5Y4',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Vancouver General Hospital',\n          'LocationCity': 'Vancouver',\n          'LocationState': 'British Columbia',\n          'LocationZip': 'V5Z 4E3',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Victoria Heart Institute',\n          'LocationCity': 'Victoria',\n          'LocationState': 'British Columbia',\n          'LocationZip': 'V8R 4R2',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': \"St. John's HSC\",\n          'LocationCity': \"St. John's\",\n          'LocationState': 'New Brunswick',\n          'LocationZip': 'A1B 3V6',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Queen Elizabeth II HSC',\n          'LocationCity': 'Halifax',\n          'LocationState': 'Nova Scotia',\n          'LocationZip': 'B3H 3H7',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Southlake Regional HC',\n          'LocationCity': 'Newmarket',\n          'LocationState': 'Ontario',\n          'LocationZip': 'L3Y 2R2',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Scarborough Grace Hospital',\n          'LocationCity': 'Scarborough',\n          'LocationState': 'Ontario',\n          'LocationZip': 'M1S 4V5',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Toronto East General',\n          'LocationCity': 'Toronto',\n          'LocationState': 'Ontario',\n          'LocationZip': 'M4C 3E7',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': \"St. Michael's Hospital\",\n          'LocationCity': 'Toronto',\n          'LocationState': 'Ontario',\n          'LocationZip': 'M5B 1W8',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'CHUS, Hopital Fleurimont',\n          'LocationCity': 'Fleurimont',\n          'LocationState': 'Quebec',\n          'LocationZip': 'J1H 5N4',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Montreal Heart Institute',\n          'LocationCity': 'Montreal',\n          'LocationState': 'Quebec',\n          'LocationZip': 'H1T 1C8',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'McGill University Health Centre, Royal Victoria Hospital',\n          'LocationCity': 'Montreal',\n          'LocationState': 'Quebec',\n          'LocationZip': 'H3A 1A1',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Montreal General Hospital',\n          'LocationCity': 'Montreal',\n          'LocationState': 'Quebec',\n          'LocationZip': 'H3G 1A4',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Hopital Sacre-Coeur',\n          'LocationCity': 'Montreal',\n          'LocationState': 'Quebec',\n          'LocationZip': 'H4J 1C5',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Hopital Laval',\n          'LocationCity': 'Ste-Foy',\n          'LocationState': 'Quebec',\n          'LocationZip': 'G1V 4G5',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Klinika Kardiologii, Panstwowy Szpital Kliniczny',\n          'LocationCity': 'Bialystok',\n          'LocationCountry': 'Poland'},\n         {'LocationFacility': 'Katedra i Klinika Kardiologii i Chorob Wewnetznych, Akademia Medyczna w Bydgoszczy',\n          'LocationCity': 'Bydgoszcz',\n          'LocationCountry': 'Poland'},\n         {'LocationFacility': '1 Katedra Kardiologii Slaskiej Akademii Medycznej',\n          'LocationCity': 'Katowice',\n          'LocationCountry': 'Poland'},\n         {'LocationFacility': 'Klinika Chorob Serca i Naczyn, Krakowski Szpital Specjalistyczny',\n          'LocationCity': 'Krakow',\n          'LocationCountry': 'Poland'},\n         {'LocationFacility': 'Oddzial Kardiologii, Wojewodzki Szpital Specjalistyczny',\n          'LocationCity': 'Krakow',\n          'LocationCountry': 'Poland'},\n         {'LocationFacility': 'Klinika Kardiologii IMW, Uniwersytet Medyczny w Lodzi',\n          'LocationCity': 'Lodz',\n          'LocationCountry': 'Poland'},\n         {'LocationFacility': 'I Klinika Kardilogii Akademii Medycznej w Poznaniu',\n          'LocationCity': 'Poznan',\n          'LocationCountry': 'Poland'},\n         {'LocationFacility': 'Oddzial Internistyczno-Kardiologiczny, Samodzieiny Publiczny Wojewodzki Szpital Zespolony',\n          'LocationCity': 'Szczecin',\n          'LocationCountry': 'Poland'},\n         {'LocationFacility': 'I Klinika Choroby Wiencowej, Instytut Kardiologii w Warszawie',\n          'LocationCity': 'Warszawa',\n          'LocationCountry': 'Poland'},\n         {'LocationFacility': 'Klinika Choroby Wiencowej, Instytut Kardiologi w Warszawie',\n          'LocationCity': 'Warszawa',\n          'LocationCountry': 'Poland'},\n         {'LocationFacility': 'Klinika Kardilogii Inwazyjnej, Centrainy Szpital MSWiA',\n          'LocationCity': 'Warszawa',\n          'LocationCountry': 'Poland'},\n         {'LocationFacility': 'Klinika Kardiologii, Szpital Grochowski',\n          'LocationCity': 'Warszawa',\n          'LocationCountry': 'Poland'}]}}},\n     'ResultsSection': {'ParticipantFlowModule': {'FlowGroupList': {'FlowGroup': [{'FlowGroupId': 'FG000',\n          'FlowGroupTitle': 'Placebo',\n          'FlowGroupDescription': 'Placebo tablet twice daily for 90 days'},\n         {'FlowGroupId': 'FG001',\n          'FlowGroupTitle': 'PG-116800 Tablet',\n          'FlowGroupDescription': 'PG-116800 tablet (200 mg) twice daily for 90 days'}]},\n       'FlowPeriodList': {'FlowPeriod': [{'FlowPeriodTitle': 'Overall Study',\n          'FlowMilestoneList': {'FlowMilestone': [{'FlowMilestoneType': 'STARTED',\n             'FlowAchievementList': {'FlowAchievement': [{'FlowAchievementGroupId': 'FG000',\n                'FlowAchievementNumSubjects': '128'},\n               {'FlowAchievementGroupId': 'FG001',\n                'FlowAchievementNumSubjects': '125'}]}},\n            {'FlowMilestoneType': 'COMPLETED',\n             'FlowAchievementList': {'FlowAchievement': [{'FlowAchievementGroupId': 'FG000',\n                'FlowAchievementNumSubjects': '108'},\n               {'FlowAchievementGroupId': 'FG001',\n                'FlowAchievementNumSubjects': '99'}]}},\n            {'FlowMilestoneType': 'NOT COMPLETED',\n             'FlowAchievementList': {'FlowAchievement': [{'FlowAchievementGroupId': 'FG000',\n                'FlowAchievementNumSubjects': '20'},\n               {'FlowAchievementGroupId': 'FG001',\n                'FlowAchievementNumSubjects': '26'}]}}]}}]}},\n      'BaselineCharacteristicsModule': {'BaselineGroupList': {'BaselineGroup': [{'BaselineGroupId': 'BG000',\n          'BaselineGroupTitle': 'Placebo',\n          'BaselineGroupDescription': 'Placebo tablet twice daily for 90 days'},\n         {'BaselineGroupId': 'BG001',\n          'BaselineGroupTitle': 'PG-116800 Tablet',\n          'BaselineGroupDescription': 'PG-116800 tablet (200 mg) twice daily for 90 days'},\n         {'BaselineGroupId': 'BG002',\n          'BaselineGroupTitle': 'Total',\n          'BaselineGroupDescription': 'Total of all reporting groups'}]},\n       'BaselineDenomList': {'BaselineDenom': [{'BaselineDenomUnits': 'Participants',\n          'BaselineDenomCountList': {'BaselineDenomCount': [{'BaselineDenomCountGroupId': 'BG000',\n             'BaselineDenomCountValue': '128'},\n            {'BaselineDenomCountGroupId': 'BG001',\n             'BaselineDenomCountValue': '125'},\n            {'BaselineDenomCountGroupId': 'BG002',\n             'BaselineDenomCountValue': '253'}]}}]},\n       'BaselineMeasureList': {'BaselineMeasure': [{'BaselineMeasureTitle': 'Age Continuous',\n          'BaselineMeasureParamType': 'Mean',\n          'BaselineMeasureDispersionType': 'Standard Deviation',\n          'BaselineMeasureUnitOfMeasure': 'years',\n          'BaselineClassList': {'BaselineClass': [{'BaselineCategoryList': {'BaselineCategory': [{'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '59.9',\n                   'BaselineMeasurementSpread': '10.22'},\n                  {'BaselineMeasurementGroupId': 'BG001',\n                   'BaselineMeasurementValue': '59.7',\n                   'BaselineMeasurementSpread': '11.71'},\n                  {'BaselineMeasurementGroupId': 'BG002',\n                   'BaselineMeasurementValue': '59.8',\n                   'BaselineMeasurementSpread': '10.96'}]}}]}}]}},\n         {'BaselineMeasureTitle': 'Sex: Female, Male',\n          'BaselineMeasureParamType': 'Count of Participants',\n          'BaselineMeasureUnitOfMeasure': 'Participants',\n          'BaselineClassList': {'BaselineClass': [{'BaselineCategoryList': {'BaselineCategory': [{'BaselineCategoryTitle': 'Female',\n                'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '34'},\n                  {'BaselineMeasurementGroupId': 'BG001',\n                   'BaselineMeasurementValue': '32'},\n                  {'BaselineMeasurementGroupId': 'BG002',\n                   'BaselineMeasurementValue': '66'}]}},\n               {'BaselineCategoryTitle': 'Male',\n                'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '94'},\n                  {'BaselineMeasurementGroupId': 'BG001',\n                   'BaselineMeasurementValue': '93'},\n                  {'BaselineMeasurementGroupId': 'BG002',\n                   'BaselineMeasurementValue': '187'}]}}]}}]}},\n         {'BaselineMeasureTitle': 'Region of Enrollment',\n          'BaselineMeasureParamType': 'Number',\n          'BaselineMeasureUnitOfMeasure': 'participants',\n          'BaselineClassList': {'BaselineClass': [{'BaselineClassTitle': 'United States',\n             'BaselineCategoryList': {'BaselineCategory': [{'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '19'},\n                  {'BaselineMeasurementGroupId': 'BG001',\n                   'BaselineMeasurementValue': '16'},\n                  {'BaselineMeasurementGroupId': 'BG002',\n                   'BaselineMeasurementValue': '35'}]}}]}},\n            {'BaselineClassTitle': 'Canada',\n             'BaselineCategoryList': {'BaselineCategory': [{'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '22'},\n                  {'BaselineMeasurementGroupId': 'BG001',\n                   'BaselineMeasurementValue': '23'},\n                  {'BaselineMeasurementGroupId': 'BG002',\n                   'BaselineMeasurementValue': '45'}]}}]}},\n            {'BaselineClassTitle': 'Poland',\n             'BaselineCategoryList': {'BaselineCategory': [{'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '87'},\n                  {'BaselineMeasurementGroupId': 'BG001',\n                   'BaselineMeasurementValue': '86'},\n                  {'BaselineMeasurementGroupId': 'BG002',\n                   'BaselineMeasurementValue': '173'}]}}]}}]}}]}},\n      'OutcomeMeasuresModule': {'OutcomeMeasureList': {'OutcomeMeasure': [{'OutcomeMeasureType': 'Primary',\n          'OutcomeMeasureTitle': 'Change From Baseline in Left Ventricular End Diastolic Volume Index (LVEDVi in mL/m2) at Day 90 Post Myocardial Infarction (MI)',\n          'OutcomeMeasureDescription': 'Mean change of left ventricular end diastolic volume index (mL/m2) as evaluated via ventricular end-diastolic volume index augmentation 90 days post Myocardial Infarction (MI)',\n          'OutcomeMeasurePopulationDescription': 'A patient was considered evaluable for the primary efficacy assessment if data were complete for at least the baseline and Day 90 visit (i.e., no data were imputed for the primary endpoint).',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Error',\n          'OutcomeMeasureUnitOfMeasure': 'mL/m2',\n          'OutcomeMeasureTimeFrame': '90 days',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Placebo',\n             'OutcomeGroupDescription': 'Placebo tablet twice daily for 90 days'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'PG-116800 Tablet',\n             'OutcomeGroupDescription': 'PG-116800 tablet (200 mg) twice daily for 90 days'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '108'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '99'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '5.48',\n                   'OutcomeMeasurementSpread': '1.41'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '5.09',\n                   'OutcomeMeasurementSpread': '1.45'}]}}]}}]},\n          'OutcomeAnalysisList': {'OutcomeAnalysis': [{'OutcomeAnalysisGroupIdList': {'OutcomeAnalysisGroupId': ['OG000',\n               'OG001']},\n             'OutcomeAnalysisGroupDescription': 'Changes from baseline in efficacy parameters at Day 90.',\n             'OutcomeAnalysisTestedNonInferiority': 'No',\n             'OutcomeAnalysisNonInferiorityType': 'Superiority or Other',\n             'OutcomeAnalysisPValue': '0.4239',\n             'OutcomeAnalysisStatisticalMethod': 'ANOVA',\n             'OutcomeAnalysisParamType': 'Mean Difference (Net)',\n             'OutcomeAnalysisParamValue': '4',\n             'OutcomeAnalysisCIPctValue': '95',\n             'OutcomeAnalysisCINumSides': '2-Sided'}]}}]}},\n      'AdverseEventsModule': {'EventsFrequencyThreshold': '5',\n       'EventGroupList': {'EventGroup': [{'EventGroupId': 'EG000',\n          'EventGroupTitle': 'Placebo',\n          'EventGroupDescription': 'Placebo tablet twice daily for 90 days',\n          'EventGroupSeriousNumAffected': '67',\n          'EventGroupSeriousNumAtRisk': '128',\n          'EventGroupOtherNumAffected': '124',\n          'EventGroupOtherNumAtRisk': '128'},\n         {'EventGroupId': 'EG001',\n          'EventGroupTitle': 'PG-116800 Tablet',\n          'EventGroupDescription': 'PG-116800 tablet (200 mg) twice daily for 90 days',\n          'EventGroupSeriousNumAffected': '75',\n          'EventGroupSeriousNumAtRisk': '125',\n          'EventGroupOtherNumAffected': '124',\n          'EventGroupOtherNumAtRisk': '125'}]},\n       'SeriousEventList': {'SeriousEvent': [{'SeriousEventTerm': 'Anaemia',\n          'SeriousEventOrganSystem': 'Blood and lymphatic system disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA',\n          'SeriousEventAssessmentType': 'Systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Pancytopenia',\n          'SeriousEventOrganSystem': 'Blood and lymphatic system disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Atrioventricular block complete',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Atrioventricular block second degree',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Bundle branch block',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Intracardiac thrombus',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Coronary Artery disease',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Cardiac failure NOS',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '9',\n             'SeriousEventStatsNumAffected': '7',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '5',\n             'SeriousEventStatsNumAffected': '3',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Cardiac failure acute',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Cardiac failure chronic',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Cardiac failure congestive',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '8',\n             'SeriousEventStatsNumAffected': '6',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Cardiogenic shock',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '3',\n             'SeriousEventStatsNumAffected': '3',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Acute coronary sydrome',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '3',\n             'SeriousEventStatsNumAffected': '3',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '3',\n             'SeriousEventStatsNumAffected': '3',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Acute myocardial infarction',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Angina pectoris',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '3',\n             'SeriousEventStatsNumAffected': '3',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Angina unstable',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Myocardial infarction',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '7',\n             'SeriousEventStatsNumAffected': '7',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Myocardial ischaemia',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Mitral valve incompetence',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Cardiac aneurysm',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': \"Dressler's syndrome\",\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Bradycardia',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Atrial fibrillation',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Tricuspid valve incompetence',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Ventricular fibrillation',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Ventricular tachycardia',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Vestibular neruontis',\n          'SeriousEventOrganSystem': 'Ear and labyrinth disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Gastritis',\n          'SeriousEventOrganSystem': 'Gastrointestinal disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Diverticular perforation',\n          'SeriousEventOrganSystem': 'Gastrointestinal disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Asthenia',\n          'SeriousEventOrganSystem': 'General disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'oedema peripheral',\n          'SeriousEventOrganSystem': 'General disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Chest pain',\n          'SeriousEventOrganSystem': 'General disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '3',\n             'SeriousEventStatsNumAffected': '3',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Discomfort',\n          'SeriousEventOrganSystem': 'General disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'General disorders and administration site conditions',\n          'SeriousEventOrganSystem': 'General disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '5',\n             'SeriousEventStatsNumAffected': '5',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '4',\n             'SeriousEventStatsNumAffected': '4',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Hepatic failure',\n          'SeriousEventOrganSystem': 'Hepatobiliary disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Bronchitis acute',\n          'SeriousEventOrganSystem': 'Infections and infestations',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Bronchopneumonia',\n          'SeriousEventOrganSystem': 'Infections and infestations',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Lower respiratory tract infection',\n          'SeriousEventOrganSystem': 'Infections and infestations',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Pneumonia',\n          'SeriousEventOrganSystem': 'Infections and infestations',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '4',\n             'SeriousEventStatsNumAffected': '4',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Coronary artery restenosis',\n          'SeriousEventOrganSystem': 'Injury, poisoning and procedural complications',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Blood potassium increased',\n          'SeriousEventOrganSystem': 'Investigations',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Blood creatinine increased',\n          'SeriousEventOrganSystem': 'Investigations',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Diabetic ketoacidosis',\n          'SeriousEventOrganSystem': 'Metabolism and nutrition disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Metabolism and nutrition disorders',\n          'SeriousEventOrganSystem': 'Metabolism and nutrition disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Intervertebral discitis',\n          'SeriousEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Joint contracture',\n          'SeriousEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Arthralgia',\n          'SeriousEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Joint range of motion decreased',\n          'SeriousEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Fasciitis',\n          'SeriousEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Nodule on extremity',\n          'SeriousEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Tendonitis',\n          'SeriousEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Rectal cancer',\n          'SeriousEventOrganSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Cerebrovascular accident',\n          'SeriousEventOrganSystem': 'Nervous system disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Syncope vasovagal',\n          'SeriousEventOrganSystem': 'Nervous system disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Transient ischaemic attack',\n          'SeriousEventOrganSystem': 'Nervous system disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'confusional state',\n          'SeriousEventOrganSystem': 'Psychiatric disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Urinary retention',\n          'SeriousEventOrganSystem': 'Renal and urinary disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Renal insufficiency',\n          'SeriousEventOrganSystem': 'Renal and urinary disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Prostatitis',\n          'SeriousEventOrganSystem': 'Reproductive system and breast disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Chronic obstructive airways disease exacerbated',\n          'SeriousEventOrganSystem': 'Respiratory, thoracic and mediastinal disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'epistaxis',\n          'SeriousEventOrganSystem': 'Respiratory, thoracic and mediastinal disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Pneumothorax',\n          'SeriousEventOrganSystem': 'Respiratory, thoracic and mediastinal disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Pulmonary hypertension',\n          'SeriousEventOrganSystem': 'Respiratory, thoracic and mediastinal disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Pulmonary oedemas',\n          'SeriousEventOrganSystem': 'Respiratory, thoracic and mediastinal disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Pulmonary embolism',\n          'SeriousEventOrganSystem': 'Respiratory, thoracic and mediastinal disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Acute respiratory failure',\n          'SeriousEventOrganSystem': 'Respiratory, thoracic and mediastinal disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Face oedema',\n          'SeriousEventOrganSystem': 'Skin and subcutaneous tissue disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Dermatitis medicamentosa',\n          'SeriousEventOrganSystem': 'Skin and subcutaneous tissue disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Vascular pesuoaneurysm',\n          'SeriousEventOrganSystem': 'Vascular disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Hypotension',\n          'SeriousEventOrganSystem': 'Vascular disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Cardiac arrest',\n          'SeriousEventOrganSystem': 'Cardiac disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Musculoskeletal chest pain',\n          'SeriousEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Tendon disorder',\n          'SeriousEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '2',\n             'SeriousEventStatsNumAffected': '2',\n             'SeriousEventStatsNumAtRisk': '125'}]}},\n         {'SeriousEventTerm': 'Renal failure acute',\n          'SeriousEventOrganSystem': 'Renal and urinary disorders',\n          'SeriousEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'SeriousEventAssessmentType': 'Non-systematic Assessment',\n          'SeriousEventStatsList': {'SeriousEventStats': [{'SeriousEventStatsGroupId': 'EG000',\n             'SeriousEventStatsNumEvents': '1',\n             'SeriousEventStatsNumAffected': '1',\n             'SeriousEventStatsNumAtRisk': '128'},\n            {'SeriousEventStatsGroupId': 'EG001',\n             'SeriousEventStatsNumEvents': '0',\n             'SeriousEventStatsNumAffected': '0',\n             'SeriousEventStatsNumAtRisk': '125'}]}}]},\n       'OtherEventList': {'OtherEvent': [{'OtherEventTerm': 'Nausea',\n          'OtherEventOrganSystem': 'Gastrointestinal disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '7',\n             'OtherEventStatsNumAffected': '6',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '5',\n             'OtherEventStatsNumAffected': '3',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Fatigue',\n          'OtherEventOrganSystem': 'General disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '10',\n             'OtherEventStatsNumAffected': '9',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '0',\n             'OtherEventStatsNumAffected': '0',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Pyrexia',\n          'OtherEventOrganSystem': 'General disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '10',\n             'OtherEventStatsNumAffected': '9',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '3',\n             'OtherEventStatsNumAffected': '2',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Arthralgia',\n          'OtherEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '12',\n             'OtherEventStatsNumAffected': '10',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '29',\n             'OtherEventStatsNumAffected': '17',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Joint range of motion decreased',\n          'OtherEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '6',\n             'OtherEventStatsNumAffected': '4',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '7',\n             'OtherEventStatsNumAffected': '6',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Joint stiffness',\n          'OtherEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '0',\n             'OtherEventStatsNumAffected': '0',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '10',\n             'OtherEventStatsNumAffected': '7',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Back pain',\n          'OtherEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '4',\n             'OtherEventStatsNumAffected': '4',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '7',\n             'OtherEventStatsNumAffected': '6',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Pain in extremity',\n          'OtherEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '12',\n             'OtherEventStatsNumAffected': '10',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '10',\n             'OtherEventStatsNumAffected': '7',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Tendon disorder',\n          'OtherEventOrganSystem': 'Musculoskeletal and connective tissue disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '3',\n             'OtherEventStatsNumAffected': '3',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '7',\n             'OtherEventStatsNumAffected': '7',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Headache',\n          'OtherEventOrganSystem': 'Nervous system disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '11',\n             'OtherEventStatsNumAffected': '11',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '9',\n             'OtherEventStatsNumAffected': '7',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Dizziness',\n          'OtherEventOrganSystem': 'Nervous system disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '11',\n             'OtherEventStatsNumAffected': '11',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '5',\n             'OtherEventStatsNumAffected': '3',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Anxiety',\n          'OtherEventOrganSystem': 'Nervous system disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '2',\n             'OtherEventStatsNumAffected': '2',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '8',\n             'OtherEventStatsNumAffected': '8',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Insomnia',\n          'OtherEventOrganSystem': 'Nervous system disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '13',\n             'OtherEventStatsNumAffected': '12',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '9',\n             'OtherEventStatsNumAffected': '9',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Dyspnea',\n          'OtherEventOrganSystem': 'Respiratory, thoracic and mediastinal disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '9',\n             'OtherEventStatsNumAffected': '8',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '10',\n             'OtherEventStatsNumAffected': '10',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Dyspnea exertional',\n          'OtherEventOrganSystem': 'Respiratory, thoracic and mediastinal disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '2',\n             'OtherEventStatsNumAffected': '2',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '7',\n             'OtherEventStatsNumAffected': '7',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Cough',\n          'OtherEventOrganSystem': 'Respiratory, thoracic and mediastinal disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '9',\n             'OtherEventStatsNumAffected': '8',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '13',\n             'OtherEventStatsNumAffected': '13',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Rash',\n          'OtherEventOrganSystem': 'Skin and subcutaneous tissue disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '5',\n             'OtherEventStatsNumAffected': '5',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '7',\n             'OtherEventStatsNumAffected': '7',\n             'OtherEventStatsNumAtRisk': '125'}]}},\n         {'OtherEventTerm': 'Hypertension',\n          'OtherEventOrganSystem': 'Vascular disorders',\n          'OtherEventSourceVocabulary': 'MedDRA (Unspecified)',\n          'OtherEventAssessmentType': 'Non-systematic Assessment',\n          'OtherEventStatsList': {'OtherEventStats': [{'OtherEventStatsGroupId': 'EG000',\n             'OtherEventStatsNumEvents': '14',\n             'OtherEventStatsNumAffected': '10',\n             'OtherEventStatsNumAtRisk': '128'},\n            {'OtherEventStatsGroupId': 'EG001',\n             'OtherEventStatsNumEvents': '5',\n             'OtherEventStatsNumAffected': '5',\n             'OtherEventStatsNumAtRisk': '125'}]}}]}},\n      'MoreInfoModule': {'CertainAgreement': {'AgreementPISponsorEmployee': 'No',\n        'AgreementRestrictionType': 'OTHER',\n        'AgreementRestrictiveAgreement': 'Yes',\n        'AgreementOtherDetails': 'Data, calculations, interpretations, opinions, and recommendations will be the property of P&GP. Manuscripts for publication will be drafted by the Expert Panel which will select appropriate journals in which to publish. P&GP, through its Expert Panel representation, will provide technical/editorial/review assistance. Other manuscript(s) will supported as appropriate. These materials must be submitted to P&GP and the Expert Panel for review prior to publication'},\n       'PointOfContact': {'PointOfContactTitle': 'Peter Thomas',\n        'PointOfContactOrganization': 'Procter & Gamble',\n        'PointOfContactEMail': 'thomas.pr@pg.com',\n        'PointOfContactPhone': '513.622.4838'}}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000006332',\n          'ConditionMeshTerm': 'Cardiomegaly'},\n         {'ConditionMeshId': 'D000007238',\n          'ConditionMeshTerm': 'Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'},\n         {'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'},\n         {'ConditionAncestorId': 'D000006984',\n          'ConditionAncestorTerm': 'Hypertrophy'},\n         {'ConditionAncestorId': 'D000020763',\n          'ConditionAncestorTerm': 'Pathological Conditions, Anatomical'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M9421',\n          'ConditionBrowseLeafName': 'Heart Failure',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10035',\n          'ConditionBrowseLeafName': 'Hypertrophy',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafAsFound': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M9420',\n          'ConditionBrowseLeafName': 'Cardiomegaly',\n          'ConditionBrowseLeafAsFound': 'Heart Enlargement',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M22519',\n          'ConditionBrowseLeafName': 'Pathological Conditions, Anatomical',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'}]}}}}},\n   {'Rank': 8,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT01911910',\n       'OrgStudyIdInfo': {'OrgStudyId': 'ReDa: 007711'},\n       'Organization': {'OrgFullName': 'Queen Mary University of London',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'Heart Attack Prevention Programme for You (HAPPY) London',\n       'OfficialTitle': 'Heart Attack Prevention Programme for You (HAPPY) London',\n       'Acronym': 'HAPPYLondon'},\n      'StatusModule': {'StatusVerifiedDate': 'September 2020',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'June 2013'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'May 2015',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'May 2015',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'July 22, 2013',\n       'StudyFirstSubmitQCDate': 'July 27, 2013',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'July 30, 2013',\n        'StudyFirstPostDateType': 'Estimate'},\n       'ResultsFirstSubmitDate': 'November 30, 2019',\n       'ResultsFirstSubmitQCDate': 'September 17, 2020',\n       'ResultsFirstPostDateStruct': {'ResultsFirstPostDate': 'October 12, 2020',\n        'ResultsFirstPostDateType': 'Actual'},\n       'LastUpdateSubmitDate': 'September 17, 2020',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'October 12, 2020',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Principal Investigator',\n        'ResponsiblePartyInvestigatorFullName': 'Dr Steffen Erhard Petersen',\n        'ResponsiblePartyInvestigatorTitle': 'Reader in Advanced Cardiovascular Imaging, Honorary Consultant Cardiologist, Centre Lead for Advanced Cardiovascular Imaging',\n        'ResponsiblePartyInvestigatorAffiliation': 'Queen Mary University of London'},\n       'LeadSponsor': {'LeadSponsorName': 'Queen Mary University of London',\n        'LeadSponsorClass': 'OTHER'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'Barts & The London NHS Trust',\n          'CollaboratorClass': 'OTHER'}]}},\n      'OversightModule': {'OversightHasDMC': 'No'},\n      'DescriptionModule': {'BriefSummary': \"Diseases of the heart and blood vessels, such as heart attacks and strokes, are very common and can lead to severe disability or death. Changes in the body leading to heart attacks and strokes usually develop over decades as a result of smoking, diet, and lack of exercise, obesity, diabetes and high blood pressure. Changes in lifestyle and diet can significantly reduce the risk of heart diseases. General Practitioners invite 40 to 74 year-olds who have no known heart disease to take part in the NHS Health Check, which measures each person's individual risk of developing a heart attack or stroke and encourages them in a face-to-face meeting to take part in programmes to help them to give up smoking, lose weight etc. where necessary. In this new clinical trial the investigators will test whether computer-tailored electronic (e)-coaching via email and the internet can help people make the necessary changes in their lifestyle to reduce the risk of heart attacks and strokes.\",\n       'DetailedDescription': \"Heart Attack Prevention Programme for You London (HAPPY London) will be conducted as a randomised controlled trial comparing the use of tailored e-coaching in addition to the standard of care vs. standard care alone. Standard care is defined as the care that would be offered by the NHS Health Check programme through the NHS primary care. We will use a range of established and novel cardiovascular markers to determine the clinical and cost effectiveness of e-coaching and gain pathophysiological insight into how lifestyle modifications affect the cardiovascular system. These measures include cardiovascular magnetic resonance imaging (CMR), aortic stiffness parameters, vascular ultrasound and other biomarkers of CV disease risk.\\n\\nIntervention\\n\\nThe HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based on the modified Framingham score and the UK specific QRisk Score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen 'buddies' from family or friends to view their progress will aim to further encourage healthier behaviour.\\n\\nThe study involves the recruitment of 400 adults between the age of 40 and 74 years who have a moderate to high 10-year CV risk score (Estimated 10 year CV risk >10%). Half of the study group will receive use of the e-coaching in addition to standard care allocated randomly stratified according to either moderate (QRisk between 10 and 20%) or high risk (QRisk more than or equal to 20%). The initial screening will take place on the www.happylondon.info web-based 'mini-check' questionnaire. Potential participants will then be seen at a physical screening visit to confirm eligibility. 3 subsequent visits will take place over 6 months; baseline, 3 month and 6 month follow up. A subgroup of the study population (65 from each intervention arm thus totalling 130 participants ) will also have a baseline and follow up cardiovascular magnetic resonance (CMR) imaging. Assessment will be performed using a variety of measures through questionnaires, blood pressure (BP) checks, blood tests, ultrasound scans, oscillometric method to assess pulse wave velocity and pulse wave analysis and CMR multi-parametric scanning.\\n\\nThe primary aim of this study is to assess the clinical effectiveness of individualised, continuous electronic (e-) coaching to support a healthier lifestyle as a primary prevention tool to reduce the CV risk and improve the quality of life in asymptomatic individuals with intermediate to high 10 year CV risk.\\n\\nOther questions that we aim to answer are:\\n\\nIs computer-tailored e-coaching cost-effective in the short-term (clinical trial period) and during the long-term (decision analysis modelling)\\nWhat are the associations of personality traits, economic preferences, and sociocultural factors with the achieved lifestyle modifications and changes in the cardiovascular phenotype?\\nWhat is the relationship between changes observed in markers derived from our multi-parametric cardiovascular magnetic resonance imaging protocols following lifestyle changes?\\nHow frequent are silent myocardial infarctions in a typical NHS Health Check population?\\nDo treatment effects differ between ethnic groups?\"},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Cardiovascular Disease']},\n       'KeywordList': {'Keyword': ['primary prevention',\n         'Cardiovascular disease',\n         'Cardiovascular magnetic resonance (CMR)',\n         'Electronic coaching (e-coaching)']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Not Applicable']},\n       'DesignInfo': {'DesignAllocation': 'Randomized',\n        'DesignInterventionModel': 'Parallel Assignment',\n        'DesignPrimaryPurpose': 'Prevention',\n        'DesignMaskingInfo': {'DesignMasking': 'Single',\n         'DesignWhoMaskedList': {'DesignWhoMasked': ['Outcomes Assessor']}}},\n       'EnrollmentInfo': {'EnrollmentCount': '402',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'Standard care',\n          'ArmGroupType': 'No Intervention',\n          'ArmGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n         {'ArmGroupLabel': 'Electronic coaching plus standard care',\n          'ArmGroupType': 'Experimental',\n          'ArmGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Behavioral: Electronic coaching plus standard care']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Behavioral',\n          'InterventionName': 'Electronic coaching plus standard care',\n          'InterventionDescription': 'The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Electronic coaching plus standard care']},\n          'InterventionOtherNameList': {'InterventionOtherName': ['Electronic coaching',\n            'E-Coaching',\n            'HAPPY E-Coaching']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Change in Pulse Wave Velocity (PWV)',\n          'PrimaryOutcomeDescription': 'Change in aortic stiffness using a Vicorder device measured in m/s',\n          'PrimaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Change in Carotid Intima Media Thickness CIMT',\n          'SecondaryOutcomeDescription': 'carotid intima media thickness CIMT as measured by ultrasound',\n          'SecondaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported'},\n         {'SecondaryOutcomeMeasure': 'Change in Quality of Life',\n          'SecondaryOutcomeDescription': 'Lifestyle, quality of life and physical activity questionnaires. Questionnaires SF-36, EQ5D-3L, RPAQ.',\n          'SecondaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Data not reported as full analysis not done due to time constraints'},\n         {'SecondaryOutcomeMeasure': 'Pulse Wave Velocity by CMR',\n          'SecondaryOutcomeDescription': 'Change in aortic stiffness as measured by CMR derived aortic pulse wave velocity measured in m/s',\n          'SecondaryOutcomeTimeFrame': 'Baseline and 6 month. Data not reported as full analysis not possible due to time and resource limitations.'},\n         {'SecondaryOutcomeMeasure': 'Aortic Distensibility by Cardiovascular Magnetic Resonance (CMR)',\n          'SecondaryOutcomeDescription': 'CMR will be performed on 65 participants in the treatment and 65 in the standard care group.\\n\\nChange in aortic stiffness - aortic distensibility (mmHg-1, CMR)).',\n          'SecondaryOutcomeTimeFrame': 'Baseline and 6 month'},\n         {'SecondaryOutcomeMeasure': 'Left Ventricular Mass by CMR',\n          'SecondaryOutcomeDescription': 'Change in LV mass index (g/m2, CMR).',\n          'SecondaryOutcomeTimeFrame': 'Baseline and 6 month'},\n         {'SecondaryOutcomeMeasure': 'Left Ventricular Ejection Fraction by CMR',\n          'SecondaryOutcomeDescription': 'LV end-diastolic and end-systolic volume indices, (ml/m2, CMR), LV EF (%, CMR).',\n          'SecondaryOutcomeTimeFrame': 'Baseline and 6 month'},\n         {'SecondaryOutcomeMeasure': 'Myocardial Fibrosis by CMR',\n          'SecondaryOutcomeDescription': 'Extent and change in diffuse myocardial fibrosis (extracellular volume fraction measured as a %, derived from CMR imaging)',\n          'SecondaryOutcomeTimeFrame': 'Baseline and 6 month. Baseline and 6 month. Data not reported as full analysis not possible due to time and resource limitations.'},\n         {'SecondaryOutcomeMeasure': 'Diastolic Function by CMR',\n          'SecondaryOutcomeDescription': 'Diastolic function (strain and strain rate in % and s-1, respectively derived from CMR imaging data).\\n\\nThis is a measure of how stiff the main chamber of the heart is. The software to analyse these data will be available in the future.\\n\\nThe raw images from the scan will be used for future analysis once software for this assessment is developed. Our group is working on developing this tool.',\n          'SecondaryOutcomeTimeFrame': 'Baseline and 6 month. Baseline and 6 month. Data not reported as full analysis not possible due to time and resource limitations.'},\n         {'SecondaryOutcomeMeasure': 'Change in Framingham Risk Score',\n          'SecondaryOutcomeDescription': 'Assessment of cardiovascular risk based on the Framingham algorithm. Minimum value 0% and maximum value theoretically 100%. Higher score means worse predicted outcome.\\n\\nAssessment of 10-year cardiovascular risk score based on the Framingham population derived algorithm.\\n\\nMinimum value 0% and maximum value theoretically 100%. Higher score means worse predicted outcome.',\n          'SecondaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported'},\n         {'SecondaryOutcomeMeasure': 'Change in QRisk Score',\n          'SecondaryOutcomeDescription': 'Assessment of cardiovascular risk score based on the QRisk risk score. Minimum value 0% and maximum value theoretically 100%. Higher score means worse predicted outcome.\\n\\nAssessment of cardiovascular risk score based on the UK standardised using the QRISK2 algorithm (www.qrisk.org).\\n\\nMinimum value 0% and maximum value theoretically 100%. Higher score means worse predicted outcome.',\n          'SecondaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported'},\n         {'SecondaryOutcomeMeasure': 'Change in Total Cholesterol to HDL Ratio',\n          'SecondaryOutcomeDescription': 'Ratio of Total cholesterol to HDL from blood test for lipid profile. Change in the ratio of total cholesterol to HDL cholesterol ratio as assessed though cholesterol blood test. Negative value suggests an improvement.',\n          'SecondaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported'},\n         {'SecondaryOutcomeMeasure': 'Change in LDL Cholesterol',\n          'SecondaryOutcomeDescription': 'Bloods for lipid profile. Change in the level of LDL cholesterol as assessed though cholesterol blood test. Negative value for change suggests an improvement.',\n          'SecondaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported'},\n         {'SecondaryOutcomeMeasure': 'Change in Glucose Levels',\n          'SecondaryOutcomeDescription': 'Fasting glucose bloods. This is an assessment for presence of diabetes and control of blood sugar levels on the day of the test.\\n\\nChange in the blood glucose level as measure on the day of the visit as a measure of blood sugar level. Negative value would suggest an improvement.',\n          'SecondaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported'},\n         {'SecondaryOutcomeMeasure': 'Change in hsCRP',\n          'SecondaryOutcomeDescription': 'baseline and change in hsCRP blood test. hsCRP is measured through a blood test and is a marker of inflammation. Change in the hsCRP level though a blood test. Negative value suggests an improvement.',\n          'SecondaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported'},\n         {'SecondaryOutcomeMeasure': 'Change in Physical Activity',\n          'SecondaryOutcomeDescription': 'Lifestyle, quality of life and physical activity questionnaires. Questionnaires SF-36, EQ5D-3L, RPAQ',\n          'SecondaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported'},\n         {'SecondaryOutcomeMeasure': 'Change in Systolic Blood Pressure',\n          'SecondaryOutcomeDescription': 'Change in systolic blood pressure measured during sitting position',\n          'SecondaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported'},\n         {'SecondaryOutcomeMeasure': 'Change in Diastolic Blood Pressure',\n          'SecondaryOutcomeDescription': 'Change in diastolic blood pressure measure during sitting position.',\n          'SecondaryOutcomeTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nSubjects will be enrolled following an informed consent. The subject will be able to understand and comply with protocol requirements, instructions and protocol-stated restrictions\\nSubjects will be between 40 and 74 years of age\\nSubjects will have unrestricted access to the Internet\\nSubjects will be sufficiently fluent in English language.\\nSubjects will have an estimated intermediate to high risk for CV events based on the web-based pre-screening tool (www.happylondon.info), which is based on the nonlaboratory Framingham risk score (>10% 10 year cardiovascular risk)\\n\\nExclusion Criteria:\\n\\nHistory of stroke or transient ischaemic attack (TIA)\\nCardiac sounding chest pain requiring further investigations\\nCurrent life threatening conditions other than vascular disease (e.g. very severe chronic airways disease, HIV positive, life-threatening arrhythmias) that may prevent a subject from completing the study\\nOnly for subgroup undergoing cardiac contrast-enhanced magnetic resonance studies: Any contraindication to a contrast-enhanced magnetic resonance study, such as known allergies to gadolinium-based contrast agents, severe claustrophobia, pacemakers, defibrillators, etc',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '40 Years',\n       'MaximumAge': '74 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Steffen E Petersen, MD DPhil',\n          'OverallOfficialAffiliation': 'Queen Mary University of London',\n          'OverallOfficialRole': 'Principal Investigator'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'Centre for Advanced Cardiovascular Imaging, William Harvey Research Institute, Queen May University of London',\n          'LocationCity': 'London',\n          'LocationZip': 'E2 9JX',\n          'LocationCountry': 'United Kingdom'}]}},\n      'ReferencesModule': {'ReferenceList': {'Reference': [{'ReferencePMID': '31298823',\n          'ReferenceType': 'result',\n          'ReferenceCitation': 'Khanji MY, Balawon A, Boubertakh R, Hofstra L, Narula J, Hunink M, Pugliese F, Petersen SE. Personalized E-Coaching in Cardiovascular Risk Reduction: A Randomized Controlled Trial. Ann Glob Health. 2019 Jul 12;85(1):107. doi: 10.5334/aogh.2496.'},\n         {'ReferencePMID': '31833441',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': 'Khanji MY, Stone IS, Boubertakh R, Cooper JA, Barnes NC, Petersen SE. Chronic Obstructive Pulmonary Disease as a Predictor of Cardiovascular Risk: A Case-Control Study. COPD. 2020 Feb;17(1):81-89. doi: 10.1080/15412555.2019.1694501. Epub 2019 Dec 13.'}]}}},\n     'ResultsSection': {'ParticipantFlowModule': {'FlowGroupList': {'FlowGroup': [{'FlowGroupId': 'FG000',\n          'FlowGroupTitle': 'Standard Care',\n          'FlowGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n         {'FlowGroupId': 'FG001',\n          'FlowGroupTitle': 'Electronic Coaching Plus Standard Care',\n          'FlowGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n       'FlowPeriodList': {'FlowPeriod': [{'FlowPeriodTitle': 'Overall Study',\n          'FlowMilestoneList': {'FlowMilestone': [{'FlowMilestoneType': 'STARTED',\n             'FlowAchievementList': {'FlowAchievement': [{'FlowAchievementGroupId': 'FG000',\n                'FlowAchievementNumSubjects': '197'},\n               {'FlowAchievementGroupId': 'FG001',\n                'FlowAchievementNumSubjects': '205'}]}},\n            {'FlowMilestoneType': 'COMPLETED',\n             'FlowAchievementList': {'FlowAchievement': [{'FlowAchievementGroupId': 'FG000',\n                'FlowAchievementNumSubjects': '184'},\n               {'FlowAchievementGroupId': 'FG001',\n                'FlowAchievementNumSubjects': '194'}]}},\n            {'FlowMilestoneType': 'NOT COMPLETED',\n             'FlowAchievementList': {'FlowAchievement': [{'FlowAchievementGroupId': 'FG000',\n                'FlowAchievementNumSubjects': '13'},\n               {'FlowAchievementGroupId': 'FG001',\n                'FlowAchievementNumSubjects': '11'}]}}]}}]}},\n      'BaselineCharacteristicsModule': {'BaselineGroupList': {'BaselineGroup': [{'BaselineGroupId': 'BG000',\n          'BaselineGroupTitle': 'Standard Care',\n          'BaselineGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n         {'BaselineGroupId': 'BG001',\n          'BaselineGroupTitle': 'Electronic Coaching Plus Standard Care',\n          'BaselineGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'},\n         {'BaselineGroupId': 'BG002',\n          'BaselineGroupTitle': 'Total',\n          'BaselineGroupDescription': 'Total of all reporting groups'}]},\n       'BaselineDenomList': {'BaselineDenom': [{'BaselineDenomUnits': 'Participants',\n          'BaselineDenomCountList': {'BaselineDenomCount': [{'BaselineDenomCountGroupId': 'BG000',\n             'BaselineDenomCountValue': '197'},\n            {'BaselineDenomCountGroupId': 'BG001',\n             'BaselineDenomCountValue': '205'},\n            {'BaselineDenomCountGroupId': 'BG002',\n             'BaselineDenomCountValue': '402'}]}}]},\n       'BaselineMeasureList': {'BaselineMeasure': [{'BaselineMeasureTitle': 'Age, Continuous',\n          'BaselineMeasureParamType': 'Mean',\n          'BaselineMeasureDispersionType': 'Standard Deviation',\n          'BaselineMeasureUnitOfMeasure': 'years',\n          'BaselineClassList': {'BaselineClass': [{'BaselineCategoryList': {'BaselineCategory': [{'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '65.9',\n                   'BaselineMeasurementSpread': '4.8'},\n                  {'BaselineMeasurementGroupId': 'BG001',\n                   'BaselineMeasurementValue': '65.1',\n                   'BaselineMeasurementSpread': '6.3'},\n                  {'BaselineMeasurementGroupId': 'BG002',\n                   'BaselineMeasurementValue': '65.5',\n                   'BaselineMeasurementSpread': '5.6'}]}}]}}]}},\n         {'BaselineMeasureTitle': 'Sex: Female, Male',\n          'BaselineMeasureParamType': 'Count of Participants',\n          'BaselineMeasureUnitOfMeasure': 'Participants',\n          'BaselineClassList': {'BaselineClass': [{'BaselineCategoryList': {'BaselineCategory': [{'BaselineCategoryTitle': 'Female',\n                'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '71'},\n                  {'BaselineMeasurementGroupId': 'BG001',\n                   'BaselineMeasurementValue': '78'},\n                  {'BaselineMeasurementGroupId': 'BG002',\n                   'BaselineMeasurementValue': '149'}]}},\n               {'BaselineCategoryTitle': 'Male',\n                'BaselineMeasurementList': {'BaselineMeasurement': [{'BaselineMeasurementGroupId': 'BG000',\n                   'BaselineMeasurementValue': '126'},\n                  {'BaselineMeasurementGroupId': 'BG001',\n                   'BaselineMeasurementValue': '127'},\n                  {'BaselineMeasurementGroupId': 'BG002',\n                   'BaselineMeasurementValue': '253'}]}}]}}]}}]}},\n      'OutcomeMeasuresModule': {'OutcomeMeasureList': {'OutcomeMeasure': [{'OutcomeMeasureType': 'Primary',\n          'OutcomeMeasureTitle': 'Change in Pulse Wave Velocity (PWV)',\n          'OutcomeMeasureDescription': 'Change in aortic stiffness using a Vicorder device measured in m/s',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'm/s',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '183'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '194'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '-0.25',\n                   'OutcomeMeasurementSpread': '1.73'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '-0.16',\n                   'OutcomeMeasurementSpread': '1.25'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Change in Carotid Intima Media Thickness CIMT',\n          'OutcomeMeasureDescription': 'carotid intima media thickness CIMT as measured by ultrasound',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'mm',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '183'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '194'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '0.01',\n                   'OutcomeMeasurementSpread': '0.09'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '0.01',\n                   'OutcomeMeasurementSpread': '0.08'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Change in Quality of Life',\n          'OutcomeMeasureDescription': 'Lifestyle, quality of life and physical activity questionnaires. Questionnaires SF-36, EQ5D-3L, RPAQ.',\n          'OutcomeMeasurePopulationDescription': 'Change in quality of life using the visual analogue scale (VAS) from the EQ-5D questionnaire. Not all participants completed both the baseline and 6-month follow-up, therefore resulting in a lower number analysed compared to other quantitative measures.The highest VAS is score was 1 (best values, highest quality of life).',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'score on a scale',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Data not reported as full analysis not done due to time constraints',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '162'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '166'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '0.01',\n                   'OutcomeMeasurementSpread': '0.06'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '0',\n                   'OutcomeMeasurementSpread': '0.16'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Pulse Wave Velocity by CMR',\n          'OutcomeMeasureDescription': 'Change in aortic stiffness as measured by CMR derived aortic pulse wave velocity measured in m/s',\n          'OutcomeMeasureReportingStatus': 'Not Posted',\n          'OutcomeMeasureAnticipatedPostingDate': '12/2023',\n          'OutcomeMeasureTimeFrame': 'Baseline and 6 month. Data not reported as full analysis not possible due to time and resource limitations.',\n          'OutcomeMeasureDenomUnitsSelected': 'Participants'},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Aortic Distensibility by Cardiovascular Magnetic Resonance (CMR)',\n          'OutcomeMeasureDescription': 'CMR will be performed on 65 participants in the treatment and 65 in the standard care group.\\n\\nChange in aortic stiffness - aortic distensibility (mmHg-1, CMR)).',\n          'OutcomeMeasureReportingStatus': 'Not Posted',\n          'OutcomeMeasureTimeFrame': 'Baseline and 6 month',\n          'OutcomeMeasureDenomUnitsSelected': 'Participants'},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Left Ventricular Mass by CMR',\n          'OutcomeMeasureDescription': 'Change in LV mass index (g/m2, CMR).',\n          'OutcomeMeasurePopulationDescription': 'CMR data were collected as part of a pilot data in a subgroup of the total number of participants enrolled in the study. Further analysis will take place once funding for further fellow who will be able to perform the detailed software analysis. The data will forms ongoing work.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'g/m2',\n          'OutcomeMeasureTimeFrame': 'Baseline and 6 month',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '42'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '44'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '-1.42',\n                   'OutcomeMeasurementSpread': '8.36'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '-1.73',\n                   'OutcomeMeasurementSpread': '9.4'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Left Ventricular Ejection Fraction by CMR',\n          'OutcomeMeasureDescription': 'LV end-diastolic and end-systolic volume indices, (ml/m2, CMR), LV EF (%, CMR).',\n          'OutcomeMeasurePopulationDescription': 'Change in the ejection fraction based on the moving images derived from the CMR scan.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': '% change in ejection fraction',\n          'OutcomeMeasureTimeFrame': 'Baseline and 6 month',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '42'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '44'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '-0.45',\n                   'OutcomeMeasurementSpread': '5.41'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '-0.88',\n                   'OutcomeMeasurementSpread': '6.29'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Myocardial Fibrosis by CMR',\n          'OutcomeMeasureDescription': 'Extent and change in diffuse myocardial fibrosis (extracellular volume fraction measured as a %, derived from CMR imaging)',\n          'OutcomeMeasureReportingStatus': 'Not Posted',\n          'OutcomeMeasureAnticipatedPostingDate': '12/2023',\n          'OutcomeMeasureTimeFrame': 'Baseline and 6 month. Baseline and 6 month. Data not reported as full analysis not possible due to time and resource limitations.',\n          'OutcomeMeasureDenomUnitsSelected': 'Participants'},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Diastolic Function by CMR',\n          'OutcomeMeasureDescription': 'Diastolic function (strain and strain rate in % and s-1, respectively derived from CMR imaging data).\\n\\nThis is a measure of how stiff the main chamber of the heart is. The software to analyse these data will be available in the future.\\n\\nThe raw images from the scan will be used for future analysis once software for this assessment is developed. Our group is working on developing this tool.',\n          'OutcomeMeasureReportingStatus': 'Not Posted',\n          'OutcomeMeasureAnticipatedPostingDate': '12/2023',\n          'OutcomeMeasureTimeFrame': 'Baseline and 6 month. Baseline and 6 month. Data not reported as full analysis not possible due to time and resource limitations.',\n          'OutcomeMeasureDenomUnitsSelected': 'Participants'},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Change in Framingham Risk Score',\n          'OutcomeMeasureDescription': 'Assessment of cardiovascular risk based on the Framingham algorithm. Minimum value 0% and maximum value theoretically 100%. Higher score means worse predicted outcome.\\n\\nAssessment of 10-year cardiovascular risk score based on the Framingham population derived algorithm.\\n\\nMinimum value 0% and maximum value theoretically 100%. Higher score means worse predicted outcome.',\n          'OutcomeMeasurePopulationDescription': 'Assessment of 10-year cardiovascular risk score based on the Framingham population derived algorithm.\\n\\nMinimum value 0% and maximum value theoretically 100%. Higher score means worse predicted outcome.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': '% risk over 10 years',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '183'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '194'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '-1.37',\n                   'OutcomeMeasurementSpread': '5.68'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '-1.23',\n                   'OutcomeMeasurementSpread': '4.47'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Change in QRisk Score',\n          'OutcomeMeasureDescription': 'Assessment of cardiovascular risk score based on the QRisk risk score. Minimum value 0% and maximum value theoretically 100%. Higher score means worse predicted outcome.\\n\\nAssessment of cardiovascular risk score based on the UK standardised using the QRISK2 algorithm (www.qrisk.org).\\n\\nMinimum value 0% and maximum value theoretically 100%. Higher score means worse predicted outcome.',\n          'OutcomeMeasurePopulationDescription': 'Assessment of cardiovascular risk score based on the UK standardised using the QRISK2 algorithm (www.qrisk.org).\\n\\nMinimum value 0% and maximum value theoretically 100%. Higher score means worse predicted outcome.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': '% risk over 10-years',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '183'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '194'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '-0.05',\n                   'OutcomeMeasurementSpread': '2.64'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '0.2',\n                   'OutcomeMeasurementSpread': '2.52'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Change in Total Cholesterol to HDL Ratio',\n          'OutcomeMeasureDescription': 'Ratio of Total cholesterol to HDL from blood test for lipid profile. Change in the ratio of total cholesterol to HDL cholesterol ratio as assessed though cholesterol blood test. Negative value suggests an improvement.',\n          'OutcomeMeasurePopulationDescription': 'Change in the ratio of total cholesterol to HDL cholesterol ratio as assessed though cholesterol blood test. Negative value suggests an improvement.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'ratio',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '183'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '194'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '-0.11',\n                   'OutcomeMeasurementSpread': '0.66'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '-0.04',\n                   'OutcomeMeasurementSpread': '0.55'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Change in LDL Cholesterol',\n          'OutcomeMeasureDescription': 'Bloods for lipid profile. Change in the level of LDL cholesterol as assessed though cholesterol blood test. Negative value for change suggests an improvement.',\n          'OutcomeMeasurePopulationDescription': 'Change in the level of LDL cholesterol as assessed though cholesterol blood test. Negative value for change suggests an improvement.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'mmol/L',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '183'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '194'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '-0.2',\n                   'OutcomeMeasurementSpread': '0.77'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '-0.16',\n                   'OutcomeMeasurementSpread': '0.68'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Change in Glucose Levels',\n          'OutcomeMeasureDescription': 'Fasting glucose bloods. This is an assessment for presence of diabetes and control of blood sugar levels on the day of the test.\\n\\nChange in the blood glucose level as measure on the day of the visit as a measure of blood sugar level. Negative value would suggest an improvement.',\n          'OutcomeMeasurePopulationDescription': 'Change in the blood glucose level as measure on the day of the visit as a measure of blood sugar level. Negative value would suggest an improvement.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'mmol/L',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '183'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '194'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '-0.27',\n                   'OutcomeMeasurementSpread': '0.87'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '-0.29',\n                   'OutcomeMeasurementSpread': '0.87'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Change in hsCRP',\n          'OutcomeMeasureDescription': 'baseline and change in hsCRP blood test. hsCRP is measured through a blood test and is a marker of inflammation. Change in the hsCRP level though a blood test. Negative value suggests an improvement.',\n          'OutcomeMeasurePopulationDescription': 'Change in the hsCRP level though a blood test. Negative value suggests an improvement.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'mg/L',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '183'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '194'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '0',\n                   'OutcomeMeasurementSpread': '7.7'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '-0.26',\n                   'OutcomeMeasurementSpread': '8.19'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Change in Physical Activity',\n          'OutcomeMeasureDescription': 'Lifestyle, quality of life and physical activity questionnaires. Questionnaires SF-36, EQ5D-3L, RPAQ',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'minutes per day over 5 days',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '183'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '194'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '8.45',\n                   'OutcomeMeasurementSpread': '118.87'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '25.1',\n                   'OutcomeMeasurementSpread': '132.85'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Change in Systolic Blood Pressure',\n          'OutcomeMeasureDescription': 'Change in systolic blood pressure measured during sitting position',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'mmHg',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '183'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '194'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '-1.69',\n                   'OutcomeMeasurementSpread': '13.91'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '-3.18',\n                   'OutcomeMeasurementSpread': '12.2'}]}}]}}]}},\n         {'OutcomeMeasureType': 'Secondary',\n          'OutcomeMeasureTitle': 'Change in Diastolic Blood Pressure',\n          'OutcomeMeasureDescription': 'Change in diastolic blood pressure measure during sitting position.',\n          'OutcomeMeasureReportingStatus': 'Posted',\n          'OutcomeMeasureParamType': 'Mean',\n          'OutcomeMeasureDispersionType': 'Standard Deviation',\n          'OutcomeMeasureUnitOfMeasure': 'mmHg',\n          'OutcomeMeasureTimeFrame': 'Assessed at Baseline visit, 3 months and 6 months; Month 6 reported',\n          'OutcomeGroupList': {'OutcomeGroup': [{'OutcomeGroupId': 'OG000',\n             'OutcomeGroupTitle': 'Standard Care',\n             'OutcomeGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.'},\n            {'OutcomeGroupId': 'OG001',\n             'OutcomeGroupTitle': 'Electronic Coaching Plus Standard Care',\n             'OutcomeGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.'}]},\n          'OutcomeDenomList': {'OutcomeDenom': [{'OutcomeDenomUnits': 'Participants',\n             'OutcomeDenomCountList': {'OutcomeDenomCount': [{'OutcomeDenomCountGroupId': 'OG000',\n                'OutcomeDenomCountValue': '183'},\n               {'OutcomeDenomCountGroupId': 'OG001',\n                'OutcomeDenomCountValue': '194'}]}}]},\n          'OutcomeClassList': {'OutcomeClass': [{'OutcomeCategoryList': {'OutcomeCategory': [{'OutcomeMeasurementList': {'OutcomeMeasurement': [{'OutcomeMeasurementGroupId': 'OG000',\n                   'OutcomeMeasurementValue': '-2.08',\n                   'OutcomeMeasurementSpread': '6.85'},\n                  {'OutcomeMeasurementGroupId': 'OG001',\n                   'OutcomeMeasurementValue': '-2.37',\n                   'OutcomeMeasurementSpread': '6.41'}]}}]}}]}}]}},\n      'AdverseEventsModule': {'EventsFrequencyThreshold': '0',\n       'EventsTimeFrame': '6 months',\n       'EventGroupList': {'EventGroup': [{'EventGroupId': 'EG000',\n          'EventGroupTitle': 'Standard Care',\n          'EventGroupDescription': 'Usual care that would be provided by the NHS Health Check or equivalent.',\n          'EventGroupDeathsNumAffected': '0',\n          'EventGroupDeathsNumAtRisk': '197',\n          'EventGroupSeriousNumAffected': '0',\n          'EventGroupSeriousNumAtRisk': '197',\n          'EventGroupOtherNumAffected': '0',\n          'EventGroupOtherNumAtRisk': '197'},\n         {'EventGroupId': 'EG001',\n          'EventGroupTitle': 'Electronic Coaching Plus Standard Care',\n          'EventGroupDescription': 'Tailored coaching for participants randomised to use the HAPPY e-coaching tool. Access to lifestyle and heart health scores and personalised advice to improve suboptimal behaviour.\\n\\nElectronic coaching plus standard care: The HAPPY London web-based tool will provide the participant with an individualised score for their lifestyle and 10 year CV risk score, based mainly on the modified Framingham score, and provide tailored advice and education on the suboptimal factors. Ideal targets will be set and the information will be updated at 3 and 6 months allowing the participant to view their progress. Weekly emails with brief health and lifestyle advice will be sent to encourage healthier behaviour based on clinical studies or topical issues in the media. Links to social networks, such as Facebook posting and the ability to allow chosen family and friends to view their progress will aim to further encourage healthier behaviour.',\n          'EventGroupDeathsNumAffected': '0',\n          'EventGroupDeathsNumAtRisk': '205',\n          'EventGroupSeriousNumAffected': '0',\n          'EventGroupSeriousNumAtRisk': '205',\n          'EventGroupOtherNumAffected': '0',\n          'EventGroupOtherNumAtRisk': '205'}]}},\n      'MoreInfoModule': {'CertainAgreement': {'AgreementPISponsorEmployee': 'Yes'},\n       'PointOfContact': {'PointOfContactTitle': 'Dr Mohammed Khanji',\n        'PointOfContactOrganization': 'Queen Mary University London/ Barts Health NHS Trsut',\n        'PointOfContactEMail': 'm.khanji@qmul.ac.uk',\n        'PointOfContactPhone': '020 7363 8079'}}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000002318',\n          'ConditionMeshTerm': 'Cardiovascular Diseases'},\n         {'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'},\n         {'ConditionAncestorId': 'D000007238',\n          'ConditionAncestorTerm': 'Infarction'},\n         {'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Heart Attack',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'}]}}}}},\n   {'Rank': 9,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT01936675',\n       'OrgStudyIdInfo': {'OrgStudyId': '12-001727'},\n       'SecondaryIdInfoList': {'SecondaryIdInfo': [{'SecondaryId': 'U01HG006379',\n          'SecondaryIdType': 'U.S. NIH Grant/Contract',\n          'SecondaryIdLink': 'https://reporter.nih.gov/quickSearch/U01HG006379'}]},\n       'Organization': {'OrgFullName': 'Mayo Clinic', 'OrgClass': 'OTHER'},\n       'BriefTitle': 'Myocardial Infarction Genes (MI-GENES) Study',\n       'OfficialTitle': 'Myocardial Infarction Genes (MI-GENES) Study - Using Genomic Data to Refine Risk Assessment for Heart Attack',\n       'Acronym': 'MI-GENES'},\n      'StatusModule': {'StatusVerifiedDate': 'May 2016',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'July 2013'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'November 2014',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'November 2014',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'September 3, 2013',\n       'StudyFirstSubmitQCDate': 'September 5, 2013',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'September 6, 2013',\n        'StudyFirstPostDateType': 'Estimate'},\n       'LastUpdateSubmitDate': 'May 2, 2016',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'May 3, 2016',\n        'LastUpdatePostDateType': 'Estimate'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Principal Investigator',\n        'ResponsiblePartyInvestigatorFullName': 'Iftikhar J. Kullo',\n        'ResponsiblePartyInvestigatorTitle': 'Professor of Medicine, Division of Cardiovascular Diseases, Department of Internal Medicine',\n        'ResponsiblePartyInvestigatorAffiliation': 'Mayo Clinic'},\n       'LeadSponsor': {'LeadSponsorName': 'Mayo Clinic',\n        'LeadSponsorClass': 'OTHER'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'National Human Genome Research Institute (NHGRI)',\n          'CollaboratorClass': 'NIH'}]}},\n      'OversightModule': {'OversightHasDMC': 'No'},\n      'DescriptionModule': {'BriefSummary': 'This study is being done to better understand how genetic information might improve assessment of heart attack risk.',\n       'DetailedDescription': \"This study aims to randomize patients to 2 arms. The first arm will receive the conventional Framingham risk score for coronary heart disease while the intervention arm will receive the genetics-informed risk for coronary artery disease.\\n\\nThe investigators will assess baseline blood lipid levels and follow the 2 arms up to 6 months after randomization. Primary endpoint is change in LDL levels between the 2 arms. Secondary outcomes include blood pressure control, weight, smoking cessation, and other lifestyle modifications.\\n\\nThis trial will help us understand whether coronary artery disease risk derived from genetic information would have a significant impact on patients' perception of coronary artery disease risk and motivate healthy lifestyle modifications that reduce their long term risk.\"},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Coronary Artery Disease',\n         'Myocardial Infarction',\n         'Genomic Risk Communication']},\n       'KeywordList': {'Keyword': ['Coronary Artery Disease',\n         'Myocardial Infarction',\n         'Genomic Risk Communication',\n         'Risk Stratification']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Not Applicable']},\n       'DesignInfo': {'DesignAllocation': 'Randomized',\n        'DesignInterventionModel': 'Parallel Assignment',\n        'DesignPrimaryPurpose': 'Health Services Research',\n        'DesignMaskingInfo': {'DesignMasking': 'None (Open Label)'}},\n       'EnrollmentInfo': {'EnrollmentCount': '216',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'Framingham Risk Score',\n          'ArmGroupType': 'No Intervention',\n          'ArmGroupDescription': 'Patients in this arm will receive their Framingham Risk Score of having a heart attack.'},\n         {'ArmGroupLabel': 'Framingham and Genetic Risk Score',\n          'ArmGroupType': 'Active Comparator',\n          'ArmGroupDescription': 'Patients in this arm will receive their Framingham Risk Score as well as their Genetic Risk Score of having a heart attack.',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Other: Genetic Risk Score']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Other',\n          'InterventionName': 'Genetic Risk Score',\n          'InterventionDescription': 'Patients in this arm will receive their genetic-informed risk for having a heart attack.',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Framingham and Genetic Risk Score']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Change in serum LDL-cholesterol level',\n          'PrimaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Change in HDL-cholesterol',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Change in systolic blood pressure measurements',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Change in fasting blood glucose measurements',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Number of Subjects Who Initiated Treatment with Statin Medications',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Number of Subjects Who Used the Patient Portal at One Year',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Shared decision making (as assessed by survey)',\n          'SecondaryOutcomeTimeFrame': 'Immediately after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Physician visit satisfaction (as assessed by survey)',\n          'SecondaryOutcomeTimeFrame': 'Immediately after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Genetic counseling satisfaction and perceived personal control (as assessed by survey)',\n          'SecondaryOutcomeTimeFrame': 'Immediately after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Body mass index measurements',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Waist circumference',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Blood pressure',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Dietary fat intake (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Physical activity (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Smoking cessation',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Anxiety (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': 'at 6 months post disclosure of CAD risk'},\n         {'SecondaryOutcomeMeasure': 'Rating of test results information (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': 'Immediately after risk disclosure and 6 months afterwards'},\n         {'SecondaryOutcomeMeasure': 'Understanding of genetic risk or family history risk (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': 'Immediately after risk disclosure and 6 months afterwards'},\n         {'SecondaryOutcomeMeasure': 'Reaction to test results information (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': 'Immediately after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Perceived risk (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': 'Immediately after risk disclosure and 6 months afterwards'},\n         {'SecondaryOutcomeMeasure': 'Intention to change (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': '3 months after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Recall and measure of locus control (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': '3 months after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Motivation and perceptions (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': '3 months after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Attitudes towards genome sequencing (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': '3 and 6 months after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Impact of events scale (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': '3 and 6 months after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Genetic knowledge (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': 'at enrollment and 6 months after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Attitude toward genetic testing (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': '6 months after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Decisional regret and treatment beliefs (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': '6 months after risk disclosure'},\n         {'SecondaryOutcomeMeasure': 'Use of internet, electronic health record, social networks, and information sharing (assessed by survey)',\n          'SecondaryOutcomeTimeFrame': '3 and 6 months after risk disclosure'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nPatients between the ages of 45-70 years\\nPatients who have participated in the Mayo Clinic Biobank or a previous research study at Mayo Clinic\\nPatients who live in Southeast Minnesota\\n\\nExclusion Criteria:\\n\\nTaking statin or other lipid lowering medications\\nPatients with a history of myocardial infarction, coronary artery disease, or other atherosclerotic medical conditions',\n       'HealthyVolunteers': 'Accepts Healthy Volunteers',\n       'Gender': 'All',\n       'MinimumAge': '45 Years',\n       'MaximumAge': '70 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Iftikhar Kullo, MD',\n          'OverallOfficialAffiliation': 'Mayo Clinic',\n          'OverallOfficialRole': 'Principal Investigator'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'Mayo Clinic',\n          'LocationCity': 'Rochester',\n          'LocationState': 'Minnesota',\n          'LocationZip': '55905',\n          'LocationCountry': 'United States'}]}},\n      'ReferencesModule': {'ReferenceList': {'Reference': [{'ReferencePMID': '22151179',\n          'ReferenceType': 'background',\n          'ReferenceCitation': 'Ding K, Bailey KR, Kullo IJ. Genotype-informed estimation of risk of coronary heart disease based on genome-wide association data linked to the electronic medical record. BMC Cardiovasc Disord. 2011 Nov 3;11:66. doi: 10.1186/1471-2261-11-66.'},\n         {'ReferencePMID': '25708169',\n          'ReferenceType': 'result',\n          'ReferenceCitation': 'Robinson CL, Jouni H, Kruisselbrink TM, Austin EE, Christensen KD, Green RC, Kullo IJ. Disclosing genetic risk for coronary heart disease: effects on perceived personal control and genetic counseling satisfaction. Clin Genet. 2016 Feb;89(2):251-7. doi: 10.1111/cge.12577. Epub 2015 Mar 23.'},\n         {'ReferencePMID': '26271327',\n          'ReferenceType': 'result',\n          'ReferenceCitation': 'Kullo IJ, Jouni H, Olson JE, Montori VM, Bailey KR. Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) study. BMC Med Genomics. 2015 Aug 15;8:51. doi: 10.1186/s12920-015-0122-0.'},\n         {'ReferencePMID': '26915630',\n          'ReferenceType': 'result',\n          'ReferenceCitation': 'Kullo IJ, Jouni H, Austin EE, Brown SA, Kruisselbrink TM, Isseh IN, Haddad RA, Marroush TS, Shameer K, Olson JE, Broeckel U, Green RC, Schaid DJ, Montori VM, Bailey KR. Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial). Circulation. 2016 Mar 22;133(12):1181-8. doi: 10.1161/CIRCULATIONAHA.115.020109. Epub 2016 Feb 25.'},\n         {'ReferencePMID': '30792945',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': 'Brown SN, Jouni H, Kullo IJ. Electronic health record access by patients as an indicator of information seeking and sharing for cardiovascular health promotion in social networks: Secondary analysis of a randomized clinical trial. Prev Med Rep. 2019 Jan 14;13:306-313. doi: 10.1016/j.pmedr.2018.12.011. eCollection 2019 Mar.'},\n         {'ReferencePMID': '28779015',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': 'Brown SN, Jouni H, Marroush TS, Kullo IJ. Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing: The MI-GENES Study (Myocardial Infarction Genes). Circ Cardiovasc Genet. 2017 Aug;10(4):e001613. doi: 10.1161/CIRCGENETICS.116.001613.'},\n         {'ReferencePMID': '27993947',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': 'Jouni H, Haddad RA, Marroush TS, Brown SA, Kruisselbrink TM, Austin EE, Shameer K, Behnken EM, Chaudhry R, Montori VM, Kullo IJ. Shared decision-making following disclosure of coronary heart disease genetic risk: results from a randomized clinical trial. J Investig Med. 2017 Mar;65(3):681-688. doi: 10.1136/jim-2016-000318. Epub 2016 Dec 19.'}]}},\n      'IPDSharingStatementModule': {'IPDSharing': 'No'}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000003324',\n          'ConditionMeshTerm': 'Coronary Artery Disease'},\n         {'ConditionMeshId': 'D000017202',\n          'ConditionMeshTerm': 'Myocardial Ischemia'},\n         {'ConditionMeshId': 'D000003327',\n          'ConditionMeshTerm': 'Coronary Disease'},\n         {'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000007238',\n          'ConditionMeshTerm': 'Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'},\n         {'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000001161',\n          'ConditionAncestorTerm': 'Arteriosclerosis'},\n         {'ConditionAncestorId': 'D000001157',\n          'ConditionAncestorTerm': 'Arterial Occlusive Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafAsFound': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafAsFound': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafAsFound': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M6549',\n          'ConditionBrowseLeafName': 'Coronary Disease',\n          'ConditionBrowseLeafAsFound': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M4469',\n          'ConditionBrowseLeafName': 'Arteriosclerosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M4465',\n          'ConditionBrowseLeafName': 'Arterial Occlusive Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'}]}}}}},\n   {'Rank': 10,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT05781087',\n       'OrgStudyIdInfo': {'OrgStudyId': '292740'},\n       'SecondaryIdInfoList': {'SecondaryIdInfo': [{'SecondaryId': 'FS/CRTF/22/24342',\n          'SecondaryIdType': 'Other Grant/Funding Number',\n          'SecondaryIdDomain': 'British Heart Foundation'}]},\n       'Organization': {'OrgFullName': \"Guy's and St Thomas' NHS Foundation Trust\",\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'Predicting the Risk of Non-culprit Coronary Artery Disease After a Heart Attack',\n       'OfficialTitle': 'Optical Coherence Tomography With Magnetic Resonance Angiography to Assess STEMI Non-culprit Risk',\n       'Acronym': 'OCT-RISK'},\n      'StatusModule': {'StatusVerifiedDate': 'September 2023',\n       'OverallStatus': 'Recruiting',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'April 25, 2023',\n        'StartDateType': 'Actual'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'July 2024',\n        'PrimaryCompletionDateType': 'Anticipated'},\n       'CompletionDateStruct': {'CompletionDate': 'July 2027',\n        'CompletionDateType': 'Anticipated'},\n       'StudyFirstSubmitDate': 'March 9, 2023',\n       'StudyFirstSubmitQCDate': 'March 21, 2023',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'March 23, 2023',\n        'StudyFirstPostDateType': 'Actual'},\n       'LastUpdateSubmitDate': 'September 12, 2023',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'September 13, 2023',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': \"Guy's and St Thomas' NHS Foundation Trust\",\n        'LeadSponsorClass': 'OTHER'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': \"King's College London\",\n          'CollaboratorClass': 'OTHER'},\n         {'CollaboratorName': \"King's College Hospital NHS Trust\",\n          'CollaboratorClass': 'OTHER'}]}},\n      'OversightModule': {'OversightHasDMC': 'No',\n       'IsFDARegulatedDrug': 'No',\n       'IsFDARegulatedDevice': 'No'},\n      'DescriptionModule': {'BriefSummary': \"Heart attacks caused by the complete blockage of a heart artery are treated by opening it with a stent. However, most people will also have 'non-culprit' narrowings found in their other arteries at this time.\\n\\nAlthough in general people do better if these non-culprit narrowings are also treated with stents if they look severe, this process has problems. This is because narrowings that look severe may be stable and not cause any trouble. For these people a stent is a wasted procedure and unnecessary risk. On the other hand, narrowings that are currently left alone because they appear mild, may progress and cause a heart attack.\\n\\nParticipants who have had a heart attack will have a scan from inside the heart arteries during an angiogram (optical coherence tomography, OCT) and a magnetic resonance angiogram (MRA).\\n\\nIf the investigators can show that it is possible to accurately predict which non-culprit narrowings are going to progress and which are going to stabilise, medical professionals may be able to better target their treatments after a heart attack.\"},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Coronary Artery Disease',\n         'ST Elevation Myocardial Infarction',\n         'Ischemic Heart Disease']},\n       'KeywordList': {'Keyword': ['optical coherence tomography',\n         'non-culprit',\n         'magnetic resonance imaging',\n         'cardiac magnetic resonance',\n         'STEMI',\n         'magnetic resonance angiography',\n         'OCT']}},\n      'DesignModule': {'StudyType': 'Observational',\n       'PatientRegistry': 'No',\n       'DesignInfo': {'DesignObservationalModelList': {'DesignObservationalModel': ['Cohort']},\n        'DesignTimePerspectiveList': {'DesignTimePerspective': ['Prospective']}},\n       'EnrollmentInfo': {'EnrollmentCount': '90',\n        'EnrollmentType': 'Anticipated'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'Standard of care',\n          'ArmGroupDescription': 'Patients after ST-elevation myocardial infarction with non-culprit coronary artery disease.',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Diagnostic Test: Optical coherence tomography and pressure wire assessment',\n            'Diagnostic Test: Cardiac magnetic resonance angiogram']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Diagnostic Test',\n          'InterventionName': 'Optical coherence tomography and pressure wire assessment',\n          'InterventionDescription': 'Non-culprit coronary arteries',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Standard of care']},\n          'InterventionOtherNameList': {'InterventionOtherName': ['OCT (Abbott)',\n            'PressureWire X (Abbott)']}},\n         {'InterventionType': 'Diagnostic Test',\n          'InterventionName': 'Cardiac magnetic resonance angiogram',\n          'InterventionDescription': '1.5T',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Standard of care']},\n          'InterventionOtherNameList': {'InterventionOtherName': ['Cardiac MRI']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Change in mean fibrous cap thickness measured by optical coherence tomography',\n          'PrimaryOutcomeTimeFrame': '6 months'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Change in mean lipid arc measured by optical coherence tomography',\n          'SecondaryOutcomeTimeFrame': '6 months'},\n         {'SecondaryOutcomeMeasure': 'Presence of thin cap fibroatheroma measured by optical coherence tomography',\n          'SecondaryOutcomeDescription': 'Plaque with lipid arc >90° and fibrous cap thickness ≤65µm',\n          'SecondaryOutcomeTimeFrame': '6 months'},\n         {'SecondaryOutcomeMeasure': 'Change in measures of shear stress made by optical coherence tomography and magnetic resonance angiography',\n          'SecondaryOutcomeDescription': 'Comparison between non-invasive and invasively derived measures',\n          'SecondaryOutcomeTimeFrame': '0 and 6 months'}]},\n       'OtherOutcomeList': {'OtherOutcome': [{'OtherOutcomeMeasure': 'Non-culprit major adverse cardiac events',\n          'OtherOutcomeDescription': 'Death, myocardial infarction, ischaemia driven revascularisation',\n          'OtherOutcomeTimeFrame': '6 months and 36 months'},\n         {'OtherOutcomeMeasure': 'Change in vessel stenosis measured by optical coherence tomography and magnetic resonance angiography',\n          'OtherOutcomeDescription': 'Comparison between non-invasive and invasively derived measures',\n          'OtherOutcomeTimeFrame': '0, 6 and 36 months'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nSuccessful primary percutaneous coronary intervention (PCI) within the previous week with no major complications at the index procedure\\nBystander disease in a non-culprit vessel planned for clinically indicated staged angiography +/- PCI\\nAble to provide written informed consent.\\n\\nExclusion Criteria:\\n\\nCardiogenic shock requiring intubation, inotropes or a mechanical support device\\nCreatinine clearance <30ml/min\\nPrior coronary artery bypass grafting\\nLife expectancy less than 3 years\\nPregnancy.\\nTarget lesion in the left main coronary artery\\nSevere calcification or tortuosity that would threaten safe placement of a pressure wire or OCT catheter\\nChronic total occlusion of a major epicardial vessel.',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']},\n       'StudyPopulation': 'Patients after presentation with ST elevation myocardial infarction.',\n       'SamplingMethod': 'Non-Probability Sample'},\n      'ContactsLocationsModule': {'CentralContactList': {'CentralContact': [{'CentralContactName': 'Matthew Li Kam Wa, MBBS',\n          'CentralContactRole': 'Contact',\n          'CentralContactPhone': '02071887188',\n          'CentralContactEMail': 'mlikamwa@nhs.net'}]},\n       'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Divaka Perera, MD',\n          'OverallOfficialAffiliation': \"King's College London\",\n          'OverallOfficialRole': 'Principal Investigator'}]},\n       'LocationList': {'Location': [{'LocationFacility': \"St Thomas' Hospital\",\n          'LocationStatus': 'Recruiting',\n          'LocationCity': 'London',\n          'LocationZip': 'SE1 7EH',\n          'LocationCountry': 'United Kingdom',\n          'LocationContactList': {'LocationContact': [{'LocationContactName': 'R&D',\n             'LocationContactRole': 'Contact',\n             'LocationContactEMail': 'R&D@gstt.nhs.uk'},\n            {'LocationContactName': 'Divaka Perera, MD',\n             'LocationContactRole': 'Principal Investigator'}]}},\n         {'LocationFacility': \"King's College Hospital\",\n          'LocationStatus': 'Recruiting',\n          'LocationCity': 'London',\n          'LocationZip': 'SE5 9RS',\n          'LocationCountry': 'United Kingdom',\n          'LocationContactList': {'LocationContact': [{'LocationContactName': 'R&D',\n             'LocationContactRole': 'Contact',\n             'LocationContactEMail': 'kch-tr.research@nhs.net'},\n            {'LocationContactName': 'Ian Webb, PhD',\n             'LocationContactRole': 'Principal Investigator'}]}}]}},\n      'IPDSharingStatementModule': {'IPDSharing': 'No'}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000003324',\n          'ConditionMeshTerm': 'Coronary Artery Disease'},\n         {'ConditionMeshId': 'D000017202',\n          'ConditionMeshTerm': 'Myocardial Ischemia'},\n         {'ConditionMeshId': 'D000003327',\n          'ConditionMeshTerm': 'Coronary Disease'},\n         {'ConditionMeshId': 'D000006331',\n          'ConditionMeshTerm': 'Heart Diseases'},\n         {'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000072657',\n          'ConditionMeshTerm': 'ST Elevation Myocardial Infarction'},\n         {'ConditionMeshId': 'D000007238',\n          'ConditionMeshTerm': 'Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000001161',\n          'ConditionAncestorTerm': 'Arteriosclerosis'},\n         {'ConditionAncestorId': 'D000001157',\n          'ConditionAncestorTerm': 'Arterial Occlusive Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafAsFound': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafAsFound': 'Heart Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafAsFound': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafAsFound': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M6549',\n          'ConditionBrowseLeafName': 'Coronary Disease',\n          'ConditionBrowseLeafAsFound': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M1072',\n          'ConditionBrowseLeafName': 'ST Elevation Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'ST Elevation Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M4469',\n          'ConditionBrowseLeafName': 'Arteriosclerosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M4465',\n          'ConditionBrowseLeafName': 'Arterial Occlusive Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'}]}}}}},\n   {'Rank': 11,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT02376244',\n       'OrgStudyIdInfo': {'OrgStudyId': 'SP 006 - HIIT'},\n       'Organization': {'OrgFullName': 'Liverpool Heart and Chest Hospital NHS Foundation Trust',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'The Health Impact of High Intensity Exercise Training With Intervals During Cardiac Rehabilitation',\n       'OfficialTitle': 'A Randomised Controlled Trial on the Efficacy of High Intensity Interval Training Compared With Moderate Intensity Interval Training for Patients Undergoing Cardiac Rehabilitation'},\n      'StatusModule': {'StatusVerifiedDate': 'August 2016',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'September 2015'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'March 2016',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'June 2016',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'February 11, 2015',\n       'StudyFirstSubmitQCDate': 'February 25, 2015',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'March 3, 2015',\n        'StudyFirstPostDateType': 'Estimate'},\n       'LastUpdateSubmitDate': 'August 17, 2016',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'August 18, 2016',\n        'LastUpdatePostDateType': 'Estimate'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'Liverpool Heart and Chest Hospital NHS Foundation Trust',\n        'LeadSponsorClass': 'OTHER'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'Edge Hill University',\n          'CollaboratorClass': 'OTHER'}]}},\n      'OversightModule': {'OversightHasDMC': 'No'},\n      'DescriptionModule': {'BriefSummary': 'Cardiac rehabilitation is a program designed to help patients regain good health through lifestyle change after a heart attack, heart surgery or other heart problems. Patients will take part in exercise sessions and education lessons, tailored to meet their personal needs. The exercise training component of cardiac rehabilitation may be delivered as intervals of short intense sessions (also known as high intensity intervals) or the current standard care of longer but less intense sessions (moderate intense intervals). Both exercises have been shown to increase fitness levels and also prevent future risk of heart disease.\\n\\nThe purpose of this study is to determine the efficacy and safety of high intensity interval exercise training (HIIT) in patients who had a recent cardiac revascularization procedure or recovering from a heart attack, in comparison to current standard of moderate intensity exercise training in terms of their physical fitness and psychological well-being.',\n       'DetailedDescription': \"Cardiac rehabilitation is an eight week program designed to help patients regain good health through changed lifestyle after a possible heart attack, heart surgery or other heart problems. Patients will take part in exercise sessions and education lessons, tailored to meet their personal needs. The exercise training component of cardiac rehabilitation may be delivered as intervals of short intense sessions (also known as high intensity intervals) or the current standard care of longer but less intense sessions (moderate intense intervals). Both exercises have been shown to increase fitness levels and also prevent future risk of heart disease. Although there is some evidence to suggest that high intensity interval training produces better body muscles recovery and fitness during cardiac rehabilitation, many important health outcomes have not yet been determined. Such outcomes include the ability of the body to safely control blood pressure and heartbeat rate. Others include health-related quality of life and emotional well-being.\\n\\nThis study will explore whether there are any differences in health outcomes before and after the introduction of the intervention for patients undergoing high intensity interval exercise compared to those on moderate intensity interval exercise in terms of the recovery of the ability to control blood pressure and heartbeat rate, and also health-related quality of life and emotional well-being. In addition, patients' opinions will be sought regarding pain levels, the acceptability and the extent of enjoyment they get from each of the two types of exercise training.\\n\\nFor each patient, their exercise program will be designed to match their preferences and requirements. Some may prefer to work in a gym environment and so will have their program designed around this type of activity. Others may prefer to work in a group exercise circuit, with their program matched to what is available. When comparing the two types of exercise, everything will be kept the same; from the warm up and cool down, to the types of movements; the only thing that will change is the intensity of the exercise.\\n\\nBefore and after the eight week training program, patients will be asked to have an assessment to measure the effects that the exercise has on their body. Things like heart rate and blood pressure will be taken and they will also undergo a physical fitness test.\\n\\nAfter the training, patients will complete questionnaires to establish their level of enjoyment of the program, how motivated they were to complete it. In addition, their quality of life and emotional well-being will be measured by completing questionnaires before and after the 8 weeks of the cardiac rehabilitation program. The investigators anticipate that a total of 46 patients will be recruited for the study over a period of 6 months. In the United Kingdom, it is believed that delivering an improved exercise training program has the potential to enhance patients' recovery from heart disease that may reduce the need for hospital services and therefore a better use of the National Health Service resources.\"},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Heart Disease',\n         'Heart Attacks']},\n       'KeywordList': {'Keyword': ['High intensity Interval Exercise training',\n         'Cardiac rehabilitation',\n         'cardiac revascularisation',\n         'Percutaneous coronary interventions',\n         'Cardiac surgery']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Not Applicable']},\n       'DesignInfo': {'DesignAllocation': 'Randomized',\n        'DesignInterventionModel': 'Parallel Assignment',\n        'DesignPrimaryPurpose': 'Treatment',\n        'DesignMaskingInfo': {'DesignMasking': 'None (Open Label)'}},\n       'EnrollmentInfo': {'EnrollmentCount': '34',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'High intensity interval training (HIIT)',\n          'ArmGroupType': 'Experimental',\n          'ArmGroupDescription': 'Patients will undergo a 15-minute warm-up, followed by a 24-minute conditioning phase, and a 10-minute cool-down. The conditioning phase will include a combination of aerobic exercise (e.g. cycling or walking) and resistance exercise (e.g. squats, bicep curls). Patients will complete 5 intervals of 3 minutes with 2 minute rest periods interspersed. The intensity will correspond to 16-17 on the Borg 6-20 Rating of perceived exertion scale.\\n\\nPatients will exercise once a week for 8 weeks.',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Other: High intensity interval training (HIIT)']}},\n         {'ArmGroupLabel': 'Standard Care',\n          'ArmGroupType': 'Active Comparator',\n          'ArmGroupDescription': 'Patients assigned to this group will participate in usual standard care of cardiac rehabilitation.\\n\\nCommonly, patients will undergo a 15-minute warm-up, followed by a 24-minute conditioning phase, and a 10-minute cool-down. The conditioning phase will include a combination of aerobic exercise (e.g. cycling or walking) and resistance exercise (e.g. squats, bicep curls). Patients will complete 5 intervals of 3 minutes with 2 minute rest periods interspersed. The intensity will correspond to 11-15 on the Borg 6-20 Rating of perceived exertion scale.\\n\\nPatients will exercise once a week for 8 weeks.',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Other: Standard care']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Other',\n          'InterventionName': 'High intensity interval training (HIIT)',\n          'InterventionDescription': 'Standard care cardiac rehabilitation classes, delivered at a higher exercise intensity',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['High intensity interval training (HIIT)']},\n          'InterventionOtherNameList': {'InterventionOtherName': ['Group 1']}},\n         {'InterventionType': 'Other',\n          'InterventionName': 'Standard care',\n          'InterventionDescription': 'Standard care cardiac rehabilitation according to current guidelines',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Standard Care']},\n          'InterventionOtherNameList': {'InterventionOtherName': ['Group 2']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Changes in Heart Rate Variability (as measured by a hemodynamic monitoring system)',\n          'PrimaryOutcomeDescription': 'The primary outcome is the difference in heart rate variability between baseline and 8 weeks after the start of the intervention measured using finger photoplethysmography',\n          'PrimaryOutcomeTimeFrame': 'Change from baseline in heart rate variability at 8 weeks after the start of the intervention'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Changes in Baroreflex Sensitivity (as measured by a hemodynamic monitoring system)',\n          'SecondaryOutcomeDescription': 'This is the difference in heart rate variability between baseline and 8 weeks after the start of intervention measured using finger photoplethysmography',\n          'SecondaryOutcomeTimeFrame': 'Change from baseline in baroreflex sensitivity at 8 weeks after the start of the intervention'},\n         {'SecondaryOutcomeMeasure': 'Changes in Peak Oxygen Uptake (as measured by a submaximal exercise test)',\n          'SecondaryOutcomeDescription': 'Submaximal Cardiopulmonary Exercise Testing will be performed to measure changes in peak oxygen uptake between baseline and 8 weeks after the start of the intervention',\n          'SecondaryOutcomeTimeFrame': 'Changes in peak oxygen uptake between baseline and 8 weeks after the start of intervention'},\n         {'SecondaryOutcomeMeasure': 'Changes in Enjoyment of Exercise (as measured by a questionnaire)',\n          'SecondaryOutcomeDescription': 'Changes in pleasure and displeasure, affect, arousal between baseline and 8 weeks after the start of intervention will be assessed by using a \"Feelings Scale\", \"Felt Arousal Scale\", \"Physical Activity Enjoyment Scale\" respectively.',\n          'SecondaryOutcomeTimeFrame': 'Changes in perception of enjoyment of exercise at between baseline and 8 weeks after the start of intervention'},\n         {'SecondaryOutcomeMeasure': 'Changes in health-related Quality of Life (as measured by a questionnaire)',\n          'SecondaryOutcomeDescription': 'Changes in health-related quality of life between baseline and 8 weeks after the start of intervention will be measured by completion of MacNew Quality of Life questionnaires',\n          'SecondaryOutcomeTimeFrame': 'Changes in health-related quality of life between baseline and 8 weeks after the start of intervention'},\n         {'SecondaryOutcomeMeasure': 'Changes in Rating of Perceived Exertion (as measured by a scale)',\n          'SecondaryOutcomeDescription': 'Ratings of perceived exertion (RPE) allow the intensity of exercise to be determined subjectively on a scale of 6-20. Changes in RPE scales will be assessed at start of each workout as part of service protocol to gauge patient effort, fatigue and muscular discomfort and the differences between baseline and 8 weeks after start of intervention will be determined. At the end of each session, patients will be expected to submit an overall session RPE of how they perceived the entire exercise session (Kilpatrick et al. 2014).',\n          'SecondaryOutcomeTimeFrame': 'Changes in the rating of perceived exertion between baseline and 8 weeks after start of intervention'}]},\n       'OtherOutcomeList': {'OtherOutcome': [{'OtherOutcomeMeasure': 'Changes in reported incidents of acute pain (as measured by a visual analogue scale)',\n          'OtherOutcomeDescription': 'Pain is a contributing factor to the displeasure experienced during some exercise (Ekkekakis et al. 2012). For this reason participants will be required to complete a visual analogue scale to quantify any pain during the sessions. Changes in perception of pain will assessed between baseline and 8 weeks after the start of intervention.',\n          'OtherOutcomeTimeFrame': 'Changes between baseline incidents of acute pain and 8 weeks after start of intervention'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nHistory of acute coronary syndromes, had a recent revascularization procedure\\nHistory of stable heart failure or stable angina.\\n\\nExclusion Criteria:\\n\\nUnstable angina\\nSystolic blood pressure of >200 mm Hg, or diastolic blood pressure >110 mm Hg (should be assessed on a case-by-case basis)\\nOrthostatic blood pressure drop of >20 mm Hg with symptoms\\nMay have had the implantation of cardiac defibrillators (ICD)\\nSynchronization devices or ventricular assist devices\\nHave had a heart valve repair/replacement, a heart transplant, or grown-up congenital heart disease, critical aortic stenosis, acute systemic illness or fever, -\\nUncontrolled atrial or ventricular arrhythmias, acute pericarditis or myocarditis\\nRecent embolism, thrombophlebitis, resting S-T segment depression (>2 mm), uncontrolled diabetes (should be assessed in accordance with local protocol and on a case-by-case basis)\\nSevere orthopedic conditions that would prohibit exercise\\nOther metabolic conditions, such as acute thyroiditis, hypokalemia or hyperkalemia, hypovolemia, severe rejection (cardiac transplant recipients), triple A >4.5 cm (if under surveillance will need confirmation from vascular surgeon as long as blood pressure remains stable)\\nTachycardia >100 beats per minute at rest, or cataracts (may commence exercise after 6 weeks)',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'StdAgeList': {'StdAge': ['Child', 'Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Alison C Welsh',\n          'OverallOfficialAffiliation': 'Edge Hill University and Liverpool Heart and Chest Hospital',\n          'OverallOfficialRole': 'Principal Investigator'},\n         {'OverallOfficialName': 'Adrian Roose',\n          'OverallOfficialAffiliation': 'Liverpool Heart and Chest Hospital',\n          'OverallOfficialRole': 'Principal Investigator'},\n         {'OverallOfficialName': 'Joseph Mills',\n          'OverallOfficialAffiliation': 'Liverpool Heart and Chest Hospital',\n          'OverallOfficialRole': 'Principal Investigator'},\n         {'OverallOfficialName': 'Bashir Matata',\n          'OverallOfficialAffiliation': 'Liverpool Heart and Chest Hospital',\n          'OverallOfficialRole': 'Principal Investigator'},\n         {'OverallOfficialName': 'Adrian Midgley',\n          'OverallOfficialAffiliation': 'Edge Hill University',\n          'OverallOfficialRole': 'Principal Investigator'},\n         {'OverallOfficialName': 'Felipe Cunha',\n          'OverallOfficialAffiliation': 'Edge Hill University',\n          'OverallOfficialRole': 'Principal Investigator'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'Liverpool Heart and Chest Hospital',\n          'LocationCity': 'Liverpool',\n          'LocationZip': 'L14 3PE',\n          'LocationCountry': 'United Kingdom'}]}},\n      'ReferencesModule': {'ReferenceList': {'Reference': [{'ReferencePMID': '19962772',\n          'ReferenceType': 'result',\n          'ReferenceCitation': 'Munk PS, Butt N, Larsen AI. High-intensity interval exercise training improves heart rate variability in patients following percutaneous coronary intervention for angina pectoris. Int J Cardiol. 2010 Nov 19;145(2):312-314. doi: 10.1016/j.ijcard.2009.11.015. Epub 2009 Dec 5.'},\n         {'ReferencePMID': '22694349',\n          'ReferenceType': 'result',\n          'ReferenceCitation': 'Guiraud T, Nigam A, Gremeaux V, Meyer P, Juneau M, Bosquet L. High-intensity interval training in cardiac rehabilitation. Sports Med. 2012 Jul 1;42(7):587-605. doi: 10.2165/11631910-000000000-00000.'},\n         {'ReferencePMID': '11581152',\n          'ReferenceType': 'result',\n          'ReferenceCitation': 'Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pina IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation. 2001 Oct 2;104(14):1694-740. doi: 10.1161/hc3901.095960. No abstract available.'},\n         {'ReferencePMID': '23724882',\n          'ReferenceType': 'result',\n          'ReferenceCitation': 'Currie KD, Rosen LM, Millar PJ, McKelvie RS, MacDonald MJ. Heart rate recovery and heart rate variability are unchanged in patients with coronary artery disease following 12 weeks of high-intensity interval and moderate-intensity endurance exercise training. Appl Physiol Nutr Metab. 2013 Jun;38(6):644-50. doi: 10.1139/apnm-2012-0354. Epub 2013 Jan 17.'}]}},\n      'IPDSharingStatementModule': {'IPDSharing': 'No'}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000006331',\n          'ConditionMeshTerm': 'Heart Diseases'},\n         {'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'},\n         {'ConditionAncestorId': 'D000007238',\n          'ConditionAncestorTerm': 'Infarction'},\n         {'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafAsFound': 'Heart Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Heart Attack',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'}]}}}}},\n   {'Rank': 12,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT02316119',\n       'OrgStudyIdInfo': {'OrgStudyId': 'FAPESP2012/04930-0'},\n       'Organization': {'OrgFullName': 'University of Sao Paulo General Hospital',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'Mechanistic Study of Bleeding Risk in Coronary Patients With Cerebrovascular Disease',\n       'OfficialTitle': 'Mechanisms Involved in the Bleeding Risk of Patients With Coronary Artery Diseased Previous Stroke or Transient Ischemic Attack in Use of Antiplatelet Therapy'},\n      'StatusModule': {'StatusVerifiedDate': 'June 2014',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'January 2013'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'December 2015',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'April 2016',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'December 3, 2014',\n       'StudyFirstSubmitQCDate': 'December 9, 2014',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'December 12, 2014',\n        'StudyFirstPostDateType': 'Estimate'},\n       'LastUpdateSubmitDate': 'April 25, 2016',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'April 26, 2016',\n        'LastUpdatePostDateType': 'Estimate'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'University of Sao Paulo General Hospital',\n        'LeadSponsorClass': 'OTHER'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'Fundação de Amparo à Pesquisa do Estado de São Paulo',\n          'CollaboratorClass': 'OTHER_GOV'}]}},\n      'OversightModule': {'OversightHasDMC': 'No'},\n      'DescriptionModule': {'BriefSummary': 'Background: About 5% of patients with acute coronary syndrome (ACS) have had previously ischemic stroke (IS) or transitory ischemic attack (TIA). This is a high-risk population, with a high incidence of ischemic events, and also of bleeding events. While the high ischemic risk in this population is attributed to a higher prevalence of cardiovascular risk factors, their predisposition to bleeding events is not well understood. Hypothesis: The increased bleeding risk in ACS patients with history of cerebrovascular event may be justified by a low platelet activity. Methods: Unicentric, prospective, case-control study, which included approximately 100 post-ACS patients with history of IS/TIA previously to the acute coronary event (Case Group) and 100 patients without IS/TIA (Control group). The groups were matched for gender, age, and ACS type and year of occurrence. All patients were taking aspirin, and the main exclusion criteria were use of dual antiplatelet therapy, previous hemorrhagic stroke, severe renal dysfunction, thrombocytopenia or coagulopathy. Main analysis: Platelet aggregation was evaluated by 6 methods: VerifyNow Aspirin®, VerifyNow P2Y12®, PFA 100®, thrombelastography (ReoRox®), light transmission aggregometry with ADP (LTA ADP) and epinephrine (LTA EPI) as agonists. Additional analysis: genetic, HDL transport and inflammatory evaliation'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Coronary Artery Disease',\n         'Cerebral Stroke',\n         'TIA (Transient Ischemic Attack)']},\n       'KeywordList': {'Keyword': ['bleeding risk, acute coronary syndrome, platelet agregation,']}},\n      'DesignModule': {'StudyType': 'Observational',\n       'PatientRegistry': 'No',\n       'DesignInfo': {'DesignObservationalModelList': {'DesignObservationalModel': ['Case-Control']},\n        'DesignTimePerspectiveList': {'DesignTimePerspective': ['Prospective']}},\n       'EnrollmentInfo': {'EnrollmentCount': '140',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'Control group',\n          'ArmGroupDescription': 'Post-ACS patients without history of IS/TIA previously to the acute coronary and taking aspirin'},\n         {'ArmGroupLabel': 'Case group',\n          'ArmGroupDescription': 'Post ACS patients with history of IS/TIA previously to the acute coronary event and taking aspirin'}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Residual platelet activity by VerifyNow Aspirin (Aspirin reactivity units)',\n          'PrimaryOutcomeTimeFrame': 'in the selection visit'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Baseline platelet activity by VerifyNow P2Y12 (P2Y12 reactivity units)',\n          'SecondaryOutcomeTimeFrame': 'in the selection visit'}]},\n       'OtherOutcomeList': {'OtherOutcome': [{'OtherOutcomeMeasure': 'light transmission aggregometry with ADP (maximum amplitude)',\n          'OtherOutcomeTimeFrame': 'in the selection visit'},\n         {'OtherOutcomeMeasure': 'light transmission aggregometry with epinephrine (maximum amplitude)',\n          'OtherOutcomeTimeFrame': 'in the selection visit'},\n         {'OtherOutcomeMeasure': 'platelet acitivity by PFA 100® (seconds)',\n          'OtherOutcomeTimeFrame': 'in the selection visit'},\n         {'OtherOutcomeMeasure': 'kinetics of clot by thromboelastography usin Reorox ® (seconds, paschal/min, paschal)',\n          'OtherOutcomeTimeFrame': 'in the selection visit'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nPost-ACS patients with history of IS/TIA previously to the acute coronary event and taking aspirin\\nSign the consent form\\n\\nExclusion Criteria:\\n\\nHemorrhagic stroke\\nAnother antiplatelet drug than aspirin\\nUse of Anti inflammatory drug\\nSevere chronic kidney dysfunction\\nLiver disease\\nCoagulopathy\\nPlatelet disfunction\\nThrombocytopenia or thrombocytosis\\nRefuse to sign the consent form',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']},\n       'StudyPopulation': 'Post-ACS patients and taking aspirin',\n       'SamplingMethod': 'Non-Probability Sample'},\n      'ContactsLocationsModule': {'LocationList': {'Location': [{'LocationFacility': 'Clinical unit of acute coronary disease',\n          'LocationCity': 'São Paulo',\n          'LocationZip': '05403000',\n          'LocationCountry': 'Brazil'}]}}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000020521',\n          'ConditionMeshTerm': 'Stroke'},\n         {'ConditionMeshId': 'D000002546',\n          'ConditionMeshTerm': 'Ischemic Attack, Transient'},\n         {'ConditionMeshId': 'D000003324',\n          'ConditionMeshTerm': 'Coronary Artery Disease'},\n         {'ConditionMeshId': 'D000006470',\n          'ConditionMeshTerm': 'Hemorrhage'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000002561',\n          'ConditionAncestorTerm': 'Cerebrovascular Disorders'},\n         {'ConditionAncestorId': 'D000001927',\n          'ConditionAncestorTerm': 'Brain Diseases'},\n         {'ConditionAncestorId': 'D000002493',\n          'ConditionAncestorTerm': 'Central Nervous System Diseases'},\n         {'ConditionAncestorId': 'D000009422',\n          'ConditionAncestorTerm': 'Nervous System Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000003327',\n          'ConditionAncestorTerm': 'Coronary Disease'},\n         {'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000001161',\n          'ConditionAncestorTerm': 'Arteriosclerosis'},\n         {'ConditionAncestorId': 'D000001157',\n          'ConditionAncestorTerm': 'Arterial Occlusive Diseases'},\n         {'ConditionAncestorId': 'D000002545',\n          'ConditionAncestorTerm': 'Brain Ischemia'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafAsFound': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M9556',\n          'ConditionBrowseLeafName': 'Hemorrhage',\n          'ConditionBrowseLeafAsFound': 'Bleeding',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M16355',\n          'ConditionBrowseLeafName': 'Syndrome',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M22306',\n          'ConditionBrowseLeafName': 'Stroke',\n          'ConditionBrowseLeafAsFound': 'Cerebral Stroke',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5810',\n          'ConditionBrowseLeafName': 'Cerebrovascular Disorders',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6549',\n          'ConditionBrowseLeafName': 'Coronary Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M27545',\n          'ConditionBrowseLeafName': 'Acute Coronary Syndrome',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5795',\n          'ConditionBrowseLeafName': 'Ischemic Attack, Transient',\n          'ConditionBrowseLeafAsFound': 'Transient Ischemic Attack',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M5204',\n          'ConditionBrowseLeafName': 'Brain Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5742',\n          'ConditionBrowseLeafName': 'Central Nervous System Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M4469',\n          'ConditionBrowseLeafName': 'Arteriosclerosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M4465',\n          'ConditionBrowseLeafName': 'Arterial Occlusive Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5794',\n          'ConditionBrowseLeafName': 'Brain Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'T170',\n          'ConditionBrowseLeafName': 'Acute Graft Versus Host Disease',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'},\n         {'ConditionBrowseBranchAbbrev': 'BC10',\n          'ConditionBrowseBranchName': 'Nervous System Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'Rare',\n          'ConditionBrowseBranchName': 'Rare Diseases'}]}},\n      'InterventionBrowseModule': {'InterventionBrowseLeafList': {'InterventionBrowseLeaf': [{'InterventionBrowseLeafId': 'M4548',\n          'InterventionBrowseLeafName': 'Aspirin',\n          'InterventionBrowseLeafRelevance': 'low'}]},\n       'InterventionBrowseBranchList': {'InterventionBrowseBranch': [{'InterventionBrowseBranchAbbrev': 'Antipy',\n          'InterventionBrowseBranchName': 'Antipyretics'},\n         {'InterventionBrowseBranchAbbrev': 'Infl',\n          'InterventionBrowseBranchName': 'Anti-Inflammatory Agents'},\n         {'InterventionBrowseBranchAbbrev': 'ARhu',\n          'InterventionBrowseBranchName': 'Antirheumatic Agents'},\n         {'InterventionBrowseBranchAbbrev': 'FiAg',\n          'InterventionBrowseBranchName': 'Fibrinolytic Agents'},\n         {'InterventionBrowseBranchAbbrev': 'Analg',\n          'InterventionBrowseBranchName': 'Analgesics'},\n         {'InterventionBrowseBranchAbbrev': 'PlAggInh',\n          'InterventionBrowseBranchName': 'Platelet Aggregation Inhibitors'},\n         {'InterventionBrowseBranchAbbrev': 'All',\n          'InterventionBrowseBranchName': 'All Drugs and Chemicals'}]}}}}},\n   {'Rank': 13,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT00597922',\n       'OrgStudyIdInfo': {'OrgStudyId': '0507000374'},\n       'SecondaryIdInfoList': {'SecondaryIdInfo': [{'SecondaryId': 'R01HL081153-01A1',\n          'SecondaryIdType': 'U.S. NIH Grant/Contract',\n          'SecondaryIdLink': 'https://reporter.nih.gov/quickSearch/R01HL081153-01A1'}]},\n       'Organization': {'OrgFullName': 'Yale University', 'OrgClass': 'OTHER'},\n       'BriefTitle': 'Examining Heart Attacks in Young Women',\n       'OfficialTitle': 'Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction (AMI) Patients (VIRGO)',\n       'Acronym': 'VIRGO'},\n      'StatusModule': {'StatusVerifiedDate': 'June 2014',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'September 2007'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'February 2013',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'February 2013',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'January 9, 2008',\n       'StudyFirstSubmitQCDate': 'January 9, 2008',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'January 18, 2008',\n        'StudyFirstPostDateType': 'Estimate'},\n       'LastUpdateSubmitDate': 'March 27, 2020',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'March 30, 2020',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'Yale University',\n        'LeadSponsorClass': 'OTHER'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'National Heart, Lung, and Blood Institute (NHLBI)',\n          'CollaboratorClass': 'NIH'}]}},\n      'OversightModule': {'OversightHasDMC': 'No'},\n      'DescriptionModule': {'BriefSummary': 'Heart disease and heart attacks pose a serious health risk to young women, and women tend to experience less successful recoveries after a heart attack than men do. This study will examine various factors that may predispose women to heart attacks and to poor recovery after a heart attack. The differences between men and women in the medical care that they receive following a heart attack will also be studied.',\n       'DetailedDescription': \"Heart disease is one of the leading causes of death in women 55 years and younger, accounting for more than 8,000 deaths each year in the United States. Approximately 40,000 young women are hospitalized each year in the United States as a result of a heart attack. Research has shown that young women who have heart attacks are twice as likely to die in the hospital as young men who have heart attacks. While there has been an increase in awareness, little research has been conducted on understanding heart disease and heart attacks in young women. Specific biologic markers involved with inflammation, metabolic abnormalities, sex hormones, and genetics may indicate a predisposition to a heart attack and poor recovery. This study will analyze the biologic, demographic, psychosocial, environmental, and behavioral factors that may contribute to premature heart disease and to poor recovery after a heart attack in women. Researchers will examine if delays in receiving medical care following a heart attack can affect recovery and health outcomes for women. Gender differences in outcomes and the quality of medical care that is received following a heart attack will also be examined.\\n\\nThis study will enroll women and men who are hospitalized following a possible heart attack. At study entry, participants will be interviewed to collect information about symptoms, functioning, quality of life, and medical care. A medical record review will also occur. At 1 month after admission from the hospital, an interview will occur via phone and a blood sample will be collected when the participant returns to the hospital or alternatively be collected at a medical clinic convenient to the participant. Another telephone interview will occur at 12 months. Participants' blood samples will be stored for future biologic and genetic studies.\"},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Acute Myocardial Infarction']},\n       'KeywordList': {'Keyword': ['Acute Myocardial Infarction',\n         'Heart Attack',\n         'Gender Differences',\n         'Risk Factors',\n         'Quality of Care']}},\n      'DesignModule': {'StudyType': 'Observational',\n       'DesignInfo': {'DesignObservationalModelList': {'DesignObservationalModel': ['Cohort']},\n        'DesignTimePerspectiveList': {'DesignTimePerspective': ['Prospective']}},\n       'BioSpec': {'BioSpecRetention': 'Samples With DNA',\n        'BioSpecDescription': 'Blood specimens for biomarker analysis and storage for future genetic studies'},\n       'EnrollmentInfo': {'EnrollmentCount': '2985',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': '1',\n          'ArmGroupDescription': '2,000 women between the ages of 18 and 55 years who are hospitalized with a heart attack'},\n         {'ArmGroupLabel': '2',\n          'ArmGroupDescription': '1,000 men between the ages of 18 and 55 years who are hospitalized with a heart attack'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nElevated cardiac markers within 24 hours of arrival at initial or enrolling institution\\nSupporting evidence suggestive of a heart attack\\n\\nExclusion Criteria:\\n\\nPreviously enrolled in the VIRGO study\\nDoes not speak English or Spanish\\nToo ill to interview\\nCurrent prisoner',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'MaximumAge': '55 Years',\n       'StdAgeList': {'StdAge': ['Adult']},\n       'StudyPopulation': '2,000 women and 1,000 men between the ages of 18 and 55 years who are hospitalized with a heart attack',\n       'SamplingMethod': 'Non-Probability Sample'},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Harlan M. Krumholz, MD, SM',\n          'OverallOfficialAffiliation': 'Yale University',\n          'OverallOfficialRole': 'Principal Investigator'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'University of Alabama at Birmingham',\n          'LocationCity': 'Birmingham',\n          'LocationState': 'Alabama',\n          'LocationZip': '35294-0007',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Providence Hospital',\n          'LocationCity': 'Mobile',\n          'LocationState': 'Alabama',\n          'LocationZip': '36685',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Sharp Gross Hospital',\n          'LocationCity': 'La Mesa',\n          'LocationState': 'California',\n          'LocationZip': '91942',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Saddleback Memorial Medical Center',\n          'LocationCity': 'Laguna Hills',\n          'LocationState': 'California',\n          'LocationZip': '92653',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Long Beach Memorial Medical Center',\n          'LocationCity': 'Long Beach',\n          'LocationState': 'California',\n          'LocationZip': '90806',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'University of Southern California',\n          'LocationCity': 'Los Angeles',\n          'LocationState': 'California',\n          'LocationZip': '90033',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Cedars-Sinai Medical Center/PRCC Cardiology Research',\n          'LocationCity': 'Los Angeles',\n          'LocationState': 'California',\n          'LocationZip': '90048',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Memorial Medical Center (Sutter Gould Medical Foundation)',\n          'LocationCity': 'Modesto',\n          'LocationState': 'California',\n          'LocationZip': '95355',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Sutter Medical Center Sacramento',\n          'LocationCity': 'Sacramento',\n          'LocationState': 'California',\n          'LocationZip': '95819-3226',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Mercy General Hospital',\n          'LocationCity': 'Sacramento',\n          'LocationState': 'California',\n          'LocationZip': '95819',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'California Medical Center',\n          'LocationCity': 'San Francisco',\n          'LocationState': 'California',\n          'LocationZip': '94120',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Stanford University Medical Center',\n          'LocationCity': 'Stanford',\n          'LocationState': 'California',\n          'LocationZip': '94305',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': \"St Joseph's Medical Center\",\n          'LocationCity': 'Stockton',\n          'LocationState': 'California',\n          'LocationZip': '95204',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Los Robles Hospital and Medical Center',\n          'LocationCity': 'Thousand Oaks',\n          'LocationState': 'California',\n          'LocationZip': '91360',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Torrance Memorial Medical Center',\n          'LocationCity': 'Torrance',\n          'LocationState': 'California',\n          'LocationZip': '90505',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Denver Health Medical Center',\n          'LocationCity': 'Denver',\n          'LocationState': 'Colorado',\n          'LocationZip': '80204',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Centura Research Center',\n          'LocationCity': 'Denver',\n          'LocationState': 'Colorado',\n          'LocationZip': '80210',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Bridgeport Hospital',\n          'LocationCity': 'Bridgeport',\n          'LocationState': 'Connecticut',\n          'LocationZip': '06610',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'St Francis Hospital and Medical Center',\n          'LocationCity': 'Hartford',\n          'LocationState': 'Connecticut',\n          'LocationZip': '06105',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Yale University School of Medicine',\n          'LocationCity': 'New Haven',\n          'LocationState': 'Connecticut',\n          'LocationZip': '06510',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Hospital of St. Raphael',\n          'LocationCity': 'New Haven',\n          'LocationState': 'Connecticut',\n          'LocationZip': '06511',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Citrus Memorial Health Systems',\n          'LocationCity': 'Inverness',\n          'LocationState': 'Florida',\n          'LocationZip': '34452',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Baptist Cardiac & Vascular Institute, Baptist Hospital of Miami',\n          'LocationCity': 'Miami',\n          'LocationState': 'Florida',\n          'LocationZip': '33176',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Orlando Health',\n          'LocationCity': 'Orlando',\n          'LocationState': 'Florida',\n          'LocationZip': '32806',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Pepin Heart Research Institute',\n          'LocationCity': 'Tampa',\n          'LocationState': 'Florida',\n          'LocationZip': '33613',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': \"St Elizabeth's Hospital\",\n          'LocationCity': 'Belleville',\n          'LocationState': 'Illinois',\n          'LocationZip': '62220',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Mercy Hospital and Medical Center',\n          'LocationCity': 'Chicago',\n          'LocationState': 'Illinois',\n          'LocationZip': '60616',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'University of Chicago Medical Center',\n          'LocationCity': 'Chicago',\n          'LocationState': 'Illinois',\n          'LocationZip': '60637',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Northshore University Health System',\n          'LocationCity': 'Evanston',\n          'LocationState': 'Illinois',\n          'LocationZip': '60201',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Memorial Health System',\n          'LocationCity': 'Springfield',\n          'LocationState': 'Illinois',\n          'LocationZip': '62781',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Parkview Hospital',\n          'LocationCity': 'Fort Wayne',\n          'LocationState': 'Indiana',\n          'LocationZip': '46805',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Krannert Heart Institute - Indiana University - Clarian Methodist Hospital',\n          'LocationCity': 'Indianapolis',\n          'LocationState': 'Indiana',\n          'LocationZip': '46202',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'The Indiana Heart Hospital',\n          'LocationCity': 'Indianapolis',\n          'LocationState': 'Indiana',\n          'LocationZip': '46250',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'St Vincent Hospital & Health Services',\n          'LocationCity': 'Indianapolis',\n          'LocationState': 'Indiana',\n          'LocationZip': '46260',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Genesis Medical Center',\n          'LocationCity': 'Davenport',\n          'LocationState': 'Iowa',\n          'LocationZip': '52803',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'University of Iowa Hospitals and Clinics',\n          'LocationCity': 'Iowa City',\n          'LocationState': 'Iowa',\n          'LocationZip': '54424',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': \"Cotton-O'Neil Clinical Research Center\",\n          'LocationCity': 'Topeka',\n          'LocationState': 'Kansas',\n          'LocationZip': '66604',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Cardiovascular Research Foundation of Louisiana',\n          'LocationCity': 'Baton Rouge',\n          'LocationState': 'Louisiana',\n          'LocationZip': '70808',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Central Maine Heart and Vascular Institute',\n          'LocationCity': 'Lewiston',\n          'LocationState': 'Maine',\n          'LocationZip': '04240',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Boston Medical Center',\n          'LocationCity': 'Boston',\n          'LocationState': 'Massachusetts',\n          'LocationZip': '02118',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Beth Israel Deaconess Medical Center',\n          'LocationCity': 'Boston',\n          'LocationState': 'Massachusetts',\n          'LocationZip': '02215',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Oakwood Hospital and Medical Center',\n          'LocationCity': 'Dearborn',\n          'LocationState': 'Michigan',\n          'LocationZip': '48123',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Henry Ford Hospital',\n          'LocationCity': 'Detroit',\n          'LocationState': 'Michigan',\n          'LocationZip': '48202',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'St John Hospital & Medical Center',\n          'LocationCity': 'Detroit',\n          'LocationState': 'Michigan',\n          'LocationZip': '48236',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Spectrum Health',\n          'LocationCity': 'Grand Rapids',\n          'LocationState': 'Michigan',\n          'LocationZip': '49503-2528',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Sparrow Hospital',\n          'LocationCity': 'Lansing',\n          'LocationState': 'Michigan',\n          'LocationZip': '48909-7980',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Mount Clemens Regional Medical Center',\n          'LocationCity': 'Mount Clemens',\n          'LocationState': 'Michigan',\n          'LocationZip': '48043',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Munson Medical Center',\n          'LocationCity': 'Traverse City',\n          'LocationState': 'Michigan',\n          'LocationZip': '49684',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Minneapolis Heart Institute',\n          'LocationCity': 'Minneapolis',\n          'LocationState': 'Minnesota',\n          'LocationZip': '55407',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': \"St John's Regional Medical Center\",\n          'LocationCity': 'Joplin',\n          'LocationState': 'Missouri',\n          'LocationZip': '64804-1694',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': \"Mid-America Heart Institute, St Luke's Hospital\",\n          'LocationCity': 'Kansas City',\n          'LocationState': 'Missouri',\n          'LocationZip': '64111',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Heartland Cardiovascular Consultants',\n          'LocationCity': 'Saint Joseph',\n          'LocationState': 'Missouri',\n          'LocationZip': '64506',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Washington University School of Medicine',\n          'LocationCity': 'Saint Louis',\n          'LocationState': 'Missouri',\n          'LocationZip': '63110',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Cox South Hospital',\n          'LocationCity': 'Springfield',\n          'LocationState': 'Missouri',\n          'LocationZip': '65804',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': \"St John's Medical Research Institute\",\n          'LocationCity': 'Springfield',\n          'LocationState': 'Missouri',\n          'LocationZip': '65807',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Bozeman Deaconess Hospital',\n          'LocationCity': 'Bozeman',\n          'LocationState': 'Montana',\n          'LocationZip': '59715',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Glacier View Cardiology',\n          'LocationCity': 'Kalispell',\n          'LocationState': 'Montana',\n          'LocationZip': '59901',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'The International Heart Institute of Montana',\n          'LocationCity': 'Missoula',\n          'LocationState': 'Montana',\n          'LocationZip': '59802',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Good Samaritan Hospital',\n          'LocationCity': 'Kearney',\n          'LocationState': 'Nebraska',\n          'LocationZip': '68848',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'BryanLGH Heart Institute',\n          'LocationCity': 'Lincoln',\n          'LocationState': 'Nebraska',\n          'LocationZip': '68506',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'The Valley Hospital',\n          'LocationCity': 'Ridgewood',\n          'LocationState': 'New Jersey',\n          'LocationZip': '07450',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Overlook Hospital',\n          'LocationCity': 'Summit',\n          'LocationState': 'New Jersey',\n          'LocationZip': '07929-0220',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Presbyterian Heart Group',\n          'LocationCity': 'Albuquerque',\n          'LocationState': 'New Mexico',\n          'LocationZip': '87106',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Jacobi Medical Center',\n          'LocationCity': 'Bronx',\n          'LocationState': 'New York',\n          'LocationZip': '10461',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Montefiore/Albert Einstein Medical Center',\n          'LocationCity': 'Bronx',\n          'LocationState': 'New York',\n          'LocationZip': '10461',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Erie County Medical Center',\n          'LocationCity': 'Buffalo',\n          'LocationState': 'New York',\n          'LocationZip': '14215',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Winthrop University Hospital',\n          'LocationCity': 'Mineola',\n          'LocationState': 'New York',\n          'LocationZip': '11501',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Stony Brook University Medical Center',\n          'LocationCity': 'Stony Brook',\n          'LocationState': 'New York',\n          'LocationZip': '11794-8167',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'University of North Carolina at Chapel Hill',\n          'LocationCity': 'Chapel Hill',\n          'LocationState': 'North Carolina',\n          'LocationZip': '27599-7075',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Presbyterian Hospital - Mid Carolina Cardiology',\n          'LocationCity': 'Charlotte',\n          'LocationState': 'North Carolina',\n          'LocationZip': '28204',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Presbysterian Hospital - Mid Carolina Cardiology',\n          'LocationCity': 'Charlotte',\n          'LocationState': 'North Carolina',\n          'LocationZip': '78704',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Forsyth Medical Center',\n          'LocationCity': 'Winston-Salem',\n          'LocationState': 'North Carolina',\n          'LocationZip': '27103',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Summa Health System (Akron City Hospital)',\n          'LocationCity': 'Akron',\n          'LocationState': 'Ohio',\n          'LocationZip': '44309',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'The Ohio State University Medical Center',\n          'LocationCity': 'Columbus',\n          'LocationState': 'Ohio',\n          'LocationZip': '43210',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': \"St Rita's Medical Center\",\n          'LocationCity': 'Lima',\n          'LocationState': 'Ohio',\n          'LocationZip': '45801',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Heart Institute of the Cascades',\n          'LocationCity': 'Bend',\n          'LocationState': 'Oregon',\n          'LocationZip': '97701-6015',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Samaritan Heart & Vascular Institute',\n          'LocationCity': 'Corvallis',\n          'LocationState': 'Oregon',\n          'LocationZip': '97330',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Butler Memorial Hospital',\n          'LocationCity': 'Butler',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '16001',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Geisinger Clinic - Cardiology',\n          'LocationCity': 'Danville',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '17822-2160',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Hamot Medical Center',\n          'LocationCity': 'Erie',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '16550-0001',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Pinnacle Health System',\n          'LocationCity': 'Harrisburg',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '17101',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Allegheny General Hospital',\n          'LocationCity': 'Pittsburgh',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '15212',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'D. Guthrie Foundation for Education & Research',\n          'LocationCity': 'Sayre',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '18840',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Sharon Regional Health System',\n          'LocationCity': 'Sharon',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '16146',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Rhode Island Hospital',\n          'LocationCity': 'Providence',\n          'LocationState': 'Rhode Island',\n          'LocationZip': '02903',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Baylor Research Institute',\n          'LocationCity': 'Dallas',\n          'LocationState': 'Texas',\n          'LocationZip': '75226',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'University of Texas Southwestern Medical Center at Dallas (UTSW)',\n          'LocationCity': 'Dallas',\n          'LocationState': 'Texas',\n          'LocationZip': '75390-9034',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Fletcher Allen Health Care',\n          'LocationCity': 'Burlington',\n          'LocationState': 'Vermont',\n          'LocationZip': '05401',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Sentara Hospital',\n          'LocationCity': 'Norfolk',\n          'LocationState': 'Virginia',\n          'LocationZip': '23507',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Virginia Commonwealth University',\n          'LocationCity': 'Richmond',\n          'LocationState': 'Virginia',\n          'LocationZip': '23298',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': \"St Mary's Medical Center\",\n          'LocationCity': 'Huntington',\n          'LocationState': 'West Virginia',\n          'LocationZip': '25702',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Waukesha Memorial Hospital',\n          'LocationCity': 'Waukesha',\n          'LocationState': 'Wisconsin',\n          'LocationZip': '53188',\n          'LocationCountry': 'United States'}]}},\n      'ReferencesModule': {'ReferenceList': {'Reference': [{'ReferencePMID': '33082173',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': 'Ding Q, Spatz ES, Lipska KJ, Lin H, Spertus JA, Dreyer RP, Whittemore R, Funk M, Bueno H, Krumholz HM. Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults. Heart. 2021 Apr;107(8):657-666. doi: 10.1136/heartjnl-2020-317101. Epub 2020 Oct 20.'},\n         {'ReferencePMID': '31441351',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': 'Ding Q, Funk M, Spatz ES, Whittemore R, Lin H, Lipska KJ, Dreyer RP, Spertus JA, Krumholz HM. Association of Diabetes Mellitus With Health Status Outcomes in Young Women and Men After Acute Myocardial Infarction: Results From the VIRGO Study. J Am Heart Assoc. 2019 Sep 3;8(17):e010988. doi: 10.1161/JAHA.118.010988. Epub 2019 Aug 23.'},\n         {'ReferencePMID': '30586733',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': \"Khera AV, Chaffin M, Zekavat SM, Collins RL, Roselli C, Natarajan P, Lichtman JH, D'Onofrio G, Mattera J, Dreyer R, Spertus JA, Taylor KD, Psaty BM, Rich SS, Post W, Gupta N, Gabriel S, Lander E, Ida Chen YD, Talkowski ME, Rotter JI, Krumholz HM, Kathiresan S. Whole-Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized With Early-Onset Myocardial Infarction. Circulation. 2019 Mar 26;139(13):1593-1602. doi: 10.1161/CIRCULATIONAHA.118.035658.\"},\n         {'ReferencePMID': '29954744',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': \"Safdar B, Spatz ES, Dreyer RP, Beltrame JF, Lichtman JH, Spertus JA, Reynolds HR, Geda M, Bueno H, Dziura JD, Krumholz HM, D'Onofrio G. Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study. J Am Heart Assoc. 2018 Jun 28;7(13):e009174. doi: 10.1161/JAHA.118.009174.\"},\n         {'ReferencePMID': '29848494',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': \"Lu Y, Ding Q, Xu X, Spatz ES, Dreyer RP, D'Onofrio G, Caulfield M, Nasir K, Spertus JA, Krumholz HM. Sex Differences in Omega-3 and -6 Fatty Acids and Health Status Among Young Adults With Acute Myocardial Infarction: Results From the VIRGO Study. J Am Heart Assoc. 2018 May 30;7(11):e008189. doi: 10.1161/JAHA.117.008189.\"},\n         {'ReferencePMID': '28228461',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': \"Lu Y, Zhou S, Dreyer RP, Spatz ES, Geda M, Lorenze NP, D'Onofrio G, Lichtman JH, Spertus JA, Ridker PM, Krumholz HM. Sex Differences in Inflammatory Markers and Health Status Among Young Adults With Acute Myocardial Infarction: Results From the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients) Study. Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2):e003470. doi: 10.1161/CIRCOUTCOMES.116.003470. Epub 2017 Feb 22.\"},\n         {'ReferencePMID': '25512442',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': \"Lindau ST, Abramsohn EM, Bueno H, D'Onofrio G, Lichtman JH, Lorenze NP, Mehta Sanghani R, Spatz ES, Spertus JA, Strait K, Wroblewski K, Zhou S, Krumholz HM. Sexual activity and counseling in the first month after acute myocardial infarction among younger adults in the United States and Spain: a prospective, observational study. Circulation. 2014 Dec 23;130(25):2302-9. doi: 10.1161/CIRCULATIONAHA.114.012709. Epub 2014 Dec 15.\"}]}}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000007238',\n          'ConditionMeshTerm': 'Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'},\n         {'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafAsFound': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'T170',\n          'ConditionBrowseLeafName': 'Acute Graft Versus Host Disease',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'Rare',\n          'ConditionBrowseBranchName': 'Rare Diseases'}]}}}}},\n   {'Rank': 14,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT02905357',\n       'OrgStudyIdInfo': {'OrgStudyId': '16-01104-2'},\n       'Organization': {'OrgFullName': 'NYU Langone Health',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'Heart Attack Research Program- Imaging Study',\n       'OfficialTitle': 'Heart Attack Research Program- Imaging Study',\n       'Acronym': 'HARP'},\n      'StatusModule': {'StatusVerifiedDate': 'April 2024',\n       'OverallStatus': 'Recruiting',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'July 1, 2020',\n        'StartDateType': 'Actual'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'June 30, 2025',\n        'PrimaryCompletionDateType': 'Anticipated'},\n       'CompletionDateStruct': {'CompletionDate': 'June 30, 2025',\n        'CompletionDateType': 'Anticipated'},\n       'StudyFirstSubmitDate': 'September 9, 2016',\n       'StudyFirstSubmitQCDate': 'September 13, 2016',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'September 19, 2016',\n        'StudyFirstPostDateType': 'Estimate'},\n       'LastUpdateSubmitDate': 'April 1, 2024',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'April 2, 2024',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'NYU Langone Health',\n        'LeadSponsorClass': 'OTHER'}},\n      'OversightModule': {'OversightHasDMC': 'Yes',\n       'IsFDARegulatedDrug': 'No',\n       'IsFDARegulatedDevice': 'No'},\n      'DescriptionModule': {'BriefSummary': 'The HARP study is a multi-center, diagnostic observational study employing standardized imaging protocols in patients with MINOCA (MI with Non Obstructive Coronary Arteries) to determine the underlying diagnosis in each participant. Participants will be followed for recurrent clinical events, every 6 months, for a maximum of 10 years.',\n       'DetailedDescription': 'HARP is a multi-center, observational study which enrolls men and women with MI who are referred for cardiac catheterization. Eligible participants with MINOCA (defined as no stenosis of >50% in any major epicardial vessel) will undergo optical coherence tomography (OCT) at the time of diagnostic angiography and cardiac magnetic resonance imaging (CMR).\\n\\nParticipants will also have the option to enroll in the HARP-Platelet Sub-Study.'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Myocardial Infarction']},\n       'KeywordList': {'Keyword': ['Myocardial Infarction', 'Imaging']}},\n      'DesignModule': {'StudyType': 'Observational',\n       'PatientRegistry': 'No',\n       'DesignInfo': {'DesignObservationalModelList': {'DesignObservationalModel': ['Cohort']},\n        'DesignTimePerspectiveList': {'DesignTimePerspective': ['Prospective']}},\n       'BioSpec': {'BioSpecRetention': 'Samples With DNA',\n        'BioSpecDescription': 'blood collection in platelet substudy'},\n       'EnrollmentInfo': {'EnrollmentCount': '450',\n        'EnrollmentType': 'Anticipated'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'MINOCA',\n          'ArmGroupDescription': 'OCT and CMR imaging',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Device: OCT']}},\n         {'ArmGroupLabel': 'MI-CAD',\n          'ArmGroupDescription': 'Screen failures with MI found to have obstructive CAD. Limited data collection for comparison to MINOCA cohort.',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Other: CMR']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Device',\n          'InterventionName': 'OCT',\n          'InterventionDescription': 'Optical Coherence Tomography (OCT): Intracoronary imaging for amount and type of plaque as well as plaque rupture, ulceration, dissection and/or thrombosis.',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['MINOCA']}},\n         {'InterventionType': 'Other',\n          'InterventionName': 'CMR',\n          'InterventionDescription': 'Cardiac Magnetic Resonance Imaging (CMR): MRI of the heart to identify areas of infarction (damage) and/or edema (swelling).',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['MI-CAD']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Proportion of patients with MINOCA who have plaque disruption (any of the following: rupture, erosion, calcified nodule with thrombosis)',\n          'PrimaryOutcomeTimeFrame': '1 week'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Proportion of patients with MINOCA who have spontaneous coronary dissection.',\n          'SecondaryOutcomeTimeFrame': '1 week'},\n         {'SecondaryOutcomeMeasure': 'Proportion of patients with MINOCA who have late gadolinium enhancement and/or myocardial edema',\n          'SecondaryOutcomeTimeFrame': '1 week'},\n         {'SecondaryOutcomeMeasure': 'Correlation of the presence and location of myocardial abnormalities on CMR with presence and location of plaque disruption on OCT among women with MINOCA.',\n          'SecondaryOutcomeTimeFrame': '1 week'},\n         {'SecondaryOutcomeMeasure': 'Proportion of patients for whom an etiology can be clearly identified after combining OCT and CMR.',\n          'SecondaryOutcomeTimeFrame': '1 week'},\n         {'SecondaryOutcomeMeasure': 'Area under curve of clinical prediction model for plaque disruption on OCT in patients with MINOCA.',\n          'SecondaryOutcomeTimeFrame': '1 week'}]},\n       'OtherOutcomeList': {'OtherOutcome': [{'OtherOutcomeMeasure': 'Composite clinical endpoint: Death, unstable angina, stroke, recurrent MI, catheterizations and revascularization, other cardiac hospitalization.',\n          'OtherOutcomeDescription': 'components of composite will also be examined',\n          'OtherOutcomeTimeFrame': '10 years'},\n         {'OtherOutcomeMeasure': 'Perceived stress',\n          'OtherOutcomeTimeFrame': '1 week'}]}},\n      'EligibilityModule': {'EligibilityCriteria': \"Inclusion Criteria:\\n\\nAcute ischemic symptoms compatible with diagnosis of MI, such as chest pain or anginal equivalent symptoms at rest or new onset exertional anginal equivalent symptoms\\n\\nObjective evidence of MI (either or both of the following):\\n\\nElevation of troponin to above the laboratory upper limit of normal\\nST segment elevation of ≥1mm on 2 contiguous ECG leads\\nWilling to provide informed consent and comply with all aspects of the protocol\\nAge ≥ 21 years\\n\\nExclusion Criteria:\\n\\nStenosis ≥50% of any major epicardial vessel on invasive angiography, as determined by the angiographer at the time of clinically ordered cardiac catheterization\\nHistory of known obstructive coronary artery disease at angiography, including history of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)\\nRecent use of vasospastic agents, such as cocaine, triptans, or ergot alkaloids (≤1 month)\\nAlternate explanation for troponin elevation, such as hypertensive urgency, acute exacerbation of heart failure, chronic elevation due to kidney disease, pulmonary embolism, cardiac trauma\\nCoronary dissection apparent on angiography\\nExcessive coronary tortuosity which, in the angiographer's opinion, increases the risks of OCT\\neGFR<45 or contraindication to additional contrast needed for OCT in the opinion of the angiographer or treating physician\\nContraindication to MRI (including but not limited to ferromagnetic implants)\\nPregnancy\\nThrombolytic therapy for STEMI (qualifying event)\",\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '21 Years',\n       'MaximumAge': '99 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']},\n       'StudyPopulation': 'Men and women with MI and no coronary stenosis of 50% or greater on angiography, consecutive.',\n       'SamplingMethod': 'Non-Probability Sample'},\n      'ContactsLocationsModule': {'CentralContactList': {'CentralContact': [{'CentralContactName': 'Harmony R Reynolds, MD',\n          'CentralContactRole': 'Contact',\n          'CentralContactPhone': '646-501-0302',\n          'CentralContactEMail': 'harmony.reynolds@nyumc.org'}]},\n       'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Harmony R Reynolds, MD',\n          'OverallOfficialAffiliation': 'NYU Langone Medical Center',\n          'OverallOfficialRole': 'Principal Investigator'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'University of Alabama-Birmingham',\n          'LocationStatus': 'Completed',\n          'LocationCity': 'Birmingham',\n          'LocationState': 'Alabama',\n          'LocationZip': '35294',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Cedars-Sinai Medical Center',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Los Angeles',\n          'LocationState': 'California',\n          'LocationZip': '90048',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'UC San Diego Medical Center',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'San Diego',\n          'LocationState': 'California',\n          'LocationZip': '92103',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Stanford University',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Stanford',\n          'LocationState': 'California',\n          'LocationZip': '94305',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'University of Florida Medical Center',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Gainesville',\n          'LocationState': 'Florida',\n          'LocationZip': '32603',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Emory University',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Atlanta',\n          'LocationState': 'Georgia',\n          'LocationZip': '30322',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Johns Hopkins Medical Center',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Baltimore',\n          'LocationState': 'Maryland',\n          'LocationZip': '21287',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Dartmouth-Hitchcock',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Lebanon',\n          'LocationState': 'New Hampshire',\n          'LocationZip': '03766',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'NYU Winthrop',\n          'LocationStatus': 'Recruiting',\n          'LocationCity': 'Mineola',\n          'LocationState': 'New York',\n          'LocationZip': '11501',\n          'LocationCountry': 'United States',\n          'LocationContactList': {'LocationContact': [{'LocationContactName': 'Wendy Drewes',\n             'LocationContactRole': 'Contact'},\n            {'LocationContactName': 'Kevin Marzo',\n             'LocationContactRole': 'Principal Investigator'},\n            {'LocationContactName': 'Juan Gaztanaga',\n             'LocationContactRole': 'Sub-Investigator'}]}},\n         {'LocationFacility': 'NYU Langone Medical Center',\n          'LocationStatus': 'Recruiting',\n          'LocationCity': 'New York',\n          'LocationState': 'New York',\n          'LocationZip': '10016',\n          'LocationCountry': 'United States',\n          'LocationContactList': {'LocationContact': [{'LocationContactName': 'Harmony R Reynolds, MD',\n             'LocationContactRole': 'Contact',\n             'LocationContactPhone': '212-263-3627',\n             'LocationContactEMail': 'harmony.reynolds@nyumc.org'}]}},\n         {'LocationFacility': 'Columbia University Medical Center/NYPH',\n          'LocationStatus': 'Completed',\n          'LocationCity': 'New York',\n          'LocationState': 'New York',\n          'LocationZip': '10032',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Ohio State University Medical Center',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Columbus',\n          'LocationState': 'Ohio',\n          'LocationZip': '43210',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': \"St. Luke's University Health Network\",\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Bethlehem',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '18015',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'University of Pittsburgh Medical Center',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Pittsburgh',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '15213',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Seton Heart (Ascension) Univeristy of Austin, Texas',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Austin',\n          'LocationState': 'Texas',\n          'LocationZip': '78705',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'University of Alberta',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Edmonton',\n          'LocationState': 'Alberta',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'Vancouver General Hospital',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Vancouver',\n          'LocationState': 'British Columbia',\n          'LocationZip': 'V5Z 1M9',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'St. Boniface General Hospital',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Winnipeg',\n          'LocationState': 'Manitoba',\n          'LocationZip': 'R2H 2A6',\n          'LocationCountry': 'Canada'},\n         {'LocationFacility': 'University of Calgary',\n          'LocationStatus': 'Active, not recruiting',\n          'LocationCity': 'Calgary',\n          'LocationCountry': 'Canada'}]}},\n      'ReferencesModule': {'ReferenceList': {'Reference': [{'ReferencePMID': '36225342',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': 'Usui E, Matsumura M, Smilowitz NR, Mintz GS, Saw J, Kwong RY, Hada M, Mahmud E, Giesler C, Shah B, Bangalore S, Razzouk L, Hoshino M, Marzo K, Ali ZA, Bairey Merz CN, Sugiyama T, Har B, Kakuta T, Hochman JS, Reynolds HR, Maehara A. Coronary morphological features in women with non-ST-segment elevation MINOCA and MI-CAD as assessed by optical coherence tomography. Eur Heart J Open. 2022 Sep 30;2(5):oeac058. doi: 10.1093/ehjopen/oeac058. eCollection 2022 Sep.'},\n         {'ReferencePMID': '34543066',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': 'Reynolds HR, Kwong RY, Maehara A, Smilowitz NR. Response by Reynolds et al to Letters Regarding Article, \"Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women\". Circulation. 2021 Sep 21;144(12):e209-e210. doi: 10.1161/CIRCULATIONAHA.121.055516. Epub 2021 Sep 20. No abstract available.'},\n         {'ReferencePMID': '33191769',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': 'Reynolds HR, Maehara A, Kwong RY, Sedlak T, Saw J, Smilowitz NR, Mahmud E, Wei J, Marzo K, Matsumura M, Seno A, Hausvater A, Giesler C, Jhalani N, Toma C, Har B, Thomas D, Mehta LS, Trost J, Mehta PK, Ahmed B, Bainey KR, Xia Y, Shah B, Attubato M, Bangalore S, Razzouk L, Ali ZA, Merz NB, Park K, Hada E, Zhong H, Hochman JS. Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women. Circulation. 2021 Feb 16;143(7):624-640. doi: 10.1161/CIRCULATIONAHA.120.052008. Epub 2020 Nov 14. Erratum In: Circulation. 2023 Feb 21;147(8):e624.'}]}},\n      'IPDSharingStatementModule': {'IPDSharing': 'Yes',\n       'IPDSharingDescription': 'De-identified data will be shared after the end of the study.'}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000007238',\n          'ConditionMeshTerm': 'Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'},\n         {'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafAsFound': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'}]}}}}},\n   {'Rank': 15,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT04790357',\n       'OrgStudyIdInfo': {'OrgStudyId': '69HCL17_0394'},\n       'SecondaryIdInfoList': {'SecondaryIdInfo': [{'SecondaryId': '2020-A00071-38',\n          'SecondaryIdType': 'Other Identifier',\n          'SecondaryIdDomain': 'IDRCB'}]},\n       'Organization': {'OrgFullName': 'Hospices Civils de Lyon',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'Assessment of One-shot Cardiac-cervical-intracranial MRI in the Etiological Work up of Ischemic Stroke and Transient Ischemic Attacks',\n       'OfficialTitle': 'Assessment of One-shot Cardiac-cervical-intracranial MRI in the Etiological Work up of Ischemic Stroke and Transient Ischemic Attacks',\n       'Acronym': 'Concise'},\n      'StatusModule': {'StatusVerifiedDate': 'March 2021',\n       'OverallStatus': 'Unknown status',\n       'LastKnownStatus': 'Not yet recruiting',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'April 1, 2021',\n        'StartDateType': 'Anticipated'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'April 1, 2023',\n        'PrimaryCompletionDateType': 'Anticipated'},\n       'CompletionDateStruct': {'CompletionDate': 'May 1, 2023',\n        'CompletionDateType': 'Anticipated'},\n       'StudyFirstSubmitDate': 'April 10, 2020',\n       'StudyFirstSubmitQCDate': 'March 5, 2021',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'March 10, 2021',\n        'StudyFirstPostDateType': 'Actual'},\n       'LastUpdateSubmitDate': 'March 5, 2021',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'March 10, 2021',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'Hospices Civils de Lyon',\n        'LeadSponsorClass': 'OTHER'}},\n      'OversightModule': {'OversightHasDMC': 'No',\n       'IsFDARegulatedDrug': 'No',\n       'IsFDARegulatedDevice': 'No'},\n      'DescriptionModule': {'BriefSummary': 'Stroke is a major public health issue in developed countries. A full etiological work up within a short time is critical to implement the appropriate preventive treatment. The etiological work up is actually based on a clinical examination and on a group of paraclinical examinations. The realization of the standard strategy is time consuming, and increase the cost of the medical care. A non-invasive one-shot examination of the heart, the aorta and the cervical and intracranial arteries (cci-MRI) could overcome these disadvantages.The investigator therefore propose to carry out an overall assessment of the performance of the cci-MR in the etiological work up of ischemic strokes and TIAs compared to the reference strategy'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Ischemic Stroke',\n         'Transient Ischemic Attack']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Not Applicable']},\n       'DesignInfo': {'DesignAllocation': 'Non-Randomized',\n        'DesignInterventionModel': 'Parallel Assignment',\n        'DesignPrimaryPurpose': 'Diagnostic',\n        'DesignMaskingInfo': {'DesignMasking': 'None (Open Label)'}},\n       'EnrollmentInfo': {'EnrollmentCount': '244',\n        'EnrollmentType': 'Anticipated'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'Reference strategy',\n          'ArmGroupType': 'Other',\n          'ArmGroupDescription': 'correspond to the reference techniques according to the current guidelines in the etiological work up of ischemic strokes and TIA',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Other: Current guidelines']}},\n         {'ArmGroupLabel': 'Evaluated strategy',\n          'ArmGroupType': 'Other',\n          'ArmGroupDescription': 'correspond to perform the cci-MR: cardiac MRI with late-enhancement, angio-MRI of the cervical and intracranial arteries',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Other: cc-MRI']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Other',\n          'InterventionName': 'Current guidelines',\n          'InterventionDescription': 'doppler ultrasound and/or angio CT-scan of the cervical arteries, angio CT-scan of the intracranial arteries, TTE wich can be supplemented by a TEE at the discretion of the investigator. The TEE is not mandatory',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Reference strategy']}},\n         {'InterventionType': 'Other',\n          'InterventionName': 'cc-MRI',\n          'InterventionDescription': 'of one-shot cardiac-cervical-intracranial MRI: cardiac MRI with late-enhancement, angio-MRI of the cervical and intracranial arteries',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Evaluated strategy']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'To evaluate the consistency between the reference strategy and the cci-MR strategy for etiological work up according to the ASCOD classification, in ischemic stroke and TIA patients',\n          'PrimaryOutcomeDescription': 'The primary endpoint will be based on the consistency for each patient of the etiological work up according to the ASCOD classification evaluated with cci-MR in comparison of the reference strategy',\n          'PrimaryOutcomeTimeFrame': 'Within 8 days after hospitalization'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'To assess the reproducibility of the assessment of the cci-MR results',\n          'SecondaryOutcomeDescription': 'The reproducibility of the assessment of the cci-MR results will be based on the following endpoints:\\n\\n- Double reading; Concordance intra and inter reviewer',\n          'SecondaryOutcomeTimeFrame': 'Within 8 days after hospitalization'},\n         {'SecondaryOutcomeMeasure': 'To evaluate the agreement between cci-MR and the reference method for each etiological subgroup: in the context of ischemic stroke or TIA.',\n          'SecondaryOutcomeDescription': 'Agreement for each etiological subgroup between cci-MR and the reference method.',\n          'SecondaryOutcomeTimeFrame': 'Within 8 days after hospitalization'},\n         {'SecondaryOutcomeMeasure': 'To assess the improvement of the detection of myocardial scar with cci-MR compared to reference strategy',\n          'SecondaryOutcomeDescription': 'Presence or absence of ischemic myocardial scar',\n          'SecondaryOutcomeTimeFrame': 'Within 8 days after hospitalization'},\n         {'SecondaryOutcomeMeasure': 'To assess the atherosclerotic burden (coronary, intracranial, cervical, aortic) assessed with cci-MR compared to the reference strategy,',\n          'SecondaryOutcomeDescription': 'Presence or absence of coronary, intracranial, cervical, aortic atheroma. The diagnostic work up will focus on cervical artery stenosis ≥ 50%; aortic arch atheroma ≥ 4 mm; intracranial artery stenosis ≥ 50% and presence of ischemic myocardial scar. The scar pattern was classified as ischemic if its distribution was sub-endocardial to transmural within a coronary vascular territory and if scar was associated with segmental systolic dysfunction on corresponding cine images. Atherosclerotic burden will be classified in 0, 1, 2, 3 and 4 atherosclerotic levels according to the number of arterial territories affected by at least one significant abnormality.',\n          'SecondaryOutcomeTimeFrame': 'Within 8 days after hospitalization'},\n         {'SecondaryOutcomeMeasure': 'To assess the additional yield of cci-MR in cryptogenic patients and in those with embolic stroke of undetermined source (ESUS) with the reference strategy (ref Hart et al., Lancet Neurol. 2014:13:429-438.)',\n          'SecondaryOutcomeDescription': 'Etiology subtype according to ASCOD classification with the reference strategy + cci-MR in cryptogenic patients and in the subgroup of patients with ESUS with the reference strategy',\n          'SecondaryOutcomeTimeFrame': 'Within 8 days after hospitalization'},\n         {'SecondaryOutcomeMeasure': 'To assess the rate of TEE recommended according to the opinion of the expert committee from data obtained with cci-MR and the reference strategy',\n          'SecondaryOutcomeDescription': 'Presence or absence of recommendation to realize a TEE according to the opinion of the expert committee from data obtained with cci-MR and with the reference strategy',\n          'SecondaryOutcomeTimeFrame': 'Within 8 days after hospitalization'},\n         {'SecondaryOutcomeMeasure': 'To assess the rate of additional cardiologic advice recommended according to the opinion of the expert committee from data obtained with cci-MR and with the reference strategy',\n          'SecondaryOutcomeDescription': 'Presence or absence of recommendation to have a cardiologic advice according to the opinion of the expert committee from data obtained cci-MR and with the reference strategy',\n          'SecondaryOutcomeTimeFrame': 'Within 8 days after hospitalization'},\n         {'SecondaryOutcomeMeasure': 'To assess the preventive treatment recommended (antithrombotic drugs and specific treatments) according to the opinion of the expert committee from data obtained with cci-MR and with the reference strategy',\n          'SecondaryOutcomeDescription': 'Presence or absence of recommendation of having antiplatelet, anticoagulant, and of having a specific care (carotid surgery, PFO closure…) according to the opinion of the expert committee from data obtained with cci-MR and with the reference strategy',\n          'SecondaryOutcomeTimeFrame': 'Within 8 days after hospitalization'},\n         {'SecondaryOutcomeMeasure': 'To assess the feasibility of the examinations (rate of completed examinations, deadline to obtain each examination, deadline to obtain all examinations including in each strategy)',\n          'SecondaryOutcomeDescription': 'Presence or absence of full completed examinations, deadline between the date of ischemic stroke or TIA and each examination, deadline between the date of ischemic stroke or TIA and the end of all examinations including in each strategy',\n          'SecondaryOutcomeTimeFrame': 'Within 8 days after hospitalization'},\n         {'SecondaryOutcomeMeasure': 'To assess the feeling of the patient about cci-MR and the reference strategy',\n          'SecondaryOutcomeDescription': 'Level of satisfaction of the patient about cci-MR and the reference strategy',\n          'SecondaryOutcomeTimeFrame': 'Within 8 days after hospitalization'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\n• Man or woman aged from 18 to 85 years old,\\nPatients victims of an ischemic stroke or a TIA in the 2 days before inclusion, Symptoms thought to be consistent with TIA were those defined by the ad hoc Committee established by the Advisory Council for the National Institute of Neurological and Communicative Disorders and Stroke65\\nRankin score: mRS ≤3\\nPatient having given their free written and informed consent, or preliminary oral informed consent attested by a third party followed by signed informed consent as soon as possible,\\nAffiliated to a social security scheme or equivalent,\\nThat are not the subject of any legal protection measures\\n\\nExclusion Criteria:\\n\\n•TIA symptoms limited to isolated numbness,\\nchanges, or isolated dizziness/vertigo\\nAgitation, severe swallowing\\nContraindication to an MRI and the injection of gadolinium,\\nKnown history of hypersensitivity to the MRI contrast product,\\nRisk of pregnancy or known pregnancy revealed when questioned, Breastfeeding,\\nPatient unable to understand or poorly understanding French.',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'MaximumAge': '85 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'CentralContactList': {'CentralContact': [{'CentralContactName': 'MECHTOUFF Laura, MD',\n          'CentralContactRole': 'Contact',\n          'CentralContactPhone': '04 27 85 67 47',\n          'CentralContactEMail': 'laura.mechtouff@chu-lyon.fr'},\n         {'CentralContactName': 'MANSUY Adeline',\n          'CentralContactRole': 'Contact',\n          'CentralContactPhone': 'O4 72 11 51 70',\n          'CentralContactEMail': 'adeline.mansuy@chu-lyon.fr'}]},\n       'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'MECHTOUFF Laura, MD',\n          'OverallOfficialAffiliation': 'Hospices Civils de Lyon',\n          'OverallOfficialRole': 'Study Director'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'Hospices Civils de Lyon',\n          'LocationCity': 'Bron',\n          'LocationZip': '69500',\n          'LocationCountry': 'France',\n          'LocationContactList': {'LocationContact': [{'LocationContactName': 'MANSUY ADELINE',\n             'LocationContactRole': 'Contact',\n             'LocationContactPhone': '04 72 11 51 70',\n             'LocationContactEMail': 'adeline.mansuy@chu-lyon.fr'}]}}]}},\n      'IPDSharingStatementModule': {'IPDSharing': 'No'}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000020521',\n          'ConditionMeshTerm': 'Stroke'},\n         {'ConditionMeshId': 'D000083242',\n          'ConditionMeshTerm': 'Ischemic Stroke'},\n         {'ConditionMeshId': 'D000002544',\n          'ConditionMeshTerm': 'Cerebral Infarction'},\n         {'ConditionMeshId': 'D000002546',\n          'ConditionMeshTerm': 'Ischemic Attack, Transient'},\n         {'ConditionMeshId': 'D000007511', 'ConditionMeshTerm': 'Ischemia'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000002561',\n          'ConditionAncestorTerm': 'Cerebrovascular Disorders'},\n         {'ConditionAncestorId': 'D000001927',\n          'ConditionAncestorTerm': 'Brain Diseases'},\n         {'ConditionAncestorId': 'D000002493',\n          'ConditionAncestorTerm': 'Central Nervous System Diseases'},\n         {'ConditionAncestorId': 'D000009422',\n          'ConditionAncestorTerm': 'Nervous System Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000020520',\n          'ConditionAncestorTerm': 'Brain Infarction'},\n         {'ConditionAncestorId': 'D000002545',\n          'ConditionAncestorTerm': 'Brain Ischemia'},\n         {'ConditionAncestorId': 'D000007238',\n          'ConditionAncestorTerm': 'Infarction'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M22306',\n          'ConditionBrowseLeafName': 'Stroke',\n          'ConditionBrowseLeafAsFound': 'Stroke',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafAsFound': 'Ischemic',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M2400',\n          'ConditionBrowseLeafName': 'Ischemic Stroke',\n          'ConditionBrowseLeafAsFound': 'Ischemic Stroke',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M5795',\n          'ConditionBrowseLeafName': 'Ischemic Attack, Transient',\n          'ConditionBrowseLeafAsFound': 'Transient Ischemic Attack',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M5793',\n          'ConditionBrowseLeafName': 'Cerebral Infarction',\n          'ConditionBrowseLeafAsFound': 'Ischemic Stroke',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5810',\n          'ConditionBrowseLeafName': 'Cerebrovascular Disorders',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5204',\n          'ConditionBrowseLeafName': 'Brain Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5742',\n          'ConditionBrowseLeafName': 'Central Nervous System Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M22305',\n          'ConditionBrowseLeafName': 'Brain Infarction',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M5794',\n          'ConditionBrowseLeafName': 'Brain Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC10',\n          'ConditionBrowseBranchName': 'Nervous System Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'}]}}}}},\n   {'Rank': 16,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT01438086',\n       'OrgStudyIdInfo': {'OrgStudyId': 'UCC-IGF-001'},\n       'SecondaryIdInfoList': {'SecondaryIdInfo': [{'SecondaryId': '2011-000480-27',\n          'SecondaryIdType': 'EudraCT Number'}]},\n       'Organization': {'OrgFullName': 'University College Cork',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack',\n       'OfficialTitle': 'A Randomised Trial Evaluating the Safety and Efficacy of a Single Low Dose of Intracoronary Insulin-like Growth Factor-1 Following Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction (RESUS-AMI)',\n       'Acronym': 'RESUS-AMI'},\n      'StatusModule': {'StatusVerifiedDate': 'March 2017',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'October 2011',\n        'StartDateType': 'Actual'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'February 2016',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'December 2016',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'September 17, 2011',\n       'StudyFirstSubmitQCDate': 'September 20, 2011',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'September 21, 2011',\n        'StudyFirstPostDateType': 'Estimate'},\n       'LastUpdateSubmitDate': 'March 28, 2017',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'March 30, 2017',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Principal Investigator',\n        'ResponsiblePartyInvestigatorFullName': 'Professor Noel Caplice',\n        'ResponsiblePartyInvestigatorTitle': 'Professor of Cardiovascular Sciences',\n        'ResponsiblePartyInvestigatorAffiliation': 'University College Cork'},\n       'LeadSponsor': {'LeadSponsorName': 'University College Cork',\n        'LeadSponsorClass': 'OTHER'}},\n      'OversightModule': {'OversightHasDMC': 'Yes'},\n      'DescriptionModule': {'BriefSummary': 'When a patient has a heart attack, a blockage occurs in a coronary artery that delivers oxygen to the heart muscle. The heart muscle may weaken, causing heart failure. The body naturally makes a protein called insulin-like growth factor-1 (IGF-1) that may protect the heart muscle cells from dying and may prevent heart failure or lessen the damage that occurs. IGF-1 is also available as a drug called mecasermin. In this study, heart attack patients will be given either a dose of mecasermin or a placebo (inactive treatment) after their coronary artery has been opened by a stent. The purpose of the study will be to evaluate the safety of the therapy and to test if the therapy will prevent or lessen heart failure by evaluating a cardiac magnetic resonance imaging (MRI) taken one day and eight weeks after the heart attack.'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Heart Failure',\n         'Myocardial Infarction']},\n       'KeywordList': {'Keyword': ['Heart Failure', 'Myocardial Infarction']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Phase 1', 'Phase 2']},\n       'DesignInfo': {'DesignAllocation': 'Randomized',\n        'DesignInterventionModel': 'Parallel Assignment',\n        'DesignPrimaryPurpose': 'Treatment',\n        'DesignMaskingInfo': {'DesignMasking': 'Triple',\n         'DesignWhoMaskedList': {'DesignWhoMasked': ['Participant',\n           'Care Provider',\n           'Investigator']}}},\n       'EnrollmentInfo': {'EnrollmentCount': '47',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'mecasermin low dose',\n          'ArmGroupType': 'Active Comparator',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Drug: mecasermin']}},\n         {'ArmGroupLabel': 'mecasermin high dose',\n          'ArmGroupType': 'Active Comparator',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Drug: mecasermin']}},\n         {'ArmGroupLabel': 'saline placebo',\n          'ArmGroupType': 'Placebo Comparator',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Drug: 0.9% sodium chloride injection']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Drug',\n          'InterventionName': 'mecasermin',\n          'InterventionDescription': 'Intracoronary bolus',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['mecasermin low dose']},\n          'InterventionOtherNameList': {'InterventionOtherName': ['rhIGF-1',\n            'IGF-1']}},\n         {'InterventionType': 'Drug',\n          'InterventionName': 'mecasermin',\n          'InterventionDescription': 'Intracoronary bolus',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['mecasermin high dose']},\n          'InterventionOtherNameList': {'InterventionOtherName': ['rhIGF-1',\n            'IGF-1']}},\n         {'InterventionType': 'Drug',\n          'InterventionName': '0.9% sodium chloride injection',\n          'InterventionDescription': 'Intracoronary bolus',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['saline placebo']},\n          'InterventionOtherNameList': {'InterventionOtherName': ['normal saline']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Serum glucose measurement',\n          'PrimaryOutcomeDescription': 'Safety outcome measure',\n          'PrimaryOutcomeTimeFrame': '30 minutes after study drug administration'},\n         {'PrimaryOutcomeMeasure': 'Percent change in global left ventricular ejection fraction (LVEF) measured by quantitative cardiac magnetic resonance imaging (MRI)',\n          'PrimaryOutcomeDescription': 'Efficacy outcome measure',\n          'PrimaryOutcomeTimeFrame': 'Baseline and 8 weeks'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nAge 18 - 75\\nPresents within 2-12 hours of at least 30 minutes of myocardial ischemic pain\\nECG evidence of myocardial infarction\\nUndergoing percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction\\nLeft ventricular ejection fraction during PCI of 40% or less\\nTIMI flow grade 3 in the infarct-related artery following reperfusion and stenting\\n\\nExclusion Criteria:\\n\\nHistory of prior myocardial infarction\\nPrior history of heart failure, left ventricular dysfunction or cardiomyopathy\\nActive or suspected neoplasia\\nKnown impaired liver function\\nCardiogenic shock\\nEstimated glomerular filtration rate < 45 ml/min/1.73m2\\nHistory of hypoglycaemia requiring hospitalisation\\nHistory of primary insulin-like growth factor-1 deficiency or growth hormone disorders\\nContraindication to cardiac magnetic resonance imaging\\nPregnancy or nursing mothers\\nKnown allergy to study drug or any of its inactive ingredients\\nTreatment with another investigational agent within 30 days of enrolment\\nSubjects unable or unwilling to comply with follow-up requirements of study\\nSubjects unable to provide written informed consent',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'MaximumAge': '75 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Noel Caplice, MB, PhD',\n          'OverallOfficialAffiliation': 'University College Cork',\n          'OverallOfficialRole': 'Principal Investigator'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'Cork University Hospital',\n          'LocationCity': 'Cork',\n          'LocationCountry': 'Ireland'},\n         {'LocationFacility': 'Leiden University Medical Center',\n          'LocationCity': 'Leiden',\n          'LocationCountry': 'Netherlands'}]}}},\n     'AnnotationSection': {'AnnotationModule': {'UnpostedAnnotation': {'UnpostedResponsibleParty': 'Professor Noel Caplice, Professor of Cardiovascular Sciences, University College Cork',\n        'UnpostedEventList': {'UnpostedEvent': [{'UnpostedEventType': 'Release',\n           'UnpostedEventDate': 'September 19, 2017'},\n          {'UnpostedEventType': 'Reset',\n           'UnpostedEventDate': 'June 29, 2018'}]}}}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024',\n       'SubmissionTracking': {'SubmissionInfoList': {'SubmissionInfo': [{'SubmissionReleaseDate': 'September 19, 2017',\n           'SubmissionResetDate': 'June 29, 2018'}]}}},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000006333',\n          'ConditionMeshTerm': 'Heart Failure'},\n         {'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000007238',\n          'ConditionMeshTerm': 'Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'},\n         {'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M9421',\n          'ConditionBrowseLeafName': 'Heart Failure',\n          'ConditionBrowseLeafAsFound': 'Heart Failure',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafAsFound': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'T170',\n          'ConditionBrowseLeafName': 'Acute Graft Versus Host Disease',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'},\n         {'ConditionBrowseBranchAbbrev': 'Rare',\n          'ConditionBrowseBranchName': 'Rare Diseases'}]}},\n      'InterventionBrowseModule': {'InterventionMeshList': {'InterventionMesh': [{'InterventionMeshId': 'C000604197',\n          'InterventionMeshTerm': 'Mecasermin'}]},\n       'InterventionAncestorList': {'InterventionAncestor': [{'InterventionAncestorId': 'D000006133',\n          'InterventionAncestorTerm': 'Growth Substances'},\n         {'InterventionAncestorId': 'D000045505',\n          'InterventionAncestorTerm': 'Physiological Effects of Drugs'}]},\n       'InterventionBrowseLeafList': {'InterventionBrowseLeaf': [{'InterventionBrowseLeafId': 'M10365',\n          'InterventionBrowseLeafName': 'Insulin',\n          'InterventionBrowseLeafRelevance': 'low'},\n         {'InterventionBrowseLeafId': 'M173166',\n          'InterventionBrowseLeafName': 'Insulin, Globin Zinc',\n          'InterventionBrowseLeafRelevance': 'low'},\n         {'InterventionBrowseLeafId': 'M11900',\n          'InterventionBrowseLeafName': 'Mitogens',\n          'InterventionBrowseLeafRelevance': 'low'},\n         {'InterventionBrowseLeafId': 'M255285',\n          'InterventionBrowseLeafName': 'Mecasermin',\n          'InterventionBrowseLeafAsFound': 'Intravitreal implant',\n          'InterventionBrowseLeafRelevance': 'high'}]},\n       'InterventionBrowseBranchList': {'InterventionBrowseBranch': [{'InterventionBrowseBranchAbbrev': 'Hypo',\n          'InterventionBrowseBranchName': 'Hypoglycemic Agents'},\n         {'InterventionBrowseBranchAbbrev': 'All',\n          'InterventionBrowseBranchName': 'All Drugs and Chemicals'}]}}}}},\n   {'Rank': 17,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT05305911',\n       'OrgStudyIdInfo': {'OrgStudyId': '1852152'},\n       'Organization': {'OrgFullName': 'Minneapolis Heart Institute Foundation',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI',\n       'OfficialTitle': 'Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition Improves Left Ventricular Function and Reduces Adverse Left-Ventricular Remodeling in High-Risk Patients With Microvascular Obstruction (MVO) Following ST-elevation Myocardial Infarction (STEMI).'},\n      'StatusModule': {'StatusVerifiedDate': 'August 2022',\n       'OverallStatus': 'Recruiting',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'August 3, 2022',\n        'StartDateType': 'Actual'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'April 15, 2024',\n        'PrimaryCompletionDateType': 'Anticipated'},\n       'CompletionDateStruct': {'CompletionDate': 'April 15, 2024',\n        'CompletionDateType': 'Anticipated'},\n       'StudyFirstSubmitDate': 'March 14, 2022',\n       'StudyFirstSubmitQCDate': 'March 23, 2022',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'March 31, 2022',\n        'StudyFirstPostDateType': 'Actual'},\n       'LastUpdateSubmitDate': 'August 4, 2022',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'August 5, 2022',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'Minneapolis Heart Institute Foundation',\n        'LeadSponsorClass': 'OTHER'}},\n      'OversightModule': {'OversightHasDMC': 'No',\n       'IsFDARegulatedDrug': 'Yes',\n       'IsFDARegulatedDevice': 'No',\n       'IsUSExport': 'Yes'},\n      'DescriptionModule': {'BriefSummary': \"The purpose of the research is to determine whether a medication called dapagliflozin will improve the heart's function and reduce its enlargement after a heart attack. Participation in this study will involve taking the medication dapagliflozin (or a placebo) once daily for six months, one cardiac magnetic resonance imaging (MRI) test during your initial hospitalization, follow-up phone calls at 1 and 3 months, and one cardiac MRI and clinic visit at six months.\"},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Heart Attack',\n         'Enlarged Heart']},\n       'KeywordList': {'Keyword': ['Dapagliflozin',\n         'Sodium Glucose Co-Transporter 2']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Phase 2']},\n       'DesignInfo': {'DesignAllocation': 'Randomized',\n        'DesignInterventionModel': 'Parallel Assignment',\n        'DesignPrimaryPurpose': 'Treatment',\n        'DesignMaskingInfo': {'DesignMasking': 'Double',\n         'DesignMaskingDescription': 'Treatment will be blinded to the participant and study team. Assignment of treatment arm will be managed by Abbott Northwestern Heart Hospital pharmacy',\n         'DesignWhoMaskedList': {'DesignWhoMasked': ['Participant',\n           'Investigator']}}},\n       'EnrollmentInfo': {'EnrollmentCount': '80',\n        'EnrollmentType': 'Anticipated'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'Treatment Group',\n          'ArmGroupType': 'Active Comparator',\n          'ArmGroupDescription': 'Treatment group will receive dapagliflozin in addition to standard heart attack medications for the duration of hospitalization and 6-month duration of the study.',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Drug: Dapagliflozin']}},\n         {'ArmGroupLabel': 'Placebo Group',\n          'ArmGroupType': 'Placebo Comparator',\n          'ArmGroupDescription': 'Placebo Group will receive placebo in addition to standard heart attack medications for the duration of hospitalization and 6-month duration of the study.',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Drug: Placebo']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Drug',\n          'InterventionName': 'Dapagliflozin',\n          'InterventionDescription': 'Dapagliflozin once daily for six months',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Treatment Group']}},\n         {'InterventionType': 'Drug',\n          'InterventionName': 'Placebo',\n          'InterventionDescription': 'Placebo once daily for six months',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Placebo Group']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Change in LVESVI',\n          'PrimaryOutcomeDescription': 'Change in LVESVI at 6 months as measured by MRI.',\n          'PrimaryOutcomeTimeFrame': '6 Months'},\n         {'PrimaryOutcomeMeasure': 'Change in LVEDVI',\n          'PrimaryOutcomeDescription': 'Change in LVEDVI at 6 months as measured by MRI.',\n          'PrimaryOutcomeTimeFrame': '6 Months'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Change in LV mass',\n          'SecondaryOutcomeDescription': 'Change in LV mass at 6 months as measured by cMRI',\n          'SecondaryOutcomeTimeFrame': '6 months'},\n         {'SecondaryOutcomeMeasure': 'Change in LVEF',\n          'SecondaryOutcomeDescription': 'Change in LVEF at 6 months as measured by cMRI',\n          'SecondaryOutcomeTimeFrame': '6 months'},\n         {'SecondaryOutcomeMeasure': 'MACE rates - including hospitalization for CHF, repeat revascularization, MI and death and ICD implantation',\n          'SecondaryOutcomeTimeFrame': '1 year'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nPatients with their first STEMI (> 18 years and < 75 years) who underwent successful primary PCI and able to give informed consent\\nAt least mild LV dysfunction (LVEF < 50%) on echocardiogram, cMRI or Left Ventriculargram following PCI\\nInfarct size that is > 10% of LV mass\\nThe presence of MVO that is > 10% of infarct size\\n\\nExclusion Criteria:\\n\\nContraindication to cardiac MRI\\nLife expectancy < 1 year\\nPrevious CABG or Valve Surgery\\nPrevious STEMI\\nPregnant or planning to become pregnant or lactating women\\nCardiogenic shock (not resolved)\\nAtrial fibrillation or recurrent sustained ventricular arrhythmias (excluding PVCs)\\nGFR<30 ml/min/1.73m2 or end-stage renal disease on dialysis\\nType 1 diabetes mellitus or history of diabetic ketoacidosis\\nType I or II diabetes with insulin use\\nPrior intolerance of SGLT2 inhibitors\\nCurrent use of SGLT2 inhibitors\\nContraindications to gadolinium',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'MaximumAge': '75 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'CentralContactList': {'CentralContact': [{'CentralContactName': 'Sarah Schwager, RN',\n          'CentralContactRole': 'Contact',\n          'CentralContactPhone': '612-863-3833',\n          'CentralContactEMail': 'sarah.schwager@allina.com'}]},\n       'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Jay Traverse, MD',\n          'OverallOfficialAffiliation': 'Minneapolis Heart Institute Foundation',\n          'OverallOfficialRole': 'Principal Investigator'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'Minneapolis Heart Institute Foundation',\n          'LocationStatus': 'Recruiting',\n          'LocationCity': 'Minneapolis',\n          'LocationState': 'Minnesota',\n          'LocationZip': '55407',\n          'LocationCountry': 'United States',\n          'LocationContactList': {'LocationContact': [{'LocationContactName': 'Sarah Schwager, RN',\n             'LocationContactRole': 'Contact',\n             'LocationContactPhone': '612-863-3833',\n             'LocationContactEMail': 'sarah.schwager@allina.com'}]}}]}},\n      'IPDSharingStatementModule': {'IPDSharing': 'No'}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000006332',\n          'ConditionMeshTerm': 'Cardiomegaly'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'},\n         {'ConditionAncestorId': 'D000007238',\n          'ConditionAncestorTerm': 'Infarction'},\n         {'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'},\n         {'ConditionAncestorId': 'D000006984',\n          'ConditionAncestorTerm': 'Hypertrophy'},\n         {'ConditionAncestorId': 'D000020763',\n          'ConditionAncestorTerm': 'Pathological Conditions, Anatomical'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Heart Attack',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M22079',\n          'ConditionBrowseLeafName': 'Ventricular Remodeling',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M1072',\n          'ConditionBrowseLeafName': 'ST Elevation Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9420',\n          'ConditionBrowseLeafName': 'Cardiomegaly',\n          'ConditionBrowseLeafAsFound': 'Enlarged Heart',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M10035',\n          'ConditionBrowseLeafName': 'Hypertrophy',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M22519',\n          'ConditionBrowseLeafName': 'Pathological Conditions, Anatomical',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'}]}},\n      'InterventionBrowseModule': {'InterventionMeshList': {'InterventionMesh': [{'InterventionMeshId': 'C000529054',\n          'InterventionMeshTerm': 'Dapagliflozin'}]},\n       'InterventionAncestorList': {'InterventionAncestor': [{'InterventionAncestorId': 'D000077203',\n          'InterventionAncestorTerm': 'Sodium-Glucose Transporter 2 Inhibitors'},\n         {'InterventionAncestorId': 'D000045504',\n          'InterventionAncestorTerm': 'Molecular Mechanisms of Pharmacological Action'},\n         {'InterventionAncestorId': 'D000007004',\n          'InterventionAncestorTerm': 'Hypoglycemic Agents'},\n         {'InterventionAncestorId': 'D000045505',\n          'InterventionAncestorTerm': 'Physiological Effects of Drugs'}]},\n       'InterventionBrowseLeafList': {'InterventionBrowseLeaf': [{'InterventionBrowseLeafId': 'M348449',\n          'InterventionBrowseLeafName': 'Dapagliflozin',\n          'InterventionBrowseLeafAsFound': 'Selected',\n          'InterventionBrowseLeafRelevance': 'high'},\n         {'InterventionBrowseLeafId': 'M1691',\n          'InterventionBrowseLeafName': 'Sodium-Glucose Transporter 2 Inhibitors',\n          'InterventionBrowseLeafRelevance': 'low'},\n         {'InterventionBrowseLeafId': 'M10054',\n          'InterventionBrowseLeafName': 'Hypoglycemic Agents',\n          'InterventionBrowseLeafRelevance': 'low'}]},\n       'InterventionBrowseBranchList': {'InterventionBrowseBranch': [{'InterventionBrowseBranchAbbrev': 'Hypo',\n          'InterventionBrowseBranchName': 'Hypoglycemic Agents'},\n         {'InterventionBrowseBranchAbbrev': 'All',\n          'InterventionBrowseBranchName': 'All Drugs and Chemicals'}]}}}}},\n   {'Rank': 18,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT00677222',\n       'OrgStudyIdInfo': {'OrgStudyId': 'AMI-07-001'},\n       'Organization': {'OrgFullName': 'Athersys, Inc',\n        'OrgClass': 'INDUSTRY'},\n       'BriefTitle': 'Safety Study of AMI MultiStem® to Treat Heart Attacks',\n       'OfficialTitle': 'A Phase I, Multicenter, Dose-Escalation Trial Evaluating the Safety of Allogeneic AMI MultiStem® in Patients With Acute Myocardial Infarction'},\n      'StatusModule': {'StatusVerifiedDate': 'May 2012',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'May 2008'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'March 2010',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'February 2012',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'May 12, 2008',\n       'StudyFirstSubmitQCDate': 'May 12, 2008',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'May 14, 2008',\n        'StudyFirstPostDateType': 'Estimate'},\n       'LastUpdateSubmitDate': 'May 10, 2012',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'May 11, 2012',\n        'LastUpdatePostDateType': 'Estimate'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'Athersys, Inc',\n        'LeadSponsorClass': 'INDUSTRY'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'PPD',\n          'CollaboratorClass': 'INDUSTRY'},\n         {'CollaboratorName': 'Angiotech Pharmaceuticals',\n          'CollaboratorClass': 'INDUSTRY'}]}},\n      'OversightModule': {'OversightHasDMC': 'Yes'},\n      'DescriptionModule': {'BriefSummary': 'The purpose of this study is to determine if escalating doses of AMI MultiStem® delivered by catheter can safely be given to patients that have had a recent heart attack treated with stent implantation.',\n       'DetailedDescription': \"The mortality rates associated with acute myocardial infarction (AMI) have significantly decreased over the past 2 decades. Beginning first with thrombolytic therapy for AMI, and more recently with growing acceptance and availability of primary percutaneous coronary intervention (PCI) for ST-elevation AMI, the mortality rates of this devastating ischemic event have decreased from almost 15% in clinical trials in the late 1980's to <5% in recent primary percutaneous coronary intervention trials. Though AMI-related mortality has been reduced, AMI survival is often accompanied by significant loss of function that may lead to subsequent treatments, congestive heart failure (CHF) and reduction in quality of life. A cell therapy that could reduce the damage associated with AMI and positively affect heart function would provide substantial benefits to the AMI patient.\"},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Acute Myocardial Infarction']},\n       'KeywordList': {'Keyword': ['Acute Myocardial Infarction, Heart Attack']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Phase 1']},\n       'DesignInfo': {'DesignAllocation': 'Non-Randomized',\n        'DesignInterventionModel': 'Parallel Assignment',\n        'DesignPrimaryPurpose': 'Treatment',\n        'DesignMaskingInfo': {'DesignMasking': 'None (Open Label)'}},\n       'EnrollmentInfo': {'EnrollmentCount': '25',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': '1',\n          'ArmGroupType': 'Experimental',\n          'ArmGroupDescription': 'Treatment arm',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Biological: AMI MultiStem®']}},\n         {'ArmGroupLabel': '2',\n          'ArmGroupType': 'No Intervention',\n          'ArmGroupDescription': 'Registry Arm -standard of care'}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Biological',\n          'InterventionName': 'AMI MultiStem®',\n          'InterventionDescription': 'AMI MultiStem® administered via catheter into peri-vascular space of the target vessel, 2-5 days post PCI. There will be 3 dose escalation cohorts, 6 patients per cohort.',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['1']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Assessment of adverse events during the first 24 hours after administration of AMI MultiStem® and post acute adverse events up to 30 days following AMI',\n          'PrimaryOutcomeTimeFrame': '30 days'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Evaluation of longer term safety and cardiac function over 12 months following AMI',\n          'SecondaryOutcomeTimeFrame': '12 months'}]}},\n      'EligibilityModule': {'EligibilityCriteria': \"Inclusion Criteria:\\n\\nPatients of either sex 18-85 years of age\\nWomen of childbearing potential or less than 2 years postmenopausal agree to use of adequate contraception during the study\\nPatients with the first time diagnosis of ST elevation myocardial infarction\\nAcute myocardial infarction (ST elevation in at least two leads >0.2 mV in V1, V2 or V3 or >0.1 mV in other leads), treated by one of the following: either\\nAcute PCI with stent implantation\\nWith thrombolysis within 12 hr of symptom onset followed by PCI with stent implantation within 24 hr after Thrombolysis\\nMaximal creatine kinase elevation >400 U/l with significant membrane-bound fraction (>6%)or troponin >2X ULN\\nDecreasing levels of CK/CK-MB or troponin following reperfusion\\nSuccessful acute PCI/stent implantation (residual stenosis visually <30% and TIMI flow >2). Absence of severe disorder of the microcirculation (e.g. pulsatile flow pattern, systolic flow reversal) at the time of administration of the trial therapy\\nSignificant regional wall motion abnormality in left ventricular angiogram or transthoracic echocardiogram ≤48 hours post PCI\\nLVEF between 30 and 45% by LV gram after the primary PCI or transthoracic echocardiogram ≤48 hours post PCI\\nWilling and able to comply with the scheduled visits, treatment, laboratory tests and other study related procedures.\\nSigned informed consent\\n\\nExclusion Criteria:\\n\\nPrior cardiovascular history\\nMechanical complications of the index acute myocardial infarction including but not limited to rupture of the mitral valve with resultant development of mitral regurgitation, rupture of the left ventricular free wall and rupture of the interventricular septum\\nPregnant or lactating\\nKnown allergy to contrast agents\\nKnown allergy or religious objections to bovine or porcine products\\nHistory of malignancy of any type except non-melanoma skin cancer\\nPresence of major hematological conditions or laboratory abnormalities (low hemoglobin (<10 gm/dl), - WBC (<3,000 cells/mm2) or platelet count (<100,000 cells/mm3))\\nProthrombin time (PT) > 1x ULN\\nPartial thromboplastin time (PTT) > 1x ULN\\nPresence of chronic systemic inflammatory disorders that requires ongoing therapy\\nPrevious autologous, allogeneic bone marrow or peripheral stem cell transplant\\nPrior solid organ transplantation\\nImmune system compromise including but not limited to history of human immunodeficiency virus (HIV), hepatitis B (HBV) and hepatitis C (HCV) infection.\\nPrior participation in any other study involving investigational pharmacological agents(s), devices or marketed products within 30 days prior to planned AMI MultiStem® administration\\nLife expectancy of six months or less\\nCurrent alcohol or substance abuse\\nOngoing systemic infection\\nRenal function: Serum creatinine >2 mg/dL or creatinine clearance ≤50 mL/min\\nHepatic function: Screening ALT and AST ≥3x upper limit of normal for the laboratory or total bilirubin ≥2.0 mg/dL (exception: acceptable if patient is identified with pre existing condition e.g. Gilbert's disease that will contribute to baseline elevations of bilirubin)\\nOther serious medical or psychiatric illness that, in the investigator's opinion, would not permit the patient to be managed according to the protocol.\",\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'MaximumAge': '80 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Marc Penn, MD',\n          'OverallOfficialAffiliation': 'The Cleveland Clinic',\n          'OverallOfficialRole': 'Principal Investigator'},\n         {'OverallOfficialName': 'Warren Sherman, MD',\n          'OverallOfficialAffiliation': 'Columbia University',\n          'OverallOfficialRole': 'Principal Investigator'}]},\n       'LocationList': {'Location': [{'LocationFacility': 'Cardiology PC',\n          'LocationCity': 'Birmingham',\n          'LocationState': 'Alabama',\n          'LocationZip': '35211',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'The Care Group',\n          'LocationCity': 'Indianapolis',\n          'LocationState': 'Indiana',\n          'LocationZip': '46260',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Henry Ford Hospital',\n          'LocationCity': 'Detroit',\n          'LocationState': 'Michigan',\n          'LocationZip': '48202',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Columbia University Medical Center',\n          'LocationCity': 'New York',\n          'LocationState': 'New York',\n          'LocationZip': '10032',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Metro Health',\n          'LocationCity': 'Cleveland',\n          'LocationState': 'Ohio',\n          'LocationZip': '44109',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Cleveland Clinic',\n          'LocationCity': 'Cleveland',\n          'LocationState': 'Ohio',\n          'LocationZip': '44195',\n          'LocationCountry': 'United States'},\n         {'LocationFacility': 'Hamot Medical Center',\n          'LocationCity': 'Erie',\n          'LocationState': 'Pennsylvania',\n          'LocationZip': '16507',\n          'LocationCountry': 'United States'}]}},\n      'ReferencesModule': {'ReferenceList': {'Reference': [{'ReferencePMID': '22052917',\n          'ReferenceType': 'derived',\n          'ReferenceCitation': 'Penn MS, Ellis S, Gandhi S, Greenbaum A, Hodes Z, Mendelsohn FO, Strasser D, Ting AE, Sherman W. Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Circ Res. 2012 Jan 20;110(2):304-11. doi: 10.1161/CIRCRESAHA.111.253427. Epub 2011 Nov 3.'}]}}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000007238',\n          'ConditionMeshTerm': 'Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'},\n         {'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafAsFound': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'T170',\n          'ConditionBrowseLeafName': 'Acute Graft Versus Host Disease',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'Rare',\n          'ConditionBrowseBranchName': 'Rare Diseases'}]}}}}},\n   {'Rank': 19,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT00000533',\n       'OrgStudyIdInfo': {'OrgStudyId': '76'},\n       'SecondaryIdInfoList': {'SecondaryIdInfo': [{'SecondaryId': 'R01HL047330',\n          'SecondaryIdType': 'U.S. NIH Grant/Contract',\n          'SecondaryIdLink': 'https://reporter.nih.gov/quickSearch/R01HL047330'}]},\n       'Organization': {'OrgFullName': 'McGill University',\n        'OrgClass': 'OTHER'},\n       'BriefTitle': 'Montreal Heart Attack Readjustment Trial (M-HART)',\n       'OfficialTitle': 'Montreal Heart Attack Readjustment Trial (M-HART)'},\n      'StatusModule': {'StatusVerifiedDate': 'March 2005',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'February 1992'},\n       'CompletionDateStruct': {'CompletionDate': 'December 1996'},\n       'StudyFirstSubmitDate': 'October 27, 1999',\n       'StudyFirstSubmitQCDate': 'October 27, 1999',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'October 28, 1999',\n        'StudyFirstPostDateType': 'Estimate'},\n       'LastUpdateSubmitDate': 'December 28, 2015',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'December 29, 2015',\n        'LastUpdatePostDateType': 'Estimate'}},\n      'SponsorCollaboratorsModule': {'LeadSponsor': {'LeadSponsorName': 'McGill University',\n        'LeadSponsorClass': 'OTHER'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'National Heart, Lung, and Blood Institute (NHLBI)',\n          'CollaboratorClass': 'NIH'}]}},\n      'DescriptionModule': {'BriefSummary': 'To examine the impact of a monitoring and social support intervention upon survival of myocardial infarction patients.',\n       'DetailedDescription': 'BACKGROUND:\\n\\nDespite evidence that social support and various aspects of negative affect may influence prognosis after a myocardial infarction, the impact of psychosocial supportive interventions had not been demonstrated. Further, little was known about the impact of psychosocial and/or interventions among women patients. Previous work by Nancy Frasure-Smith and colleagues suggested that a one-year post-myocardial infarction program of monthly telephone monitoring of psychological stress symptoms, coupled with home nursing visits for patients reporting high stress levels, had an impact on one-year cardiac mortality and long-term myocardial infarction recurrences among men. However, methodological difficulties prevented drawing firm conclusions. A trial which corrected for these difficulties was conducted involving 948 post-myocardial infarction patients. However, the project was too small to study enough patients to assess program impact separately for men and women. The trial was supported by Canadian sources. The NHLBI supplemented the study in order to expand the sample size from 948 patients to 1,376 patients to allow gender analysis.\\n\\nDESIGN NARRATIVE:\\n\\nRandomized, with a multi-hospital design. At the time of discharge from the hospital following a documented myocardial infarction, patients were randomized to treatment and control groups. The control group received usual care from their physicians. In addition to usual care, treatment patients were phoned monthly and responded to a standardized index of psychological symptoms of stress. Those with high stress levels received home nursing visits to reduce their stress. Patients in both groups took part in three interviews: in the hospital, at three months, and at one year post-discharge. Interviews assessed depression, anxiety, anger, self-perceived stress, social support, medication compliance, and cardiac risk factors. Salivary cortisol, a physiological indicator of stress, was assessed on the evening following each interview. Indicators of residual myocardial infarction, ischemia, and arrhythmias were obtained from hospital charts. Outcome data were obtained from hospital charts, death certificates, and Quebec Medicare data and were blindly classified by study cardiologists.'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Cardiovascular Diseases',\n         'Coronary Disease',\n         'Heart Diseases',\n         'Myocardial Infarction',\n         'Myocardial Ischemia']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Phase 3']}},\n      'ArmsInterventionsModule': {'InterventionList': {'Intervention': [{'InterventionType': 'Behavioral',\n          'InterventionName': 'social support'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Men and women myocardial infarction patients.',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '18 Years',\n       'MaximumAge': '75 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'OverallOfficialList': {'OverallOfficial': [{'OverallOfficialName': 'Nancy Frasure-Smith',\n          'OverallOfficialAffiliation': 'McGill University'}]}},\n      'ReferencesModule': {'ReferenceList': {'Reference': [{'ReferencePMID': '8542512',\n          'ReferenceType': 'background',\n          'ReferenceCitation': 'Frasure-Smith N. The Montreal Heart Attack Readjustment Trial. J Cardiopulm Rehabil. 1995 Mar-Apr;15(2):103-6. doi: 10.1097/00008483-199503000-00002. No abstract available.'},\n         {'ReferencePMID': '9274583',\n          'ReferenceType': 'background',\n          'ReferenceCitation': 'Frasure-Smith N, Lesperance F, Prince RH, Verrier P, Garber RA, Juneau M, Wolfson C, Bourassa MG. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet. 1997 Aug 16;350(9076):473-9. doi: 10.1016/S0140-6736(97)02142-9.'}]}}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000002318',\n          'ConditionMeshTerm': 'Cardiovascular Diseases'},\n         {'ConditionMeshId': 'D000006331',\n          'ConditionMeshTerm': 'Heart Diseases'},\n         {'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000003327',\n          'ConditionMeshTerm': 'Coronary Disease'},\n         {'ConditionMeshId': 'D000017202',\n          'ConditionMeshTerm': 'Myocardial Ischemia'},\n         {'ConditionMeshId': 'D000007238', 'ConditionMeshTerm': 'Infarction'},\n         {'ConditionMeshId': 'D000007511', 'ConditionMeshTerm': 'Ischemia'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafAsFound': 'Heart Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafAsFound': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafAsFound': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafAsFound': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M6549',\n          'ConditionBrowseLeafName': 'Coronary Disease',\n          'ConditionBrowseLeafAsFound': 'Coronary Disease',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'}]}}}}},\n   {'Rank': 20,\n    'Study': {'ProtocolSection': {'IdentificationModule': {'NCTId': 'NCT04050163',\n       'OrgStudyIdInfo': {'OrgStudyId': 'csho19052112001'},\n       'Organization': {'OrgFullName': 'Honya Medical Inc',\n        'OrgClass': 'INDUSTRY'},\n       'BriefTitle': 'MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction)',\n       'OfficialTitle': 'Safety and Preliminary Efficacy Study of Intravenous Administration of MiSaver® (Myocardial Infarction Saver) After Acute Myocardial Infarction, a Phase I/IIa Clinical Trial.',\n       'Acronym': 'MiSaver®'},\n      'StatusModule': {'StatusVerifiedDate': 'March 2024',\n       'OverallStatus': 'Completed',\n       'ExpandedAccessInfo': {'HasExpandedAccess': 'No'},\n       'StartDateStruct': {'StartDate': 'January 26, 2021',\n        'StartDateType': 'Actual'},\n       'PrimaryCompletionDateStruct': {'PrimaryCompletionDate': 'May 4, 2023',\n        'PrimaryCompletionDateType': 'Actual'},\n       'CompletionDateStruct': {'CompletionDate': 'May 4, 2023',\n        'CompletionDateType': 'Actual'},\n       'StudyFirstSubmitDate': 'August 6, 2019',\n       'StudyFirstSubmitQCDate': 'August 7, 2019',\n       'StudyFirstPostDateStruct': {'StudyFirstPostDate': 'August 8, 2019',\n        'StudyFirstPostDateType': 'Actual'},\n       'LastUpdateSubmitDate': 'March 27, 2024',\n       'LastUpdatePostDateStruct': {'LastUpdatePostDate': 'March 29, 2024',\n        'LastUpdatePostDateType': 'Actual'}},\n      'SponsorCollaboratorsModule': {'ResponsibleParty': {'ResponsiblePartyType': 'Sponsor'},\n       'LeadSponsor': {'LeadSponsorName': 'Honya Medical Inc',\n        'LeadSponsorClass': 'INDUSTRY'},\n       'CollaboratorList': {'Collaborator': [{'CollaboratorName': 'Chung Shan Medical University',\n          'CollaboratorClass': 'OTHER'}]}},\n      'OversightModule': {'OversightHasDMC': 'Yes',\n       'IsFDARegulatedDrug': 'No',\n       'IsFDARegulatedDevice': 'No'},\n      'DescriptionModule': {'BriefSummary': 'The objective of the present study is to establish the safety and efficacy of MiSaver® Stem Cell Treatment After a Heart Attack (Acute Myocardial Infarction)'},\n      'ConditionsModule': {'ConditionList': {'Condition': ['Myocardial Infarction']},\n       'KeywordList': {'Keyword': ['Heart Attack']}},\n      'DesignModule': {'StudyType': 'Interventional',\n       'PhaseList': {'Phase': ['Phase 1', 'Phase 2']},\n       'DesignInfo': {'DesignAllocation': 'Non-Randomized',\n        'DesignInterventionModel': 'Sequential Assignment',\n        'DesignInterventionModelDescription': 'Sequential dose escalating',\n        'DesignPrimaryPurpose': 'Treatment',\n        'DesignMaskingInfo': {'DesignMasking': 'Single',\n         'DesignMaskingDescription': 'Single/participant blinded',\n         'DesignWhoMaskedList': {'DesignWhoMasked': ['Participant']}}},\n       'EnrollmentInfo': {'EnrollmentCount': '11',\n        'EnrollmentType': 'Actual'}},\n      'ArmsInterventionsModule': {'ArmGroupList': {'ArmGroup': [{'ArmGroupLabel': 'Low Dose',\n          'ArmGroupType': 'Experimental',\n          'ArmGroupDescription': 'Cells dosage, 0.5x10^7 cells/kg body weight',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Biological: MiSaver®']}},\n         {'ArmGroupLabel': 'Intermediate Dose (aka Effective or High)',\n          'ArmGroupType': 'Experimental',\n          'ArmGroupDescription': 'Cells dosage, 1.6x10^7 cells/kg body weight',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Biological: MiSaver®']}},\n         {'ArmGroupLabel': 'Toxic Dose',\n          'ArmGroupType': 'Experimental',\n          'ArmGroupDescription': 'Cells dosage, 5.0 x10^7 cells/kg body weight',\n          'ArmGroupInterventionList': {'ArmGroupInterventionName': ['Biological: MiSaver®']}}]},\n       'InterventionList': {'Intervention': [{'InterventionType': 'Biological',\n          'InterventionName': 'MiSaver®',\n          'InterventionDescription': 'Intravenous administration of MiSaver® Stem Cell via peripheral vein access.',\n          'InterventionArmGroupLabelList': {'InterventionArmGroupLabel': ['Intermediate Dose (aka Effective or High)',\n            'Low Dose',\n            'Toxic Dose']},\n          'InterventionOtherNameList': {'InterventionOtherName': ['stem cells']}}]}},\n      'OutcomesModule': {'PrimaryOutcomeList': {'PrimaryOutcome': [{'PrimaryOutcomeMeasure': 'Incidence of Treatment Emergent Adverse Events',\n          'PrimaryOutcomeDescription': 'Number of Adverse Events',\n          'PrimaryOutcomeTimeFrame': '12 months'}]},\n       'SecondaryOutcomeList': {'SecondaryOutcome': [{'SecondaryOutcomeMeasure': 'Left ventricle stroke volume',\n          'SecondaryOutcomeDescription': 'Echocardiogram assessment on left ventricle stroke volume (volume of blood pumped from the left ventricle per beat (ml).',\n          'SecondaryOutcomeTimeFrame': '12 months'},\n         {'SecondaryOutcomeMeasure': 'End diastolic volume',\n          'SecondaryOutcomeDescription': 'Echocardiogram assessment on volume of blood in the left ventricle at the end of diastolic filling (cc)',\n          'SecondaryOutcomeTimeFrame': '12 months'},\n         {'SecondaryOutcomeMeasure': 'Left ventricular ejection fraction (LVEF)',\n          'SecondaryOutcomeDescription': 'Calculated by dividing the volume of blood pumped from the left ventricle per beat (stroke volume) by the volume of blood collected in the left ventricle at the end of diastolic filling (end-diastolic volume).',\n          'SecondaryOutcomeTimeFrame': '12 months'},\n         {'SecondaryOutcomeMeasure': 'Participants Functional Activity by NYHA Classification',\n          'SecondaryOutcomeDescription': \"The New York Heart Association (NYHA) Functional Classification is a useful tool for classifying the extent of functional limitations in patients with heart conditions. The system categorizes patients into one of four categories based on the level of limitation they experience during physical activity, with symptoms ranging from mild shortness of breath or angina to more severe breathing difficulties. The NYHA classification focuses specifically on limitations related to physical activity and provides a straightforward approach to assessing a patient's condition. By using this system, healthcare providers can quickly and easily determine the level of functional limitation in their patients and tailor treatment plans accordingly.\",\n          'SecondaryOutcomeTimeFrame': '12 months'},\n         {'SecondaryOutcomeMeasure': 'Participants Functional Activity by CCS Classification',\n          'SecondaryOutcomeDescription': 'The Canadian Cardiovascular Society grading of angina pectoris, also known as the CCS Functional Classification, is a widely used clinical tool that classifies the severity of exertional angina. It allows doctors to assess the degree of angina severity in patients, and subsequently develop a tailored treatment plan. Although there are no definitive therapy guidelines specific to each class, healthcare providers can use the CCS grading system as a framework to guide treatment planning based on the severity of angina and other individual factors such as age and the risk of major cardiac complications. By utilizing the CCS grading system, healthcare providers can ensure that patients receive personalized treatment that addresses their unique needs and circumstances.',\n          'SecondaryOutcomeTimeFrame': '12 months'}]}},\n      'EligibilityModule': {'EligibilityCriteria': 'Inclusion Criteria:\\n\\nPatients aged 20~80\\nAcute Myocardial Infarction 1 to 10 days\\nCardiac enzyme CK-MB or Troponin > 2X of high-end normal value\\nST-elevation on EKG (STEMI)\\nPresence of regional wall motion abnormality\\nLeft ventricular ejection fraction (LVEF) of ≤40%\\nHemodynamically stable past 24 hour\\nParticipants with adequate pulmonary function\\nPeripheral artery oxygen saturation ≥97%\\nKarnofsky performance status scores of ≥60.\\n\\nExclusion Criteria:\\n\\nAge <20 or >80\\nPregnant or breast feeding\\nPositive adventitious infections (such as HIV, hepatitis )\\nRevascularization via coronary artery bypass surgery is required\\nCoronary revascularization procedures is anticipated during the 6-month study period\\nSevere aortic or mitral valve narrowing\\nEvidence of life-threatening arrhythmia on baseline electrocardiogram (ECG)\\nShort of breath unable to receive PCI examination or treatment\\nMalignant tumor\\nHematopoietic dysplasia\\nSevere organ disease\\nWith less than 1 year of life expectancy\\nChronic kidney disease with CCr<20ml/min\\nKidney disease on renal dialysis',\n       'HealthyVolunteers': 'No',\n       'Gender': 'All',\n       'MinimumAge': '20 Years',\n       'MaximumAge': '80 Years',\n       'StdAgeList': {'StdAge': ['Adult', 'Older Adult']}},\n      'ContactsLocationsModule': {'LocationList': {'Location': [{'LocationFacility': 'Chung Shan Medical University Hospital',\n          'LocationCity': 'Taichung',\n          'LocationState': 'Taichung City',\n          'LocationZip': '402',\n          'LocationCountry': 'Taiwan'},\n         {'LocationFacility': 'HONYA Medical Inc',\n          'LocationCity': 'Tainan',\n          'LocationZip': '74147',\n          'LocationCountry': 'Taiwan'}]}},\n      'IPDSharingStatementModule': {'IPDSharing': 'No'}},\n     'DerivedSection': {'MiscInfoModule': {'VersionHolder': 'April 04, 2024'},\n      'ConditionBrowseModule': {'ConditionMeshList': {'ConditionMesh': [{'ConditionMeshId': 'D000009203',\n          'ConditionMeshTerm': 'Myocardial Infarction'},\n         {'ConditionMeshId': 'D000007238',\n          'ConditionMeshTerm': 'Infarction'}]},\n       'ConditionAncestorList': {'ConditionAncestor': [{'ConditionAncestorId': 'D000007511',\n          'ConditionAncestorTerm': 'Ischemia'},\n         {'ConditionAncestorId': 'D000010335',\n          'ConditionAncestorTerm': 'Pathologic Processes'},\n         {'ConditionAncestorId': 'D000009336',\n          'ConditionAncestorTerm': 'Necrosis'},\n         {'ConditionAncestorId': 'D000017202',\n          'ConditionAncestorTerm': 'Myocardial Ischemia'},\n         {'ConditionAncestorId': 'D000006331',\n          'ConditionAncestorTerm': 'Heart Diseases'},\n         {'ConditionAncestorId': 'D000002318',\n          'ConditionAncestorTerm': 'Cardiovascular Diseases'},\n         {'ConditionAncestorId': 'D000014652',\n          'ConditionAncestorTerm': 'Vascular Diseases'}]},\n       'ConditionBrowseLeafList': {'ConditionBrowseLeaf': [{'ConditionBrowseLeafId': 'M10282',\n          'ConditionBrowseLeafName': 'Infarction',\n          'ConditionBrowseLeafAsFound': 'Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M12155',\n          'ConditionBrowseLeafName': 'Myocardial Infarction',\n          'ConditionBrowseLeafAsFound': 'Myocardial Infarction',\n          'ConditionBrowseLeafRelevance': 'high'},\n         {'ConditionBrowseLeafId': 'M10543',\n          'ConditionBrowseLeafName': 'Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M12284',\n          'ConditionBrowseLeafName': 'Necrosis',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M6546',\n          'ConditionBrowseLeafName': 'Coronary Artery Disease',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M19506',\n          'ConditionBrowseLeafName': 'Myocardial Ischemia',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M9419',\n          'ConditionBrowseLeafName': 'Heart Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'M17400',\n          'ConditionBrowseLeafName': 'Vascular Diseases',\n          'ConditionBrowseLeafRelevance': 'low'},\n         {'ConditionBrowseLeafId': 'T170',\n          'ConditionBrowseLeafName': 'Acute Graft Versus Host Disease',\n          'ConditionBrowseLeafRelevance': 'low'}]},\n       'ConditionBrowseBranchList': {'ConditionBrowseBranch': [{'ConditionBrowseBranchAbbrev': 'BC23',\n          'ConditionBrowseBranchName': 'Symptoms and General Pathology'},\n         {'ConditionBrowseBranchAbbrev': 'All',\n          'ConditionBrowseBranchName': 'All Conditions'},\n         {'ConditionBrowseBranchAbbrev': 'BC14',\n          'ConditionBrowseBranchName': 'Heart and Blood Diseases'},\n         {'ConditionBrowseBranchAbbrev': 'Rare',\n          'ConditionBrowseBranchName': 'Rare Diseases'}]}}}}}]}}"
     },
     "execution_count": 85,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response = requests.get(  # GET request\n",
    "    url=\"https://classic.clinicaltrials.gov/api/query/full_studies\",  # URL of the API\n",
    "    params={  # Parameters of the request\n",
    "        \"expr\": \"heart+attack\",\n",
    "        \"min_rnk\": 1,\n",
    "        \"max_rnk\": 20,\n",
    "        \"fmt\": \"json\",\n",
    "    }\n",
    ").json()  # Parse the response as JSON\n",
    "response"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-05T12:15:16.286926Z",
     "start_time": "2024-04-05T12:15:11.356112Z"
    }
   },
   "id": "2ada1920ac41facf",
   "execution_count": 85
  },
  {
   "cell_type": "markdown",
   "source": [
    "There are many more fields in this response, but we can extract the number of studies that match our search term, and the titles and IDs of the first 20 studies."
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "bd71ebff03de2c4c"
  },
  {
   "cell_type": "code",
   "outputs": [
    {
     "data": {
      "text/plain": "2108"
     },
     "execution_count": 86,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response[\"FullStudiesResponse\"][\"NStudiesFound\"]"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-05T12:15:16.289435Z",
     "start_time": "2024-04-05T12:15:16.287588Z"
    }
   },
   "id": "3f334f5410d9a451",
   "execution_count": 86
  },
  {
   "cell_type": "code",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NCT00929994 Effects of Cardiac Rehabilitation for Individuals With Transient Ischemic Attack\n",
      "NCT00536562 Comprehensive Cardiac Rehabilitation Programming For Patients Following Transient Ischemic Attack\n",
      "NCT05230069 Assessment of a Prehospital Mobile App and Sensor Triage System to Detect Neurologic and Cardiac Emergencies: The ECHAS Assessment Study (ECHAS- One)\n",
      "NCT05090618 Preventive and Personalized Medicine (2021-2023)\n",
      "NCT00102128 Evaluation of Skeletal Myoblast Transplant for Treating Ischemic Heart Failure\n",
      "NCT05843006 SWEAT Analysis for Predicting Patient Outcome After HEART Attack\n",
      "NCT00067236 A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral PG-116800 Following a Heart Attack\n",
      "NCT01911910 Heart Attack Prevention Programme for You (HAPPY) London\n",
      "NCT01936675 Myocardial Infarction Genes (MI-GENES) Study - Using Genomic Data to Refine Risk Assessment for Heart Attack\n",
      "NCT05781087 Optical Coherence Tomography With Magnetic Resonance Angiography to Assess STEMI Non-culprit Risk\n",
      "NCT02376244 A Randomised Controlled Trial on the Efficacy of High Intensity Interval Training Compared With Moderate Intensity Interval Training for Patients Undergoing Cardiac Rehabilitation\n",
      "NCT02316119 Mechanisms Involved in the Bleeding Risk of Patients With Coronary Artery Diseased Previous Stroke or Transient Ischemic Attack in Use of Antiplatelet Therapy\n",
      "NCT00597922 Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction (AMI) Patients (VIRGO)\n",
      "NCT02905357 Heart Attack Research Program- Imaging Study\n",
      "NCT04790357 Assessment of One-shot Cardiac-cervical-intracranial MRI in the Etiological Work up of Ischemic Stroke and Transient Ischemic Attacks\n",
      "NCT01438086 A Randomised Trial Evaluating the Safety and Efficacy of a Single Low Dose of Intracoronary Insulin-like Growth Factor-1 Following Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction (RESUS-AMI)\n",
      "NCT05305911 Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition Improves Left Ventricular Function and Reduces Adverse Left-Ventricular Remodeling in High-Risk Patients With Microvascular Obstruction (MVO) Following ST-elevation Myocardial Infarction (STEMI).\n",
      "NCT00677222 A Phase I, Multicenter, Dose-Escalation Trial Evaluating the Safety of Allogeneic AMI MultiStem® in Patients With Acute Myocardial Infarction\n",
      "NCT00000533 Montreal Heart Attack Readjustment Trial (M-HART)\n",
      "NCT04050163 Safety and Preliminary Efficacy Study of Intravenous Administration of MiSaver® (Myocardial Infarction Saver) After Acute Myocardial Infarction, a Phase I/IIa Clinical Trial.\n"
     ]
    }
   ],
   "source": [
    "for study in response[\"FullStudiesResponse\"][\"FullStudies\"]:\n",
    "    print(study[\"Study\"][\"ProtocolSection\"][\"IdentificationModule\"][\"NCTId\"],\n",
    "          study[\"Study\"][\"ProtocolSection\"][\"IdentificationModule\"][\"OfficialTitle\"])"
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "b2e4e7f7b88e2af0",
   "execution_count": 87
  },
  {
   "cell_type": "markdown",
   "source": [
    "Because we have all the data in a structured format, we can easily manipulate it. For example, we can extract the list of conditions that are being studied in these trials."
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "909050587cdbbe25"
  },
  {
   "cell_type": "code",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['Transient Ischemic Attack']\n",
      "['TIA (Transient Ischemic Attack)']\n",
      "['Heart Attack and Stroke']\n",
      "['Heart Attack']\n",
      "['Ischemic Heart Failure', 'Ischemic Heart Disease', 'Ischemic Cardiomyopathy']\n",
      "['Acute Myocardial Infarction']\n",
      "['Myocardial Infarction', 'Heart Failure', 'Heart Enlargement']\n",
      "['Cardiovascular Disease']\n",
      "['Coronary Artery Disease', 'Myocardial Infarction', 'Genomic Risk Communication']\n",
      "['Coronary Artery Disease', 'ST Elevation Myocardial Infarction', 'Ischemic Heart Disease']\n",
      "['Heart Disease', 'Heart Attacks']\n",
      "['Coronary Artery Disease', 'Cerebral Stroke', 'TIA (Transient Ischemic Attack)']\n",
      "['Acute Myocardial Infarction']\n",
      "['Myocardial Infarction']\n",
      "['Ischemic Stroke', 'Transient Ischemic Attack']\n",
      "['Heart Failure', 'Myocardial Infarction']\n",
      "['Heart Attack', 'Enlarged Heart']\n",
      "['Acute Myocardial Infarction']\n",
      "['Cardiovascular Diseases', 'Coronary Disease', 'Heart Diseases', 'Myocardial Infarction', 'Myocardial Ischemia']\n",
      "['Myocardial Infarction']\n"
     ]
    }
   ],
   "source": [
    "for study in response[\"FullStudiesResponse\"][\"FullStudies\"]:\n",
    "    print(study[\"Study\"][\"ProtocolSection\"][\"ConditionsModule\"][\"ConditionList\"][\"Condition\"])"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-05T12:15:16.294529Z",
     "start_time": "2024-04-05T12:15:16.292244Z"
    }
   },
   "id": "8d26389e248e2344",
   "execution_count": 88
  },
  {
   "cell_type": "markdown",
   "source": [
    "We can even start to make some simple analyses. For example, we can count the number of studies that are being conducted in each country."
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "1ec5c213f094f994"
  },
  {
   "cell_type": "code",
   "outputs": [
    {
     "data": {
      "text/plain": "           Country  Count\n0    United States    137\n1           Canada     26\n2           France     13\n3           Poland     12\n4   United Kingdom      7\n5            Italy      5\n6          Belgium      4\n7          Germany      3\n8           Taiwan      2\n9       Kazakhstan      1\n10     Switzerland      1\n11          Sweden      1\n12          Brazil      1\n13         Ireland      1\n14     Netherlands      1",
      "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Country</th>\n      <th>Count</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>United States</td>\n      <td>137</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>Canada</td>\n      <td>26</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>France</td>\n      <td>13</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>Poland</td>\n      <td>12</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>United Kingdom</td>\n      <td>7</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>Italy</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>Belgium</td>\n      <td>4</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>Germany</td>\n      <td>3</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Taiwan</td>\n      <td>2</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>Kazakhstan</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>Switzerland</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>Sweden</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>12</th>\n      <td>Brazil</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>13</th>\n      <td>Ireland</td>\n      <td>1</td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>Netherlands</td>\n      <td>1</td>\n    </tr>\n  </tbody>\n</table>\n</div>"
     },
     "execution_count": 89,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from collections import Counter\n",
    "\n",
    "# Stores the number of studies per country\n",
    "countries = Counter()\n",
    "\n",
    "# Iterates over the studies\n",
    "for study in response[\"FullStudiesResponse\"][\"FullStudies\"]:\n",
    "    locations = study[\"Study\"][\"ProtocolSection\"][\"ContactsLocationsModule\"]\n",
    "    if \"LocationList\" in locations:  # Some studies don't have location information\n",
    "        location = study[\"Study\"][\"ProtocolSection\"][\"ContactsLocationsModule\"][\"LocationList\"][\"Location\"]\n",
    "        for loc in location:  # Some studies have multiple locations\n",
    "            if \"LocationCountry\" in loc:  # Some locations don't have country information\n",
    "                countries.update([loc[\"LocationCountry\"]])  # Increments the count of studies in this country\n",
    "\n",
    "df_countries = pd.DataFrame.from_records(countries.most_common(), columns=[\"Country\", \"Count\"])\n",
    "df_countries"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-05T12:15:16.302217Z",
     "start_time": "2024-04-05T12:15:16.295966Z"
    }
   },
   "id": "78e42eb1e0b170fa",
   "execution_count": 89
  },
  {
   "cell_type": "markdown",
   "source": [
    "We can even plot this data to make it easier to understand."
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "3ce9720482814cc5"
  },
  {
   "cell_type": "code",
   "outputs": [
    {
     "data": {
      "text/plain": "<Axes: xlabel='Country'>"
     },
     "execution_count": 90,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "text/plain": "<Figure size 640x480 with 1 Axes>",
      "image/png": "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"
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_countries.plot(x=\"Country\", y=\"Count\", kind=\"bar\")"
   ],
   "metadata": {
    "collapsed": false,
    "ExecuteTime": {
     "end_time": "2024-04-05T12:15:16.550659Z",
     "start_time": "2024-04-05T12:15:16.302669Z"
    }
   },
   "id": "614ff191d467ac3",
   "execution_count": 90
  },
  {
   "cell_type": "markdown",
   "source": [
    "## Summary\n",
    "\n",
    "In this notebook, we've learned the basics for how to interact with APIs in Python and perform some basic analysis. In the next chapter, we'll build on these concepts to show some real use-cases for these APIs.\n",
    "\n",
    "---\n",
    "[top](https://github.com/hscells/apis-for-evidence-identification)<br/>\n",
    "[next: Searching PubMed](https://github.com/hscells/apis-for-evidence-identification/blob/main/3-use-cases/3-1-searching-pubmed.ipynb)<br/>\n",
    "[previous: Using APIs via HTTPie](https://github.com/hscells/apis-for-evidence-identification/blob/main/2-how/2-3-using-apis-via-httpie.md)<br/>"
   ],
   "metadata": {
    "collapsed": false
   },
   "id": "d230e1041d3579b4"
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
